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GENERAL INTRODUCTION
Venous thromboembolism is a frequent disorder in general medical practice, since
it affects 1 to 2 out of every 1000 persons per year in the population. Considerable
progress has been achieved over the last two decades in the diagnosis and manage-
ment of deep vein thrombosis. The introduction of home treatment with low
molecular weight heparin has changed the management of venous thrombo-
embolism dramatically'. However, the tendency to treat the majority of patients
with deep vein thrombosis at home carries an increasing risk for the neglect of the
importance of the disease and its impact mediated by long-term sequelae such as
the post-thrombotic syndrome. Residual damage inflicted to the deep veins might,
together with other mechanisms, including hypercoagulable states, predispose
patients to a high risk of recurrent deep vein thrombosis, as well as to a substantial
risk of the clinical manifestation of the post-thrombotic syndrome. The clinical
presentation of the post-thrombotic syndrome may vary from minor signs, includ-
ing discomfort, pain, venous ectasia, skin discoloration, leg swelling and skin
indurations to severe manifestations including venous leg ulceration. These signs
and symptoms are clinically also known as chronic venous insufficiency. It is usu-
ally manifest within one year after the index deep vein thrombosis^"\ In the best
studies on the risk of subsequent post-thrombotic syndrome, it became apparent
that, based on the population incidence of deep vein thrombosis of the lower
extremities of 1 in 1000 per year and a 20-50% risk, approximately 3000 to 8000
patients in the Netherlands will develop a post-thrombotic syndrome, annually.
Ideally, patients who experience a deep vein thrombosis and are at risk of develop-
ing a (severe) post-thrombotic syndrome could be recognized and optimal meas-
ures could be taken to prevent this happening. Currently, we are far from this
objective. Firstly, the definition of the post-thrombotic syndrome is unclear, and
many proposed clinical scales are currently used, that have largely unknown meas-
urement characteristics. Secondly and more importantly, a better understanding of
the pathophysiological mechanisms underlying post-thrombotic complaints is
important. Venous thrombus resolves itself naturally by a slow process of
thrombolysis, organization and recanalization"*". Accelerating this process may
prevent the development of the post-thrombotic syndrome by reducing valvular
damage and residual obstruction''. In this thesis about the post-thrombotic syn-
drome, various studies on the post-thrombotic syndrome are described that high-
light the complexity of this syndrome which may seem quite simple at first glance.
These studies are dedicated to the diagnosis, prevention, and treatment as well as to
the pathophysiological mechanisms of this syndrome.
GENERA1 INTRODUCTION It
PARTI
An overall definition of the post-thrombotic syndrome is lacking; the clinical diag-
nosis is based on the findings during physical examination and the patients' com-
plaints, which together with the history of deep vein thrombosis, establishes the
presence of the disorder During the physical examination the clinical signs .is
described by Widmer remain the classical components of the post-thrombotic syn-
drome. All of the objective signs of chronic venous insufficiency that mark leg
symptoms as due to this condition are located in the skin. Hence, it is important to
have a good pictorial knowledge ot the clinical features. Only clinical signs of
chronic venous insufficiency are classified by Widmer, which makes it ditFicult to
assess the actual clinical status of the patients and to describe the potentially benefi-
cial effects of interventions.
Eventually, the need for a new definition became apparent. Therefore, a consensus
meeting held in the early 199()'s led to the CEAP classification. The consensus
meeting and broad implementation of the CEAP classification in the literature not-
withstanding, different definitions are still used in practice. In all these definitions,
clinical symptoms as well as objective signs are used.
Since the diagnosis of chronic insufficiency and thus that of the post-thrombotic
syndrome are based on clinical phenomena alone, other disorders of anatomical
structures in the leg can also give rise to those complaints. Symptoms such as leg
swelling, pain and signs of inflammation .ire found in twisting injury, primary
lymph-edema, cellulitis, erysipelas and miscellaneous other conditions of the skin,
fascia and muscles. Those conditions can mimic venous disease, in which also pain,
redness and leg swelling is found, i.e. hypodermitis, this accounts for an acute stage
of lipodermatosclerosis, or secundary lymphedema due to longstanding venous
insufficiency with dermal backflow. In chapter 2, a comprehensive guide for diag-
nosis of clinical signs is given, to get a better impression of definitions.
In chapter 3, we focus on at which point the ambulant venous pressure, (i.e. the
gold standard) should be read according to different sources. In chapter 4, clinical
definitions of post-thrombotic syndrome are compared to each other and to the
gold standard. Their accuracy in allowing for discrimination between deep vein
thrombosis and control legs, as well as the observed prevalence of the post-throm-
botic syndrome is discussed.
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PART II
The aim of treatment of patients with venous thromboembolism is not just to pre-
vent (fatal) pulmonary embolism, recurrent deep vein thrombosis, but also the
development of the post-thrombotic syndrome. In this part we focused on the pre-
vention of the post-thrombotic syndrome. In chapter 5 the results of a survey are
described that evaluated the involvement of dermatologists in the treatment of
deep vein thrombosis and post-thrombotic syndrome. In this survey, advice about
bed rest for one or more days was still given. In addition, in chapter 6, we evaluated
inappropriate hospital stay in the past for patients with venous thromboembolism.
The Dutch Appropriateness Evaluation Protocol criterion takes into account sev-
eral factors involved in decisions about bed rest in order to provide guidelines to
improve the efficiency of the hospital stay. In chapter 7 and 8, systematic reviews
are described to assess the efficacy of physical measurements in the prevention and
treatment of the post-thrombotic syndrome.
P A R T III
Deep vein thrombosis is an important cause of venous leg ulcers. In patients with
venous leg ulcers a prevalence rate for thrombophilia of 41% was found, similar to
the rate reported in deep vein thrombosis^. The case report with combined
thrombophilia, presented in chapter 9, made it plausible to hypothesize that
post-thrombotic changes are more severe because the thrombosis was recurrent,
more extensive, and possibly more resistant to endogenous fibrinolysis and
recanalization. Adequate compression therapy alone was insufficient and tended to
fail due to thrombophilia. It has been suggested that microthrombi play an impor-
tant role in the pathogenesis of progressive venous insufficiency. The influence of
venous hypertension on the vascular endothelial wall in patients with previous
deep vein thrombosis as compared to age and gender matched subjects is presented
in chapter 10.
During, the last two decades increasing progress has been made in delineating the
pro- and anticoagulant properties of the vascular endothelial wall". A simplified
schematic representation of the coagulation system is shown in figure 1. Inhibition
of thrombus formation of the endotheliuin is achieved by continuous production
of prostacyclin and nitrous oxide, which inhibit platelet activation and lead to
vasodilatation. as well as the heparin like molecule coating which enhances the
inhibition of coagulation. In addition, the vascular endothelial wall produces
pro-fibrinolytic factors and facilitates protein C activation by its surface bound
thrombomodulin. Thrombin can bind to thrombomodulin, thereby losing its
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EPCR endothclial protein C receptor
TAFI thrombin activated fibrinolysis inhibitor
PAI-1 plasmuiogcn activator inhibitor type 1
uPA urokinase type plasniinogeii activator
tPA tissue type plasminogcn activator
APO activated protein C
procoagulant properties and activating protein C. This activated protein C (APC)
forms a complex with its cofactor protein S. This complex neutralizes factors Va
and Villa, dovvnregulating the thrombin fonnation. The fibrin deposit will be bro-
ken down by the fibrinolytic system shown in detail in figure 1. The central
enzyme is plasmin, formed from plasminogen by the action of tissue-type
plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA).
Fibrinolysis is regulated by plasminogen activator inhibitors (FA I's),
CXo-antiplasmin, and by the thrombin activated inhibitor of fibrinolysis (TAFI).
In chapter 11 skin biopsies of different stages of venous insufficiency,
immunostained with vWF, PAI-1, uPA and tPA to get a better understanding of
procoagulant and fibrinolytic response, are discussed.
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A comprehensive guide to clinical diagnosis of
venous leg symptoms
Dinanda N. Kolbach and H.A. Martino Neumann
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DIAGNOSIS OF THE POST-THROMBOTIC SYNDROME
The overall diagnosis of venous signs and symptoms is chronic venous insuffi-
ciency. Chronic venous insufficiency is either the result of deep and/or superficial
valvular reflux, obstruction of the deep venous system or the combination of both
aforementioned mechanisms. Either of these mechanisms alone can lead to sus-
tained high venous pressure while walking.
The diagnosis of post-thrombodc syndrome is based on the findings made during
physical examination and from the patients' complaints, which, together with the
history of deep vein thrombosis, establishes the presence of the disorder.
To provide a better understanding of the post-thrombotic syndrome, we describe
below the skin changes and present pictures of skin signs observed during physical
examination of patients with venous complaints.
Venous circulation of the lower extremities consists of superficial and deep veins,
which are connected by communicating veins. Communicating veins
(perforantes) transport blood from the superficial to the deep venous system by
means of valves. The superficial system originates from the dorsal venous arch of
the foot. Changes observed comprise a wide spectrum of clinical severity varying
from asymptomatic venous incompetence, telangiectases, reticular veins, varicose
veins, stasis skin changes to the most severe presentation with leg ulceration.
Telangiectases (photo 1) are confluences of permanently dilated intradermal ven-
ules of less than I mm in caliber. Synonyms include spider veins, hyphen webs,
thread veins and "besenreiser varices"
Reticular veins are permanently dilated; tortuous bluish intradermal veins with a
diameter from 1 mm to less than 3 nun. Synonyms include blue veins, intradermal
varicose veins and venulectases.
Varicose veins (photo 2) are subcutaneous permanently dilated, tortuous veins
equal to or more than 3 mm in diameter in the standing position. Synonyms
include varix, varices and varicosities.
IM
A special form of teleangiectases can be seen in early stages of venous insufficiency.
It is known among dermatologists and phlebologists as corona phlebectatica
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Photo 1 Tclangiei'ta*<rv Photo 2 Vamojc veil».
Photo 3 Corona phlebectatica paraplantans.
Photo 4 Pitting edema. Photo 7 LipodcnnaUHclcrotn, leg ulcer.
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Photo 5 I )erinatite jaunr d'oirc.
Photo 8 HypoiU-nmtis, i-dcin.i. Photo 9 Atrophie blanche.
PICTOR.I.M GUIDE 1*)
I'hoto 6
1 izcnu cruris.
Pholo 10
I Idled venous leg ulcer
(war).
Photo 11
Venous leg ulcer, marked
dcsquamation.
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Photo 12 Onychogryphosis. Photo 13 Acroangiodennatitis.
Photo 14 Lymph-cdcma, skin sign according
to Stemmer.
Photo 15 Supi.ipubu v.ii Photo 16 Superficial abdominal vances.
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paraplantaris (photo 3). Synonyms include nulleolar flare and ankle flare. Corona
phlebecutica paraplantans are tan-shaped intradennal telangiectases found on the
medial or lateral sides ot the foot. This sign can be seen in combination with ery-
thema. These two skin changes are seen in early stages of venous insufficiency.
They are often accompanied by subdinical edema.
Edema is an increase in the volume of fluid in subcutaneous tissue characterized by
indentation with pressure (photo 4). Venous edema usually occurs in the ankle
region, but it may extend to the leg and foot.
By pigmentation is generally IIUMIU a brownish pigment, a darkening of the skin,
usually in the ankle region. Dermatite jaune d'ocre (photo 5) is a yellow-brown
colored pigmentation that appears before more extended pigmentation occurs.
Eczema cruris (photo 6) is defined as erythematic, blistering, weeping, or scaling
eruption of the skin of the leg often located near varicose veins. It mostly appears in
more advanced stages of venous insufficiency, synonyms include stasis dermatitis.
ADVANCED CHRONIC VENOUS INSUFFICIENCY
Lipodennatosclerosis (photo 7) is a localized chronic induration of the skin, char-
acterized by fibrosis and chronic inflammation of the skin, subcutaneous tissues and
sometimes the fascia. Hypodermitis (photo 8) is an acute stage of lipodermato-
sclerosis, characterized by diffuse reddening and tenderness of the skin. Confusion
with erysipelas or cellulitis can occur, but lymphadenitis and fever accompany
these conditions. Sometimes even recurrence of deep vein thrombosis is diagnosed
because of tenderness, pain, redness and edema. Compression echography can be
interpreted wrongly, because an old thrombus can be seen in patients with prior
deep vein thrombosis. Nothing is known about laboratory measurements such as
d-dimer in these cases; it might be increased because of the acute phase reaction in
the skin.
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Atrophie blanche (photo 9) or white atrophy are circumscribed, whitish and atro-
phic skin areas surrounded by dilated capillary spots and some hyperpigmentation.
Also scars of healed ulcers (photo 10) can give the same impression, but must be
excluded in this definition.
Venous ulcer (photo 7, 11) is a chronic defect of the skin that fails to heal spontane-
ously and which is caused by chronic venous insufficiency.
sy»NS o/V/iron/V WHOM; iMSM/firi'«icy
In advanced chronic venous insufficiency, other changes in skin and skin appendi-
ces are also found, such as marked desquamation (photo 10), nail changes (photo
12), acroangiodermatitis (photo 13) and secondary lymph-edema (photo 14).
Extensive deep vein thrombosis and subsequently persistant obstruction of major
veins give rise to collateral formation. This can be seen as suprapubic varices (photo
15) usually one large vessel along the superior margin of the pubic bone, which
crosses to the opposite site. In this way de Palma reconstructed a new venous route
to relieve a deep vein insufficiency, so another name for it is spontaneous De
I'alina. Other collaterals are found as extensive superficial abdominal varices (photo
16). The presence of extensive collateral formation in the vertebral and the
paravertebr.il venous system in aplasia of the inferior vena cava can be shown by
Magnetic Resonance Imaging
23
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Interobserver variation in reading ambulant venous
pressure from invasive venous pressure curves
Dinanda N. Kolbach'•-. I'ieter Letters'. H. A. M.irtmo Neumann'.
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Dt'p.irtmfiits of 'l)frni.itoU>^\. CÜiun.il Lpuk-miolo^y .mil Mi-ilic.il
Assessment. Academic Hospital Maastricht, Department of 'Dermatology,
Erasmus Medical Centre. Rotterdam. 'Emeritus Head of the Dermatological
Department. University Medical Center St R.idboud. Nijnie^en. The
Netherlands. Enu-ntiis Head of the Dermatological Department of the
Wilhelminen Hospr City of Vienna. Austria.
24 CHAPTER 3
ABSTRACT
To assess the intcr-obscrver variation between 3 experts by reading AVP from graphs of
intravenous pressure measurements.
Invasive venous pressure measurement in a dorsal foot vein was performed in 38 legs
with and 50 legs without a history of objectively diagnosed proximal deep vein thrombosis during a
standardized exercise. Three experts independently estimated AVP from the pressure curves. Pres-
ence of post-thrombotic syndrome was determined for each leg according to the criteria of
Prandoni.
For each observer the association between the presence of post-thromboric syndrome and
the level of AVP readings was statistically significant (p < 0.001). Median AVP readings by the 3
experts for all graphs were 51.4, 43.0 and 32.2 mmHg, showing systematic differences in the way
AVP was estimated. The random interobserver variation was expressed as the standard deviation of
the differences in readings by a pair of experts. For the 3 pairs these standard deviations were 13, 10
and 10 mmHg, respectively.
Even though AVP readings from the 3 experts in this study seemed as correct as those
reported in the literature, there is proof of large systematic and random errors in estimating AVP
from intravenous pressure measurement graphs. It is likely that other phlebologists would show at
least similarly large measurement error. In order to improve the situation, clear reading instructions
should be devised, based on consensus between experts in the field of intravenous pressure measure-
ments.
INTRODUCTION
Chronic venous insufficiency is characterized by symptoms or signs produced by
venous hypertension. Sustained high venous pressure is the result of failure of the
calf and foot muscle pump to adequately empty the veins of the lower extremity.
This can be caused by valvular incompetence or destruction, venous obstruction,
calf or foot muscle dysfunction or any combination of these factors.
Anatomical and functional information can be obtained by Duplex ultrasono-
graphy, which however, does not provide a quantitative measure of the calf and
foot muscle pump function. Invasive ambulators' pressure measurement is there-
tore considered the "gold standard' for the evaluation ot other techniques to quan-
tity the muscle pump function'.
In a study about prognostic factors for the development of the post-thrombotic
syndrome we used a plethysmographic technique* that was reported to have been
validated against the 'gold standard'*. When we tried to replicate this validation, it
became apparent that reading the ambulant venous pressure (AVP) from the graphs
was not as clear-cut as is suggested in textbooks'*"". To evaluate the importance of
the consequent measurement error, we assessed the interobserver variations between
3 experts in determining the ambulant venous pressure in venous pressure curves.
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METHODS
In order to have a wide range of ambulant venous pressures, measurements were
done in one or both legs of patients with a history of deep vein thrombosis (DVT)
and in healthy volunteers. The patients who entered into the study had experi-
enced their DVT more than one year before and the diagnosis of a proximal DVT
had been confirmed by compression ultrasonography or ascending venography.
Volunteers did not have any symptoms and/or signs of DVT or chronic venous
insufficiency. Only mobile subjects were included. This study is part of a larger
project that was approved by the institutional ethical review board of the Aca-
demic Hospital Maastricht. All subjects gave informed consent.
Venous pressure was measured continuously using a 21 gauge (0.8 nun) butterfly
needle (VYCJON microflex ref 246.08) which was inserted into a vein on the dor-
sum of the foot**''*. The needle was connected to a computer via a pressure moni-
toring set (Edwards life sciences ref T100200A) and an amplifier. Pressure readings
were taken every 2 msec and stored in the computer. Pressure versus tune graphs
were visible on the computer screen and were printed out. Recordings of about 60
sec were made, starting with the subject in standing position while holding onto a
frame. After stabilization of the pressure the subject w.is asked to make 10 tiptoe
movements at the rate ot 1 per 1.5 seconds, synchronously with a metronome.
Then the subject had to stand still again until venous pressure had stabilized. If pos-
sible, the exercise was repeated once or twice. Some subjects participated in more
than one measurement session.
Printed graphs of the invasive venous pressure measurements were sent to three
experts (MN, JK. and HP). These experts are phlebologists and they have ample
experience with the measurement of intravenous pressure. They independently
estimated AVP from the graphs.
Patients after objectively documented DVT were scored concerning the severity
of post thrombotic syndrome (PTS) according to the critera of Prandoni'•*•'*.
Symptoms (pain, cramps, heaviness, pruritus, and paraesthesia) and signs (pretibial
edema, induration of the skin, hyperpigmentation, new venulectasies, redness and
pain during calf compression) were graded as absent (0), mild (1), moderate (2), or
severe (3). A total score of more than 5 on two consecutive visits and/or the pres-
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ence of venous ulcer were considered as indicative of PTS. None of the volunteers
had any symptoms or signs of FTS or chronic venous insufficiency and they were
therefore classified as not having FTS.
AVF estimates based on all graphs from both the same and from different measure-
ment sessions were considered as independent observations for the purpose of
measuring inter-observer variation. For comparison of the distributions of AVP
values for legs with and without symptoms of FTS the lowest of all available AVP
readings on the leg involved was chosen.
Because the distributions of AVP estimates were clearly not normal, the median
and inter-quartile ranges are reported. Wilcoxon's U test was used for statistical
testing of difVerences between subgroups. Bland -Altman plots'^ including least
squares regression lines are made to show the relationship of the difference in AVF
measurements between 2 experts as a function of the level of AVF.
SPSS 1 1.0 was used for statistical data analyses.
RESULTS
A total of 108 sheets were printed with 187 interpretable graphs from 87 legs. In
127 of these curves, AVF was estimated by all 3 experts; in 46 graphs by 2 experts;
anil in 14, by only »»lie expert. For the purpose of another analysis for which the
same intravenous pressure measurements were used, a tourniquet was applied in 11
measurement sessions to eliminate the influence of refilling from superficial veins.
Of the 87 legs, 31 were diagnosed with PTS. According to the readings by the 3
experts (expl, exp2, exp3), legs without the post-thrombotic syndrome had a
median AVF (inter-qu.irtile range) of 39.7 mniHg (23.6; 54.6), versus 29.1 mmHg
(18.0; 45.6) and 23.6 mmHg (I 1.2; 36.0). For the legs with FTS, these values were
64.5 mmHg (51.5; 81.8). 60.8 mmHg (40.9; 70.7) and 45.9 mmHg (34.1; 64.5),
respectively. For all experts the difference in AVF readings between PTS legs and
non-PTS legs was highly statistically significant (p < 0.001).
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The medians of the AVP (inter-quartile range) in the 127 graphs that were scored
by all three experts were 51.4 mmHg (33.5; 70.7), 43.0 mmHg (23.6; 63.2) and
32.2 mmHg (16.1; 4S.4) respectively. In figures la to 1c Bland Altman plots are
shown for each of the three combinations of observers. The level of the regression
line above the x-axis is a measure for the systematic difference in readings. The
regression lines also show that the difference between the readings of the observers
tended to be larger for higher values of AVP, i.e. an increase in the difference
between readings of expl and exp3 of 0.05 mmHg (95% confidence interval:
-0.02; 0.11) per mmHg AVP. For the other comparisons the slope of the regres-
sion line is 0.16 (expl vs exp2; 95% CF: 0.05; 0.28) and 0.10 (exp3 vs exp2; 95%
CI: 0.02; 0.18). The vertical scatter of the dots indicates the degree to which the
error is non-systematic (random) which can be expressed as the standard devia-
tions: 13, 10 and 10 mmHg, respectively.
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Exclusion of the graphs in which a tourniquet was used gave virtually the same
results (data not shown).
A'rtonW dMd/ys«
We did not do a formal analysis of the characteristics of graphs that were associated
with the level of inter-observer variation. Based on a subjective impression, we
selected 4 graphs in which there was quite small or quite large disagreement
between the experts. In figure 2, AVP readings from the three experts were almost
equal: 23.6, 19.8 and 18.6 mmHg, respectively (figure 2a) and 74.4, 74.4 and 75.6
mmHg, respectively (figure 2b). In figure 3, AVP values were quite different: 55.8,
9.9 and 16.1 mmHg, respectively (figure 3a) and 91.8, 24.8, and 89.3 mmHg,
respectively (figure 3b). From these pictures it seems that variation tends to be
smaller when the amplitude of the pressure spikes is small. When curves with large
anil small amplitudes were sorted by estimation, only in about one quarter of the
graphs was the amplitude judged to be 'small'.
DISCUSSION
In this study we determined the interobserver variation in reading the ambulant
venous pressure (AVP) from graphs of intravenous pressure measurement in the
legs ot subjects with and without a history of deep vein thrombosis. The AVP as
estimated by three experts seemed as correct as reported in the literature regarding
the associated PTS"'"'". This supports the fact that the assessors in our study have
the same level of expertise as other authors in the field of intravenous pressure mea-
surement.
However, when comparing the readings of the 3 experts, there turned out to be
systematic differences of about 10 and 20 mmHg. These systematic differences
become larger with increasing intravenous pressure. In addition to these systematic
differences, there was a large random variation. As there is no information about
the 'true' intravenous pressure and there is no clear indication that any one of the
experts is better than the others, it is likely that these differences reflect systematic
and random measurement errors of all 3 observers.
These results merely reflect the differences in reading AVP from the graphs of
intravenous pressure measurement. However, there are many more sources of sys-
tematic and/or random error, such as problems with proper insertion of the needle
and incomplete compliance of the subject with the instructions given during the
measurement session''. Therefore the measured interobserver variation is likely to
be an underestimate of the total variation, when including all sources of error.
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ao
Figure 2 a-b Ambulant venous pressure measurement graphs in which all expert gave a «null
disagreement of the reading of AVI'.
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Figure 3 «-b Ambulant venous pressure measurement graphs in which the experts had a quite
large disagreement of the reading ot AVP.
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For any measurement, correct test results are needed for proper communication
between colleagues, both in daily patient care and through the medical literature.
Also, when using intravenous pressure measurement as the gold standard for vali-
dation of non-invasive techniques, such measurement should be as free from sys-
tematic and random error as possible. A first step in that direction would be the
standardization of the method for reading the graphs.
When searching through phlebological textbooks and the relevant medical litera-
ture, we found no clear instructions for estimating AVF from graphs. Belcaro and
co-workers do state that the AVP should be read as the lowest value of the pressure
curve''. However, as shown in figure 4, they themselves mark the AVP somewhat
above the lowest point. The graphs presented in the literature are almost exclu-
sively based on measurements in healthy subjects where the amplitude ot the pres-
sure spikes is relatively small . An example of these graphs is shown in figure 5;
these graphs are much easier to interpret than those from most patients with a mus-
cle pump function problem. Therefore the lack of clarity in the reading instruc-
tions will lead to much larger inter-observer variation in estimating AVF in daily
patient management.
Because there is no 'true' value of intravenous pressure available, improved reading
instructions should come from a task force of experts in the field of intravenous
pressure measurement. Proposed instructions should be evaluated for clarity and
strength of association with the clinical severity of the venous insufficiency. More-
over, such instructions should pertain to all the pressure curves that will be
encountered in daily practice and not only to the easy to interpret graphs from
healthy volunteers. Among the issues that need to be taken into account are criteria
for judging the adequacy of the curves for valid reading of AVF and the interpreta-
tion of the pressure spikes in relation to the relevant level of intra-venous pressure
for diagnosis of existing or development of new chronic venous insufficiency.
CONCLUSION
Even though the individual AVP readings from the 3 experts in this study seemed
as correct as those reported in the literature, there is also proof of large systematic
and random errors in estimating AVF from intravenous pressure measurement
graphs. It is likely that other phlebologists would show at least similarly large mea-
surement error. In order to improve the situation, clear reading instructions should
be devised. These should then be evaluated for intra- and interobserver variability
and strength of association with the clinical syndrome. Then a justifiable, data
driven, consensus between experts in the field of intravenous pressure measure-
ments could be reached.
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Definitions of the post-thrombotic syndrome
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ABSTRACT
For the diagnosis of deep vein thrombosis (DVT) accepted diagnostic criteria exist.
However, no uniform definition for the diagnosis and treatment of the post-thrombotic syndrome
(PTS) exists. We examined the various definitions of PTS that are used and their relationships with
invasive venous pressure measurement.
Patients with ultrasound documented DVT underwent a clinical evaluation of both
lower extremities, in which five clinical definitions to grade PTS were used. Evaluated were the
definition of Widmer, the CEAP classification, the Venous Clinical Severity score (also without
compression therapy), and the definitions according to Prandoni and Brandjes. Comparison of
none, nuld-to moderate and severe scoring was done with invasive ambulant venous pressure mea-
surement.
In total 124 patients were enrolled, of whom both legs were evaluated. Thirteen patients
had bilateral DVT and 9 patients had an ipsilateral recurrent DVT. In the DVT legs, 10 (7%) to 29
(21%) were defined as severe PTS, compared to 0 to 4 (4%) in the control legs. Mild-to-inoderate
PI'S in the DVT legs ranged from 23-49%, compared to 13-34% in the control legs. Overall, the
presence of any PTS in the DVT legs varied from 3()% (VCS without compression) to 66%
(Brandjes). The scoring systems of Brandjes and VCS showed a tendency towards more legs to be
defined .is severe PTS. Absolute frequencies of PTS in DVT legs were highest for the classifications
according to Widmer. 1'r.indom and Brandjes. Differences in proportions of any PTS calculated
between I )V I and control legs varied from 18 to 39%, while odds ratios varied between 2.2 and 5.2
for the dillereut definitions.
The CF.AP classification and definition of Brandjes show a moderate relation to Widmer, K = 0.53
and K ~ 0.52, respectively. The VCS shows in .ill comparisons a poor correlation (K 0.22-0.41).
Pr.iiulom lias a moderate correlation with most definitions (K 0.40-0.44).
C'CMI/K.VIOH Although all clinical definitions of PTS were highly statistically significantly associated
with the gold standard, mvasively determined ambulant venous pressure, their ability to discrimi-
nate between I >VT ami control legs as well as the observed prevalence of PIS differed substantially.
The definition that combined good discriminatory power with a plausible correlation to the gold
standard was the definition ot PIS according to Prandoni. Since this definition has known measure-
ment properties, it seems to be the definition of choice for future studies, especially if criteria for the
grading of individual elements of the scorings systems were to be made explicit.
BACKGROUND
For the diagnosis of deep vein thrombosis (DVT) accepted diagnostic criteria
exist ' . However, the definition, and thus the identification of the post-throm-
botic syndrome (PTS) remains a challenge. Several means of measuring and classi-
fying chronic venous disease exist, most of which are based on clinical signs and
symptoms* . Only a few definitions exist specifically for the post-thrombotic syn-
drome, a tonn coined for the long-tenn local complications after an episode of
deep vein thrombosis. For the evaluation of methods to prevent and treat PTS, it is
crucial that the outcome of the disease be objectively documented.
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The fundamental pathophysiologic disturbance found in patients with severe leg
symptoms or signs alter deep vein thrombosis is sustained venous hypertension,
which results from valvular incompetence, outflow obstruction, calf muscle dys-
function, or a combination of these". Sustained venous hypertension can be mea-
sured with invasive venous pressure measurement, which can be regarded as the
gold standard, since it directly measures the pressure in the venous system of the
lower extremity. However, this technique requires special equipment, is invasive,
time-consuming and cumbersome. On the other hand non-invasive equivalents
are insufficiently validated. In order to shed some light on the similarities and dif-
ferences between the various definitions of PTS that can be used and their relation-
ship with invasive venous pressure measurement, this study was conducted on a
group of patients who had previously experienced a deep vein thrombosis.
METHODS
Patients with a documented deep vein thrombosis diagnosed by compression
ultrasonography or phlebogr.iphy between 1991 and 2<M)| were asked by letter to
participate in our study of PTS. Exclusion criteria for participation in the clinical
evaluation were diabetes mellitus, coexistent arterial disease and immobility. The
current evaluation is part of a larger study that was approved by the institudoiial
review board. Written informed consent was obtained from all patients prior to
study entry. Included patients underwent a physical examination of the lower
extremities by the clinician. For this purpose a standardized form was used that
included items as defined in the various scores for PTS as well as a thorough
dermatologic description of the legs.
Scomy» system off/iepoif-f/irowi/jonV synrfroMif
At the baseline visit the physician examined the patient's legs and classified the clin-
ical categories and severity of PTS using the different scoring systems. The five dif-
ferent scoring systems: Widmer classification, the CEAP classification, the venous
clinical severity (VCS), classification according to Prandoni and lirandjes, are pre-
sented in tables la-le. The scoring according to Widmer was meant to classify
chronic venous insufficiency and took only objective signs into account, these
were graded classes I, II and III""*. Another system of scoring venous diseases is the
CEAP classification devised in 1994 by the committee of the American Venous
Forum, the North American Society of Phlebology in co-operation with the
European Societies of Phlebology and published widely in many languages'".
CEAP classification was developed to obtain comparison of diagnosis and treat-
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Table la Classification of Chronic Venous Insufficiency according to Widmcr
Symptom
Class I Ankle flare
Subclinical edema
Class II Edema
Pigmentation
Lipodermatosclcrosis
White (»kin) atrophy
Class III Leg ulcer
Leg ulcer in (he past
Table lb CEAI'-classification as developed by the American Venous Forum and North American
Society of l'hlcbology in co-operation with the European Societies on l'hlebology.
Clinical signs Class 0 No visible or palpable signs of venous disease
Class I Tcleangicctascs or reticular veins
("lass 2 Varicose veins
("lass 3 Edem.i
("lass 4 Skin changes ascribed to venous disease
Class 5 Skin changes as defined above with healed ulceration
Class 6 Leg ulceration. skin changes as defined above
Etiologic classification Congenital, primary, secondary
Anatomic distribution Superficial, deep, or perforator, alone or in combination
I'jthophysiologic dysfunction Reflux or obstruction, alone or in combination
inont in patients with venous diseases; the scoring of clinical symptoms represented
a progressive gradation ot disease severity (CO-6). Based on the best usable ele-
ments of the CEAP system, the Venous Clinical Severity score (VCS) has been
developed to form a quantifiable system with gradable elements that could change
in response to treatment . It consists of nine clinical characteristics of chronic
venous disease graded from 0 to 3 (absent, mild, moderate, severe) with specific
criteria to avoid overlap or arbitrary scoring. Zero to three points is added for dif-
ferences in background conservative therapy (compression and elevation) to pro-
duce a 30 point-inaxinuini tlat scale. Threshold values for the VCS were vali-
dated' . Absence of disease was defined by scores of 3 or less and presence of severe
disease defined by scores 8 or more. The scoring system of Prandoni assessed five
symptoms and six signs, in which each item could be scored from 0 to 3' . For each
item, the investigators assigned a score of 0 (not present or minimal) to 3 (severe).
A total score of more than 14 or the presence of a venous ulcer indicated severe
post-thrombotic syndrome. Five to 15 indicated mild post-thrombotic syndrome.
The scoring according to Brandjes had an equivalent system of objective symptoms
and subjective signs, but these were graded as absent or present''. Brandjes scoring
Table lc Venous Clinical Severity (VCS) score
Attribute Absent = 0 Mild= Moderate = 2 Severe = 3
Run None
V.incose veins* None
Venous edemaf None
Skin pigmentation^ None or focal, low
intensity (tan)
lnti.mimation
Induration
No. ot active ulcers
Active ulceration.
duration
Active ulcer. sue§
Compressive therapy
None
None
0
None
None
Not used or not
compliant
Occasional, not restricting activity
or requiring analgesics
Few, scattered: branch VV's
Evening ankle edema only
Diffuse, but limited in area and old
(brown)
Mild celluütis, limited to marginal
area around ulcer
Focal, circununalleolar (< 5 cm)
1
< 3 mo
< 2-cm diameter
Intermittent use of stockings
Daily, moderate activity limitation.
occasional analgesics
Multiple: CiS vancote veins confined
to calf or thigh
Afternoon edema, above ankle
Diffuse over mo« of gaiter
distribution (lower 1 /3) or
recent pigmentation (purple)
Moderate cellulitis. involves most
of gaiter area (lower 1 /3)
Medial or lateral, leu than lower
third of leg
2
> 3 mo, < 1 y
2- to 6-cm diameter
Wean elastic stockings most days
Daily, severe limiting activities or
requiring regular use of analgesic!
Extensive: Thigh and calf or CiS and
LS distribution
Morning edenu above ankle and
requiring activity change, elevation
Wider distribution (above lower
1 /3) and recent pigmentation
Severe cellulitis (lower 1/3 and
above) or significant venous eczema
Entire lower third of leg or more
> 2
Not healed > I y
> 6-cm diameter
Full compliance: stockings +
elevation
•"V.incose" veins must be > 4-mni diameter to quality so that diferentianon is ensured between Cl and C2 venous pathology.
"t" Presumes venous origin by characteristics (eg. Brawny [not pitting or spongy] edema), »nth significant effect of ttanding/Umb elevation and/or other clinical
evidence ot venous etiology- (le. varicose veins, history of DVT) Edenu must be regular finding (eg. dairy occurrence;. Occasional or mild edema docs not
quality.
t Focal pigmentaoon over varicose veins does not quality.
§ Largest dimension diameter of largest ulcer
| | Sliding scale to adjust for background differences in use of conipressive therapy.
CS. Greater saphenous; LS, lesser saphenous. •<
2
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Table Id Scoring system of PTS according to Prandoni
Symptoms Sign*
Pain Prctibial edema
Cramps Induration of the skin.
Heaviness Hyperpigmcntation
Pruritus New venous ectasia
Paraesthesia Redness
Pain during calf compression
Leg ulceration
For each item a »core of 0 (= no or minimal) to 3 (severe) is assigned. A total score 5-14 is a mild-to
moderate ITS, a score of <> 15 or a leg ulcer is always severe PTS
Table 1e Scoring system according to Brandjes for mild-to-moderate and severe post-thrombotic
syndrome.
Mild-to-modcrate ITS (score £ 3 including one objective criterion)
Subjective criteria
Symptoms
Objective criteria
Signs
Spontaneous p.iin in calf
Spontaneous pun in thigh
I'.im in (.ill on standing/walking
I'.Illl Ill (I l lgl l Oil M.HRlMJ^, » . l i k i n
lulcm.i of foot/calf
"1 Icivmess" of leg
("alf circumference increased by I cm
Ankle circumference increased by 1 cm
Pigmentation
Newly formed varicosis
Phlebitis
Severe ITS (score 2 4)
Subjective criteria
Symptoms
Objective criteria
score Signs
Spontaneous pain and pain on
standing/walking
r.ili'in.i of calf
Impairment of duly activities
Calf circumference increased by 1 cm 1
1
1 Pigmentation, discolouration, and venectasia 1
1 Venous ulcer 4
is done with separate scales for mild-to-moderate and severe post-thrombotic syn-
drome. Mild-to-moderate PTS was defined as score 3 or more including one
objective criterion. Severe post-thrombotic syndrome consisted of a score of 4 or
more.
A 21 gauge butterfly needle was inserted into a vein on the dorsum of the foot and
connected through a pressure transducer and an amplifier to a computer system.
The pressure transducer was stabilized at the same height as the inserted needle on a
flexible standard. The patient stood while holding to a frame in order to avoid con-
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tractions of the calf muscles. The ambulant venous pressure (AVI*) was recorded
after a short, standardized exercise regimen (10 tiptoe movements performed at the
rate of one per 1.5 second). At the end of the exercise the patient remained still,
until stable recovery of the standing venous pressure. Then the exercise was
repeated once again. The lower of the two repeated measurements of AVP was
recorded.
77irw/io/<fc O/'MO, »m7</-fc>-»i<H/cr«if«' <IN</ sorrr P7"S
To evaluate the relationship between the different scoring systems, thresholds for
scoring of no, inild-to-moderate and severe PTS are given. In definition of thresh-
olds for PTS severity, Widmer class 0 represents no disease, Widmer classes I and II
are considered inild-to-moderate PTS and Widmer class III severe ITS. In defini-
tion of thresholds for PTS seventy of the CEAP clinical classification, CEAP classes
0 and 1 are considered no PTS, CEAP classes 2 and 3 are considered to represent
mild-to-moderate PTS and CEAP classes 4 through 6 severe PTS'. Thresholds for
venous disease of the VCS score are used similarly for PTS. Absence of disease
defined by scores of 3 or less is considered no PTS, score 4 through 7 represents
mild-to-moderate PTS and a threshold of 8 or more is considered severe PTS.
Since stockings .ire routinely described in our patients with DVT, the use of stock-
ings would be a measure of compliance rather than disease. Therefor, we made a
second group of VCS scores in which we excluded compression therapy from the
scoring. The thresholds were the same as for VCS, only the total score after exclu-
sion of therapy produced a 27 point-maximum flat scale. Prandoni and Hrandjes
had already graded in their classification system for no, mild-to-moderate and
severe PTS.
Descriptive statistics were calculated for the separate groups. Differences in pro-
portions of any PTS between DVT and control legs were calculated and both
expressed as absolute differences and odds ratio with a 95% confidence interval.
Inter-observer agreement, differences between scorings systems and invasive
venous pressure measurement were assessed by the weighted kappa test (K) for the
classification of the seventy of the PTS. Values for K of more than 0.75 usually rep-
resent excellent agreement beyond chance, K values between 0.40 and 0.75 fair to
good agreement and K values less than 0.40 poor agreement'*. One-way AN( )VA
was perfonned, with the ambulant venous pressure measurement as vanable of
outcome and the different sconng systems as experimental variable. All data analy-
ses were performed using the SPSS-PC software package, version 11.3.
T ^ U 2 Proponion of legs d e f i n ^ d a s j * ^ ™ ^ ™ * o ™ according to the Cerent denn,oons_
Post-thrombodc syndromeDVT legs (n=13T)Post-thrombonc syndrome
No
Widmet 0, I-II*. »I
OEAP 0-1.2-3**, 4-6***
VCS 0-3, 4-7. >8
VCS without therapy
0-3, 4-7, 28
1'randoni
Brandjes
37 (42)
71 (52)
63(46)
95 (69)
54 (39)
47(34)
Mild-to- Severe No
moderate
67 (49)
48 (35)
33 (39)
32 (23) 10 (7)
67 (49) 16 (12)
61 (45)
Mild-to-
moderate
97(87)
85(77)
8K73)
14(13)
23(21)
25(23)
Severe
0
3(3)
5(5)
Absolute Differences
in proponion ot
anyPTS
% (95% CI)
22% (9-35%)
18% (5-31%)
35% (23-46%)
Odds Ratio for
anyPTS
(DVT vs. control)
OR (95% Cl)
-_— —
2.5 (1.4-4.3)
2.2(1.3-3.9)
5.0 (2.7-9.4)
^ 1 0 - „ 25.on».,. ,7 »ft ; "CBAP * . « B-„„.I. 37 PVT: d . 2 : 22 » „ „ , . „ DVT, - « - «
18% (7-27%) 3.1(1.5-6.3)
37% (24-48%) 5.0(2.8-9.1)
39% (26-50%) 5.2 (2.9-9.3)
2 control. 5 DVT; class 5: 1 control, 9 DVT.
l)VT(n=137)
Prandom
VCS without therapy
ves
CEAP
Widnier
Kappa (95% Cl)
0.52 (0.40 -0.64)
0.44 (0.29-0.58)
0.33 (0.21-0.46)
0.24(0.10-0.38)
0.53 (0.40-0.65)
CEAP
Kappa (95% Cl)
0.54 (0.43-0.66)
0.42 (0.29-0.56)
0.39 (0.25-0.53)
0.27 (0.12-0.41)
VCS
Kappa (95% Cl)
0.22 (0.09-0.36)
0.41 (0.28-0.55)
VCS (without therapy)
Kappa (95% Cl)
0.23(0.11-0.34)
0.31 (0.19-0.43)
Prandom
Kappa (95% Cl)
0.40 (0.27-0.53)
Table 4 Mean ambulant venous pressure (AVP) measured in 76 le^ compared wiih the definitions for post-thrombooc syndrome.
Mean AVP (±sd) Normal AVP Mild increased AVP. Increased AVP. i.e. One way Companion of
i.e. 30 thru 40 mm Hg 40 mniHg thru higher ANOVA agreement
p-value Kappa (95% Cl)
0-29.9 mniHg
n=36 n=15 n=25
Widmer 0
Widmer 1-11
Widmer 111
Cup 0-1
Ceap 2-3
Ceap 4-6
VCS 0-3
vc:s 4-7
VGS 8 thru higher
VGS without therapv
0-3
4-7
8 thru higher
Praiuioni 0
Prandom 1
l'r.mdotu 2
Ur.ind|cs 0
Brandies 1
Brandies 2
38
34
4
47
24
5
40
27
9
57
17
• >
42
30
4
39
26
II
28.1 (±17.4)
40.4 (±20.4)
66.4 (±17.0)
31.2 (±16.7)
37.5 (±23.4)
67.9 (±15.1)
27.5 (±16.1)
44.4 (±20.1)
45.4 (±28.5)
32.2 (±18.5)
41.5 (±21.9)
81.8 (±11.4)
29.0 (±17.3)
40.8 (±21.1)
66.4 (±17.0)
26.3 (±14.7)
43.6 (±20.9)
49.8 (+24.8)
25
11
0
26
10
0
25
7
4
30
6
0
26
10
0
27
7
i
6
9
0
10
5
0
8
6
1
11
4
0
8
7
0
7
14
4
II
9
5
7
14
4
16
7
2
8
13
4
4
14
7
< 0.001 0.30(0.11 to 0.49)
< 0.001 0.22 (0.10 to 0.41)
0.001 0.21 (0.20 to 0.41)
0.001 0.13 (-0.07 to 0.35)
< 0.001 0.27 (0.07 to 0.46)
<0.00» 0.35 (0.16 to 0.55)
z
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Figure 1 «-f Anibnl.int venous pressure (nunHg) in legs classified for the different definitions.
AVP = •; mean = -
DEFINITIONS OF POST-THROMHOTIC SYNDROME!
RESULTS
In total 124 patients were enrolled, 54 men (mean age: 57113 years) and 70
women (mean age: 47±13 years). Thirteen patients had bilateral DVT and 9
patients had had an ipsilateral recurrent DVT. The median time elapsed since the
first DVT was 6 years, interquartile range 3 to 9 years.
The classification of the leg status according to the clinical definitions is given in
table 2. In the DVT group, 10 (7%) to 29 (21%) logs were defined as severe ITS.
compared to 0 to 4 (4%) in the control legs. Mild-to-moderate ITS in the DVT
group ranged from 23% to 49%, compared to 13% to 34% in the control group.
Overall the presence of any ITS m the DVT group varied from 30% (VCS with-
out compression) to 66% (Brandjes). The scoring systems of Brandjes .uui VCS
showed a tendency towards more legs being defined as severe ITS. Absolute fre-
quencies of ITS in DVT legs were highest for the classifications according to
Widmer. I'randoni and Brandjes. I )irfcrences in proportions of any ITS calculated
between DVT and control legs varied from 18% to 39%, while odds ratios varied
between 2.2 and 5.2 for the different definitions.
Table 3 shows the measurement of agreement between the different scoring sys-
tems for the 137 legs with documented DVT. The CEAP classification and defini-
tion of Brandjes show a moderate relation to Widmer, K 0.53 and K 0.52, respec-
tively. The VCS shows a poor correlation in all comparisons (K 0.22-0.41).
Prandoni has a moderate correlation with most definitions (K 0.40-0.44); only with
VCS without compression therapy was a poor relationship (K 0.31) shown.
Invasive venous pressure measurement was done in 46 patients. In thirty patients
both legs were measured and in sixteen patients only one leg. Of the legs, 43 had
been affected by DVT and 33 were control. The mean AVP values, measured in
DVT and control legs, were 41 (±21) mmHg and 28 (±18) mniHg (p = 0.005),
respectively.
In figure la-f results of the different ITS scorings systems and their relation to the
AVP are presented. Table 4 shows the comparison of the scoring systems to the
invasive venous pressure measurement. The mean AVP for legs without PTS
according to the various definitions varied between 26.3 and 32.2 mmHg. Also the
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difference in mean AVP for mild-to-moderate PTS was limited for the different
definitions, 37.5 to 44.4 mmHg. A larger difference occurred in the severe PTS
group, with a mean AVP of 49.8 mmHg for the definition of Brandjes compared
to Hl.K mmHg for the VCS score without compression therapy. All classification
systems showed a tendency for higher AVP values among legs with PTS. It is note-
worthy that 2 of 11 legs and 4 of 9 legs classified as severe PTS according to the
scoring systems of Brandjes and VCS, respectively, had normal AVP values. While
more severe PTS in all classification systems was associated with a higher mean
AVP (all p values < 0.001, ANOVA), the association was strongest in the Widmer,
Urandjes and Prandoni classification systems.
DISCUSSION
In general, all PTS classification systems showed a reasonable correlation with the
AVP. 1 lowcver, the clinical classification systems varied strongly in the number of
legs that were classified as having PTS, as well as in their ability to discriminate
between DVT and control legs.
Ideally, a clinical classification system would be easy to obtain, have a good associa-
tion with the pathophysiological mechanism as well as the ability to discriminate
between affected and non-affected legs. Additionally, good reproducibility and
clinical meaningfulness arc required. Moreover, for leg symptoms after deep vein
thrombosis, ,m ideal outcome measure would be sensitive enough to identity the
post-thrombotic syndrome and allow for detection of stabilization, improvement
or deterioration of this disorder.
The clinical component of the CEAP classification system has been widely imple-
mented as a descriptive means of categorizing patients with venous diseases. In our
evaluation the discriminatory power was limited in comparison to other defini-
tions, .tiut many patients with increased AVP were classified as no PTS. In addi-
tion, many components of the CEAP clinical classification are static over time and
subtle changes can't be classified. Hence, possibilities to describe changes over time
in leg symptoms after deep vein thrombosis are limited.
The VCS was designed to include only those manifestations of chronic venous dis-
ease that can potentially change over time and has been shown to have a moderate
to good inter-observer variability*. It showed a high discriminatory power
between PVT and control legs. However, when the compression therapy was left
out of the score, this power decreased. In addition, many patients with normal
venous pressure were scored as severe PTS when stockings were taken into
account. Moreover, the VCS score showed a poor correlation with all other defi-
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moons of PTS and when compression therapy was excluded, the relation with
other definitions diminished even more. The VCS score showed only a limited
difference in mean AVF between legs classified as mild-to-moderate and severe
PTS. A problem with the VCS score is that it takes into account the use of com-
pression therapy. Three points are added for the compliance with compression
therapy and with a total score of 4. mild-to-moderate disease is classified. Conse-
quently, non-compliant patients are graded as less severe disease and patients who
wear stockings to prevent development of" ITS after DVT have, by definition with
only one minor symptom present, already mild-to-moderate disease. The VCS
without compression therapy showed a larger difference in mean AVP between
mild-to-moderate and severe PTS, but the discriminatory power decreased.
The Widmer classitication is based on objective signs, which rarely improve over
time. Thus, only detection of deterioration is possible. Hence, it can be used to
measure prevalence of I'TS after previous DVT. but is not useful as an outcome for
treatment after DVT or of treatment of I'TS. We observed a low discriminator)'
power between DVT and control legs for the Widmer classification in comparison
to other definitions. However, a moderate to good association with the Hrandjes,
l'randoni and CEA1' scores, and a fair correlation with the AVI' were observed.
The definition of Brandjes includes subjective complaints and objective clinical
signs. It had a good discriminatory power, but patients with normal or only mildly
increased AVI' were also classified as severe disease. Potentially this can be
explained by the use of the binary classification of the presence of signs and symp-
toms rather than an ordinal scale, which is generally recommended for scoring of
signs and symptoms.
Finally, the score of l'randoni, also based on subjective complaints and objective
clinical signs, combined a good discriminatory power with a reasonable relation
with AVP. Moreover, this score has been shown to have good reproducibility, and
to correlate well with the patient's perception of the interference with daily life'''
and generic quality of life measures'^. The only disadvantage is the absence of spe-
cific criteria for grading of the individual elements of the score.
Another definition of PTS used by Ginsberg et al. included the measurement of
valvular reflux and was not included in our evaluation. This definition requires the
combination of pain and swelling, that are of at least 1 month duration and typical
in character"'. Hence, this definition is likely to be less sensitive. In addition, the
measurement characteristics have not been assessed.
Some methodological aspects of our evaluation merit attention. The different scor-
ing systems were all separately scored on the same day, by the same observer.
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Hence, differences between the different classifications cannot be due to inter-
observer variation of fluctuation of signs and symptoms'^. However, this classifica-
tion was made by an observer who was unaware of AVP results. The AVP mea-
surements were made blind from scores on PTS on a later occasion using a software
algorithm to define the AVP. Of all patients included, both legs were clinically
scored and analyzed separately, without taking into account the correlated
data-structure. For the development of tests, however, this was regarded as accept-
able. In addition, the presence of patients with bilateral DVT in the current study
would have made such a case control type of analysis difficult.
CONCLUSION
Although all clinical definitions of PTS were highly statistically significantly associ-
ated with the gold standard, invasively determined ambulant venous pressure, their
ability to discriminate between DVT and control legs as well as the observed prev-
alence of PTS differed substantially. The definition that combines good discrimi-
natory power with «1 plausible correlation to the gold standard was the definition of
PTS according to Prandoni. Since this definition has known measurement proper-
ties it seems to be the definition of choice for future studies, especially if criteria for
the grading of individual elements of the scoring system were to be made explicit.
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RESULTS
«S'/wr/y /k>/?»/
Of the 324 questionnaires sent to all of the dermatologists in the Netherlands, 203
(63%) were returned at first mailing. The 121 reminders resulted in the return of an
additional 58 questionnaires. Thus a total response rate of 81% (261/324) was
achieved. Of the respondents, 191 (73%) were involved in phlebology. Their
responses were used for further analyses. Of the other 70 respondents, 11 had
recently retired, and 59 were not or only rarely involved in phlebology.
Of the 191 dermatologists, 93 referred patients to other specialists upon suspicion
of deep vein thrombosis (radiologists, internists, and surgeons), and 98 performed
diagnostic procedures themselves. Of these, a small group of 7 (7%) dermatologists
were doing the diagnostic procedure for deep vein thrombosis for the entire hospi-
tal, where.is the other 91 did the diagnostic procedure only for their own patients.
In a great majority of cases (94/98) duplex ultrasound was used for diagnostic pur-
poses. Hefore they sent the patient for further diagnostic procedures to the radiolo-
gist or vascular laboratory, 32 (33%) dermatologists used bidirectional doppler and
9 (9%) performed impedance plethysmography.
7 '//cni/x'HfiY <j/)/>rcw/i
The majority 174/191 (91%) indicated that treatment of deep vein thrombosis in
the acute phase was initiated by internists, while 40/191 (21%) of the dermatolo-
gists also initiated treatment for deep vein thrombosis in referred patients.
Of the 191 dermatologists, 114 (60%) indicated that a standardised protocol for
treatment of deep vein thrombosis was available in their hospital, 55 (29%) indi-
cated that no such protocol existed, while 22 (12%) were not aware of its presence
or absence. Involvement of the general practitioner in at-home administration of
subcutaneous low-molecular-weight heparin was indicated by 95 (50%) dermatol-
ogists. Of these dermatologists, 56 (59%) were involved in the development of the
protocol for out-patient treatment.
In table 1 compression therapy in the acute phase was related to the use of diagnos-
tic measures for deep vein thrombosis. A dear association was found between the
command of diagnostic measures for deep vein thrombosis and compression ther-
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Table 1 Compression therapy given by dermatologists in the acute phase ot'iiecp vein thrombosis
against initiating diagnostic procedures tor suspected deep vein thrombosis (Chi square to\t: p <
0.001).
l>iagnostic procedures initiated by
dermatologists involved in phlcbology
Total
Compression
Yes
No
therapy
Yes
78
56
134
in the acute phase
No
IS
42
57
Total
93
98
191
apy in the acute phase (p < 0.001). It is noteworthy that not all patients with deep
vein thrombosis received compression therapy. Compression therapy in the acute
phase mostly consisted of compression bandages. The majority of dermatologists
preferred early mobilisation. As indications tor bed rest, deep vein thrombosis ol the
pelvic region, common femoral vein and pulmonary embolism were mentioned.
' ft»»i/w55ioM
Before installing compression therapy, an ankle-brachial index was done on indi-
cation to detect arterial insufficiency by 48/189 (26%) dermatologists. In the main-
tenance phase, elastic compression stockings were prescribed. Information about
the length of the elastic compression stockings was received from 179 dermatolo-
gists. Knee-length elastic compression stockings were prescribed by 69 (39%), 6
dermatologists (3%) always gave thigh-length elastic compression stockings and
104/179 (58%) prescribed both lengths. Of these last 104 dermatologists, 45 (43%)
indicated that extension of the thrombus mass was a reason to use thigh-length
elastic compression stockings, 8 (8%) indicated leg swelling, and 14 (14%) always
started with thigh-length elastic compression stockings. Table 2 shows that most
dermatologists (54%) gave class HI elastic compression stocking as final therapy.
The brand of the elastic compression stockings to be used in the maintenance phase
was decided by dermatologists alone in 97/185 (53%) cases, in 31 (17%) cases the
decision was made in deliberation with the bandager, while in 57 (31%) cases the
bandager alone decided on the brand generally. The bandager took measurements
of individual leg size. Only 27 (15%) dermatologists indicated that they measured
stockings themselves in patients with abnormal leg sizes. Advice about the duration
of use of elastic compression stockings varied as shown in table 3. Lifelong elastic
compression stockings were prescribed when signs of post-thrombotic syndrome
appeared. Estimation of the compliance with elastic compression stockings ranged
from 12-100%, average 71% (SD 18%).
143/184 (78%) of the dermatologists indicated that after the prescription of elastic
compression stockings, the patient was seen at least once at the outpatient depart-
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Dermatologists
4/181
4/181
12/181
34/181
73/181
49/181
»/
2
2
7
22
40
27
Table 2 Elastic compression stockings prescribed by dermatologists in the maintenance phase of
deep vein thrombosis.
Different compression classes according Pressure at the ankle level in Prescription by
to the C'.EN (European Committee for Dermatologists
Standardization) hPa inmHg (%)
Hat-knitted class II 31-43 23-32 27(15%)
Circular-knitted class II 21 (11%)
Flat-knitted class III 45-61 34-46 99(54%)
Circular-knitted class III 33 (18%)
Mi« CII.IIH-OUS 4 (2%)
Total 184 (100%)
Table 3 Advise which period after deep vein thrombosis patients have to wear elastic compression
stockings given by Dutch dermatologists involved in phlcboiogy.
No advise
3 months
3 d months
6-12 months
12-24 months
More than 24 months
inont. ] 73/ 1 HS (94%) of the dermatologists indicated that other specialists con-
sulted them for a second opinion for patients with post-thrombotic syndrome.
DISCUSSION
Our survey indicates that dermatologists in the Netherlands are interested in the
prevention of the post-thrombotic syndrome of patients with acute deep vein
thrombosis. However, their involvement in the actual management of these
patients as well as the development of standardised treatment protocols for these
patients is limited. For referred patients, compression bandages are usually applied
in the .»cute phase, while class III elastic compression stockings are used in the
maintenance phase. There seems to be a great uncertainty about the strategy of
mobilisation in the acute phase, which can be linked to the absence of clear evi-
dence.
Compression therapy reduces the edema of the leg in acute deep vein thrombosis.
Although the precise mechanism of compression therapy is unknown, it is hypoth-
esised that in dilated veins the function of valves is improved by moving these
venous valves closer together through reduction of the venous capacity. In addi-
tion, constriction of the veins increases the flow velocity, reduces transcapillary fil-
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traoon and decreases the venous hypertension in the leg vein system'*'"'. In spite
of the available evidence for the efficacy of compression therapy with elastic com-
pression stockings to reduce the incidence of the post-thrombotic syndrome in
patients with deep vein thrombosis", our survey indicates that this non-phamu-
ceutical treatment is not used for all patients. In a recent survey of the management
of deep vein thrombosis in general practice in the Netherlands, compression ther-
apy was not even mentioned as part of the treatment strategy"'. Since (><>'•» of gen-
eral practitioners indicate that they treat patients with deep log vein thrombosis at
home, sufficient attention to the use of coniprevsion therapy m treatment protocols
involving the general physician and hospital based care is needed. Otherwise, the
beneficial effects of compression therapy may be withheld from the majority of
patients with deep vein thrombosis. In view of the experience of dermatologists in
the use ot compression therapy, both acute and long-term, it would be optimal to
involve this group ot specialists in the development of shared care management
models for patients with deep vein thrombosis, to avoid sub-optimal care for these
patients.
In general, compression bandages with short-stretch materials should be given in
the acute phase: as they exert moderate compression at rest but high pressure dur-
ing walking because of poor elasticity. Therefore, they are well tolerated and can
be left on the leg at night. When care has been taken about arterial circulation as in
patients with diabetes mellitus and arterial insufficiency (ankle-brachial index
below 0.8), compression therapy will give relief from pain and restore the ability to
walk freely within a short period of time".
Compliance with compression therapy was estimated at 7(1% in this survey,
whereas, in the Tübingen study only 47% of the patients actually wore their elastic
compression stockings'". Only well-informed patients understand the necessity for
treatment and agree to wear elastic compression stockings. Learning simple skills
like putting on elastic compression stockings is also important. The prescribing
physician needs to be acquainted with the manufacturer's product range in order to
combine individual requirements in terms of compression class, fit and ease of
putting on elastic compression stockings.
Outpatient treatment of acute deep vein thrombosis is effective, safe and practica-
ble. Mobile patients treated with LMWH and ambulant compression therapy have
no increased risk of pulmonary embolism regardless of the size or location of the
thrombi**. In our questionnaire, dermatologists indicated that bed rest was given to
avoid clots from breaking off and causing pulmonary embolism of patients with
extensive ileofemoral thromboses. In contrast with this, the study of Fartsch"
showed that the progression of thrombi in the femoral vein was greater and
occurred more frequently in the bed rest group than in ambulant groups. Throm-
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bus propagation depends on the level of anticoagulation and is influenced by the
amount of stasis. Therefore mobilisation of patients with deep vein thrombosis
directly after diagnosis and application of LMWH is essential. Guidelines about
ambulant compression therapy were not clearly given in the consensus meeting ot
the I )utch organisation for quality care because no literature was available at that
time. However, dear guidelines concerning selection of patients for hospital or
home treatment are needed.
The use of surveys to review current practice has pitfalls. We believe that our
results represent the Dutch practice, since we achieved a favourably high response
rate of 81%. However, willingness to provide the 'correct' answer, rather than the
true reflection of current practice could have resulted in an overly optimistic view
of the current state of affairs. Still, our results indicate that considerable improve-
ments are required in the use ot compression therapy. For other areas ot our sur-
vey, such as duration of compression therapy and mobilisation in the acute phase
no hard evidence is available, and it is likely that these answers truly reflect current
practice.
We conclude from this survey that internists are mainly in charge of treating deep
vein thrombosis with anticoagulants. Compression therapy is mostly done by der-
matologists.
RECOMMENDATIONS
Dermatologists are willing to treat and capable of management of deep vein
thrombosis with ambulant compression therapy. Shared care type management
models should be developed to ensure optimal care ot patients with deep vein
thrombosis. All professionals involved in the care of these patients should partici-
pate in this development.
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ABSTRACT
Traditionally, venous thromboembolism was treated in a hospital setting. Nowadays,
low molecular weight heparin preparations allow most deep vein thrombosis patients to have home
therapy. The objective of this study was to evaluate if in the past the treatment of deep vein throm-
bosis in a hospital setting was appropriate, in the context of modem opinion, using the Dutch
Appropriateness Evaluation Protocol. If so, the Dutch Appropriateness Evaluation Protocol could
be used to assess the appropriateness of the present hospital stay of other patient groups.
A/<7/i<)(/.« A retrospective research of patients treated during 1995 - 1998 for deep vein thrombosis
or pulmonary embolism was conducted; assessing the appropriateness of the patient's hospital stay
using the Dutch Appropriateness Protocol.
Only 27.1% of the treatment for deep vein thrombosis was found to be appropriate in a
hospit.il setting and related to specific hospital care. Inappropriate stay was mostly caused by delays in
liospit.il ,itul discharge procedures. Of the patients with pulmonary embolism, 50.2% needed hospi-
tal stay. This proportion was statistically significantly higher than in deep vein thrombosis patients
(p < 0.001). The extent of the deep vein thrombosis was not related to the length of bed rest pre-
scribed or mortality.
The Dutch Appropriateness Evaluation Protocol was sensitive enough to identify
inappropriate hospital stay in the past within venous thromboembolism patients. Additional research
into other patient groups is indicated to provide guidelines to improve the efficiency of the hospital
stay of every patient group.
INTRODUCTION
The annual incidence of deep vein thrombosis (DVT) and / or pulmonary embo-
lism (IT.) is 2-3 per 1000 inhabitants. Traditionally, patients with venous thrombo-
embolism (VTE) were treated with intravenous heparin and strict bed rest, fol-
lowed by oral anticoagulants. Hospital admission was recommended to facilitate
treatment with intravenous (IV) heparin for at least five days and was frequently
associated with bed rest. The approval of low molecular weight heparin prepara-
tions (I MWl I) tor the treatment of DVT has revolutionized the management of
this disease. Several meta-analyses involving randomized controlled studies have
shown that I MWH administered subcutaneously is as effective and safe as
unfractionated heparin given intravenously'. Laboratory monitoring is not neces-
sary and body weight adjusted doses of l.MWH can be injected subcutaneously
which allows a majority of patients suffering form DVT to have home therapy^.
Nowadays, there is a tendency to reduce the length of hospital stay or even avoid
hospital admissions, mostly due to budget restrictions and for efficiency reasons.
This tendency has led to the development of several tools to assess the appropriate-
ness of hospital admissions and / or stay and to provide management information
to control these processes'*. Appropriate stay is considered to be: up to standard,
effective, efficient and tailored to the patients" actual needs'". In other words: map-
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propnate patient stay is neither effective (it serves no clinical purpose) nor efficient
(resources cannot be used optimally). Tools to assess appropriateness of hospital
stay could also be used in order to systematically search tor patient groups for
whom hospital stay could be avoided.
Since the management of DVT has been proven as effective and safe in an ambula-
tors' setting as in a hospital setting, the hospital stay of most DVT patients in the
past can be considered inappropriate in the context of modern opinion. If the past
"inappropriate' hospital stay could be identified by the use of a 'modern' tool, this
would be an indication that this tool could indeed be used to assess the appropriate-
ness of present hospital stay of other patient groups. Hence, the objective ol this
study was to evaluate if in the past the treatment of deep vein thrombosis in a hos-
pital setting was appropriate in the context of modern opinion, using the 1 hitch
Appropriateness Evaluation Protocol (DAEP). Therefore, in this study, patients
admitted for PE were included as comparative group.
METHODS
This study was conducted at the university hospital of Maastricht. This 715-bed
teaching hospital is located in the south-eastern part of the Netherlands. In 2001
this hospital admitted about 22,000 patients and generated about 200,000 clays of
stay with an average length of stay of 9 days. The treatment protocol of both DVT
and PE consisted until 1996 of intravenous unfractionated heparin. Subsequently
the DVT treatment protocol changed to LMWH, one-day bed rest, and ambulant
compression therapy. PE continued to be treated intravenously with unfraction-
ated heparin and bed rest. At-home treatment of deep vein thrombosis was intro-
duced during 1999.
We used the Dutch Appropriateness Protocol (DAEP) as the initial tool to asses»
the appropriateness of bed rest in the treatment of DVT. This tool is a crite-
ria-based decision support tool for determining the necessity of hospital stay based
on sets of generic (diagnosis-independent) and explicit (care-related) criteria''. It
consists of 19 criteria for appropriate stay, related to medical and nursing services
and a list of reasons for inappropriate patient stay (appendix 1). If none of the crite-
ria can be met the day of stay is considered to be "inappropriate" in an in-patient
setting and the list of reasons has to be filled out, specifying the reason for inappro-
priate stay. In this study the IV administration of heparin was not scored for as a cri-
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tenon for appropriate stay. Appropriate hospital stay was defined as: "Inpatient
stay, requiring continuous and active medical, nursing or paramedical treatment,
which could not be provided through extramural care, day care or outpatient care
with regard to existing legislation." Bed rest was defined as "compulsory stay in
bed all day, with permission to go to the bathroom".
The study was set up as a retrospective cohort study. The written and electronic
medical charts from patients admitted for venous thromboembolism (VTE) during
the period from January 1995 to January 1999 were reviewed. If a patient was
admitted several times during this period, each hospital stay of this patient was
assessed separately. Periods of hospital stay that concerned VTE other than in leg
and/or lung were excluded from further review. The following data were
extracted from the hospital information system and patient charts: age, gender, date
of admission and discharge, date of death, existence and date of occurrence of
malignancy and data on objective tests for DVT and PE. In addition, it was assessed
whether VTH was the main reason for hospital admission (primary diagnosis) or
not (secondary diagnosis). Thereafter, all days of hospital stay during treatment of
VTH were evaluated using the DAEP to assess the appropriateness of the patient's
stay for treatment of VTH in a hospital setting. All deaths and occurrence of malig-
nancy were recorded until May 2002.
The analysis was restricted to patients with objectively documented diagnosis of
DVT or PE. Periods of stay were considered to be related to DVT or PE with or
without DVT. Based on the available medical data, patients were divided in four
groups; DVT and PE positive or negative. Descriptive statistics were calculated for
the separate groups. We used the Student's t-test to test the difference in means
between groups if data were normally distributed, while the Mann Whitney U-test
was used if data were not normally distributed. The Pearson Chi-square test was
used to test the significance of differences in frequencies between groups. All data
analyses were performed using the SPSS-PC software package, version 10.0.
RESULTS
Between January 1995 and January 1999 a total of 639 admissions (596 patients)
coded as venous thromboembolisin (VTE) occurred. Data on 29 admissions (27
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Table 1 Clinical charactenstics
Sex(%)
- nulc
female
Age (SO)
Primary diagnosis (%)
secondary diagnosis
Malignancy (%)
- in ihc past
• present on ailnuuion
• occurring during follow-up*
Deceased (until May 2(102)
Months after admiwion (median / iqr**)
Within 1 month after admission (%)
Length of'stay (median / 25-75 percentilc)
DVT patients
n=262
135(51.5)
127 (48.5)
60.1 (18.4)
163 (62.2)
98 (37.4)
83(31.7)
23 (8.8)
22 (8.4)
38(14.5)
90 (34.4)
9 /21.25
22 (8.4)
') / 7-2«
PE patients ( • / -
n=249
10« (43.4)
141 (56.6)
64.5 (16.9)
144 (57.8)
KM (41 8)
60(24.1)
23 (9.2)
32 (12.9)
5 (2.0)
104 (41.8)
1 / 19.5
56 (22.5)
12 /8 -18
DVT) p
0.054
0.005
0.481
<UM5
< 0.001
0.084
< ».(Nil
0.268
* until may 2002; **iqr: interquartile range
patients) were not available and 51 admissions (50 patients) for other than leg vein
thrombosis or pulmonary embolism were not assessed. Hence, information on 559
admissions (519 patients) for DVT and/or PE was available for analysis. The diag-
nosis of VTE was objectively documented by ultrasonography and / or perfusion
ventilation lung scanning in 511 admissions.
The clinical characteristics of these patients are shown in table 1. Data showed the
mean age to be statistically significantly higher in I'E patients. There was no differ-
ence found in gender. Overall, in 60% of the patients DVT and/or I'E was the pri-
mary diagnosis. In both DVT and I'E groups the occurrence of malignancy in the
past or during admission showed no differences (8.4 to 12.9%) (p = 0.354), while
the occurrence of malignancy during follow up was found to be higher among
patients with DVT (14.5%) than with I'E (2.0%,) (p < 0.001). The median length of
hospital stay was rather high in both groups (DVT: 9 days, I'E: 12 days). This
length of stay was mainly due to patients with secondary DVT or F'E (median: 19
days, iqr 25 days), while in all patients with a primary diagnosis the median length
of stay was only 9 days (iqr 6 days).
Since co-morbidities can influence the length of hospital stay and bed rest, only
data on the group with a primary diagnosis were used for further analysis. The
median length of stay of the patients with a primary DVT or I'E diagnosis was 8 -
10 days (table 2). During this stay the patients were actively treated for DVT
and/or PE for 4 or 7 days. Data collected at the height of the DVT did not show
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Table 2 Treatment of primary DVT / P E
Primary
median
DVT
25-75 n
percentile
Primary
median
PE
25-75 n
percencile
Overall length of hospital «ay in days 8 7-10 163 10 8-14 144
Length of anticoagulant therapy during 4 3-6 156 7 6-9 141
hospital May in day«
Length of combination bed rest with
• intravenous Heparin 5 3-7 7 7 5-10 24
• subcutaneous I.MWII 5 4-7 132 5 3-7 3
No bed rest prescribed, only
• intr.iveiuuisllep.irin 3 2-4 9 7 5-8 108
• subcutaneous LMWH 0 0 9 0 0 7
Table 3 Keasons for appropriate hospital stay during treatment primary DVT / PE
DVT positive PE positive
Patients meeting DAEP criteria </nnm» rnytrmrnr of DVT / PE* n=44 (27.1%)
Kc.isons for appropriate stay in percentages
' threatening situations, requiring .ictite clinical care
• care, requiring clinical control or observation
• monitoring
' infusion .nid / or medii .ition
• nursing care
* Intravenous administration is a criterion for hospital admission, excluded as criterion in this study
was intravenous 1 U-p.mtt
any difference between levels of thrombosis, mortality, and the length of bed rest
prescribed. Mortality in the first month after admission within the DVT group was
8.4% (n=22) while it was in PE patients 22.5% (n=56) (p < 0.001). During further
follow up another I 16 patients died, leading to a total mortality in the DVT group
of 34.4% (n=W) and 41.8% in the PE group (n=104).
 .
7.8
48.3
5.8
3(>.6
_
n=73 (50.2%)
23.2
42.0
10.1
23.2
1.4
As said before, only data on patients with a primary diagnosis were assessed. The
length of stay and the type and duration of the treatment for DVT and PE are given
in table 2. The treatment consisted of intravenous (IV) heparin, IV heparin com-
bined with bed rest, subcutaneous low molecular weighted heparin (LMWH) and
bed rest or only LMWH.
As shown in table 3. of the 163 patients with a primary DVT, only 27.1% (n=44)
met one or more of the DAEP criteria during the period of treatment, indicating
this stay to be 'appropriate". In PE patients (n= 144), the proportion of'appropriate
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Table 4 Reasons tor uupproprulc hospital stay
DVT positive PE positive
Median time of overall uupproprute hospital stay in days
Reasons tor inappropriate stay in percentages
- delay ui hospital procedures
application not in nine
not clear defined medical policy due to procedures,
products or refusal patient
• delay in discharge procedures
- unavailability ot other health care facilities
• unavailability of test results
• other 3.7
59.3
(25.9)
(14.9)
29.6
7.4
_
44.4
(22.1)
(-)
38.8
5.6
11.t
stay' was 50.2%. This proportion was statistically significantly higher than in
patients admitted for DVT (p < 0.001). In 73 patients with PH. the frequency of
(imminent) threatening situations was higher than in the 44 DVT-patients (23.2%
vs. 7.8%).
Table 4 shows that this stay was mainly related to care, requiring specific observa-
tion (48.3%) or the administration ot medication / mtusion (3(>.(>%) excluding the
IV administration of heparin. Inappropriate stay in both groups was mainly related
to delays in internal hospital and discharge procedures (88.9% vs. 83.2%). About
one quarter ot this inappropriate stay was related to delays in the application or the
logistics ot diagnostic test performance. Within the DVT group not clear defined
medical policy caused about 15% of the inappropriate stay. The unavailability of
other care facilities (e.g. homes for the elderly, rehabilitation homes, primary
and/or home care) resulted in only a small proportion of inappropriate st.iy (7.4 vs.
5.6%) in both groups.
DISCUSSION
This study showed that the DAEP can be used to assess the appropriateness of hos-
pital stay for DVT and PE patients and can provide reasons why patients need spe-
cific hospital care or why patients remain hospitalized inappropriately. The instru-
ment is sensitive enough to differentiate between different patient groups. This
study also showed that bed rest is not appropriate in the treatment of DVT. The
idea of a higher risk tor PE in patients with extensive DVT in not supported by the
data found on co-morbidity in this and other studies'. If bed rest was indicated it
was mainly due to co-morbidity. There was no relation found between the loca-
tion of DVT and the prescnption of bed rest. Except for frequent APTT monitor-
ing and specific infusions, there is no indication for hospital stay. So, the appropri-
ateness of hospital stay is mostly determined by reasons not directly related to the
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treatment of DVT / PE. This study confirms previous research reporting that in
most cases hospital stay is inappropriate in treating DVT'"'". Yet, regarding the
data in this study, there is reason to believe that there are possibilities for improve-
ment measures for FE patients. Approximately half of these patients could possibly
be treated outside a hospital setting. Further research on this matter is indicated.
Although it was not the scope of this study, the incidence of malignancy during the
follow up was remarkably higher in DVT patients. This finding is confirmed by
other studies'''"'. Therefore, DVT as a possible predictor of malignancy needs fur-
ther research
The retrospective use of an AEP-based instrument depends on accurate record
keeping. Due to deficient record keeping data can be missed. This is already dem-
onstrated in the literature"'^. By using the DAEF concurrently, these disadvan-
tages would disappear and more and better data could be collected.
Previous studies at the university hospital of Maastricht'' showed, that over 20% of
the total hospital stays are inappropriate and almost half of these inappropriate stays
arc related to delays in hospital procedures (e.g. not clear defined medical policy,
delay in diagnostics, therapy or discharge). Other international studies" showed an
even higher proportion of inappropriate hospital stay. If inappropriate stay can be
reduced, considerable profits in terms of quality, efficiency and costs are possible.
Even if medical record keeping (patient files) is not always as perfect as it should be,
this kind of study can provide useful data to analyze specific patient processes or
treatment and the operation.il management of an organization. The data can also
provide additional information leading to agreement on medical policy (hospital
admission vs. out patient treatment).
CONCLUSION
We demonstrated that the DAEF was sensitive enough to identify inappropriate
hospital stay in the past within a specific patient group for which it has been proven
that it can be treated in an outpatient setting. Therefore, it is plausible to use this
tool to systematically assess the current hospital stays of other patient groups to
reduce or even avoid hospital stays in order to increase hospital efficiency and
decrease health care costs. Even so, additional research into other patient groups is
indicated to provide guidelines so the treatment or hospital stay can be as efficient
as possible for every patient group.
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APPENDIX
DAEP LIST of CRITERIA,
Criteria for appropriate clinical May
1.
a
u
u
[j
Li
3.
LI
[.
3.
11
U
Threatening situations, requiring acute clinical
care:
(Imminent) circulatory disorders
(Imminent) respiratory disorder»
(Imminent) CVA / spinal cord lesion
Inability to void or move bowel
Other criteria, (to be specified):
Monitoring
Close medical monitoring by a nurse (>3
times a day) under physii lan's orders, or
according to existing procedure
Intake and output measurements
Nursing care
Care JI cording to existing procedure/
it ft it j a« • 11]
I ' l l Hi *1 * M
Isolation of the patient
Endotracheal suction
2.
u
Ü
f-
4.
6.
Care, requiring clinical control or observation:
Scheduled for procedure the next day
Surgical procedure in operating room
Diagnostic procedures
Adjustment of medication
Adjustment of hematological disorders
Wound and drainage care
Patient instruction in nursing techniques
Infusions and/or medication
IV administration of fluids and/or nutrition
IV or epidural administration of medication
Assessment of appropriate stay is not possible
Reasons, (to be specified):
DAEP LIST of REASONS
Reasons lor in.ippropn.nc clinical stay
7. Delay in hospital procedures
(diagnostics and / or therapy)
Specify
1 >uc to p.itient
I'.iiu'iit rrfm.il
Due to personnel
1 Applu JIIIIM not in time
1 liuoiupUii- .ulimimtration
1 I Not cle.ir defined medical policy
1 lue to procedures
Inetlii tent M ln-iluling
lj Insiiflicient out patient work up
U Waiting lists
!"' Admission lor urgent diagnostics
Due to products
Products not available
9. Unavailability' of (test) results
. ' Specify:
11. Primary care facilities not (yet) available
• ' Specify:
8. Delay due to discharge procedures
Due to patient
J Patient refusal
1 1 )iffu ulties in home situation
Due to personnel
LJ Discharge procedure not stated in tune
' Incomplete administration
!_' not clear defined medical planning
Due to procedures
T" Discharge planning not performed
~ N o consultation with other care facilities
Therapy diagnostics not completed in tune
Due to products
Product* not available
It». Patient is waiting for transfer to other care facility
Specify:
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Non-pharmaceutical measures for prevention
of post-thrombotic syndrome
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ABSTRACT
Post-thrombotic syndrome (PTS) is a long-term complication of deep vein thrombo-
sis characterized by chronic complaints, swelling, and skin changes in the affected limb. One in
every three patients with deep vein thrombosis develops post-thrombotic sequelae within five years.
« The objective of this review is to determine the relative effectiveness of, and the rate of
complications in using non-phannaceutical interventions in patients with deep vein thrombosis in
prevention of the post-thrombotic syndrome.
5/ra/r^y All published reports of non-pharmaceutical interventions in patients with deep
vein thrombosis were traced through MHDI.INE, and EMUASE (up to and including March 2(K)3)
using the search strategy described by the Cochrane Peripheral vascular diseases group. Additional
searches included the Cochrane CCTR/CentraJ database, handsearching non-listed journals, and
personal communications with researchers.
Xr/rrfion m'frn'd Randomised controlled trials of non-pharmaceutical interventions of clinically
confirmed deep vein thrombosis were selected. Primary outcome consisted of the extent to which
they prevented development of the post-thrombotic syndrome. There was no restriction on date or
language.
roffrrriiin <* <»i<»/yjis Details of eligible studies were extracted and summarised using a data
extraction sheet. Data extraction was verified by three reviewers independently.
iM WSM/»> Three randomised controlled trials on the development of the post-thrombotic syn-
drome were identified. Two studies compared elastic compression stockings with a pressure of
30-40 mini Ig .it the .inkle with no intervention applied directly .lfter the deep vein thrombosis. The
other small study compared clastic compression stockings (pressure 20-30 mniHg) with one to two
sizes too large stockings in patients one year after the deep vein thrombosis. In the treatment group,
the overall use of clastic compression stockings was associated with a highly statically significant
reduction in the incidence of .my post-thrombotic syndrome with OR (1.31 0*5% CI 0.20-0.48).
Also the incidence of severe PTS w.is reduced with OR 0.3"- ('»5% CI 0.20-0.76). In another ran-
domised controlled trial regarding the first nine days after deep vein thrombosis, no difference in
pulmonary embolism and extent of thrombus in the femoral vein was found. A statistically signifi-
cant reduction (p < 0.05) of pain, swelling and clinical scores was found, favoring the compression
group.
Rct'lfIIITX ' <wif/iisic>N.< There is substantial evidence that elastic compression stockings reduced
the occurrence of the post-thrombotic syndrome after deep vein thrombosis. N o serious adverse
effects were mentioned in the studies. 1 lence, elastic compression stockings should be added to the
treatment of deep vein thrombosis to prevent the development of the post-thrombotic syndrome.
HACKC.ROUNO
I )ctails of" eligible studies were extracted and summarized using a data extraction
sheet. Data extraction was verified by three reviewers independently.
One out of even- three patients with deep vein thrombosis will develop
post-thrombotic sequelae within five years' v Although there is no consensus on
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the definition in the literature, several scoring systems are used to define
post-thrombotic syndrome""'. The main item in all definitions is a (documented)
deep vein thrombosis preceding chronic complaints of the leg(s). Complaints may
include subjective symptoms of the legs e.g. pain, cramps, heaviness, pruritus (itch-
ing), and paresthesia (numbness and tingling sensation), signs of stasis (pre-tibial
edema, redness, induration (hardening) of the skin, hypcrpigmcntation. new
venous ectasia (dilatation) and pain during calf compression and venous leg ulcer-
adon. All of these complaints have an impact on the quality of life**.
The pathophysiology of the post-thrombotic syndrome is not entirely understood.
Contributing factors are thought to be deep vein obstruction, venous reflux, and
calf muscle pump dysfunction''. In the acute phase of deep vein thrombosis, a fresh
thrombus in the deep vein produces an obstruction. In the first tew months follow-
ing deep vein thrombosis, recanalisation, a complex process involving tibrinolysis,
thrombus organization, and neovasculanzation (proliferation of blood vessels),
occurs*'. This process can result in valve destruction. Damaged valves, insufficient
closure and/or occlusion of the veins increase pressure in the veins (venous hyper-
tension). It is postulated that this venous hypertension disturbs the normal flow in
small capillaries, resulting in increased capillary filtration loading to .inkle flare,
edema in the lower leg, and a number of skin changes which include dermatitis,
hpodennatosclerosis and white skin atrophy. (Lipodermatosclerosis is the term
given to a hardening of the skin, which may gain a red/brown pigmentation, and is
accompanied by wasting of the subcutaneous fat. White skin atrophy consists of
small depressions of ivory-coloured hard skin with stippled red spots). I'm.illy, this
disturbed microcirculation may lead to a decrease of cutaneous oxygen concentra-
tion (TcPOj), contributing to delayed healing after cutaneous injury or leading to
spontaneous breakdown of the skin (venous leg ulceration) . These changes arc
called chronic venous insufficiency, and when deep vein thrombosis is the source
of this insufficiency, it is called the post-thrombotic syndrome.
A number of non-phanmceutical measures are used for the prevention of
post-thrombotic syndrome in the acute phase of deep vein thrombosis. These
include elevation of the legs and compression therapy. Compression therapy may
consist of circular pressure on the leg with either removable bandages or perma-
nent bandages such as adherent bandage and Unna's paste boot, medical elastic
compression stockings, anti-thrombosis stockings or an external intermittent
pneumatic device**"'". Medical elastic compression stockings are classified accord-
ing to the pressure they exert, although unfortunately, grading systems are not
internationally standardised". This difference complicates analyses. The European
Economic Community is working on a European standard for medical compres-
sion stockings, the so called CEN (Comite Europeen de Normalisation) classifica-
tion"
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The mechanism of action of compression therapy of the legs is reduction of edema,
acceleration of venous blood flow, and improvement of the venous pump func-
tion'''. Very tight non-elastic bandages are used in an attempt to reverse the venous
hypertension"'. Although compression therapy is potentially harmless at first sight,
it can lead to complications. Pressure sores may develop if pressure is given at an
extremely high level, because it will reduce blood supply to the skin'^. Similarly,
the application of moderate pressures to patients with impaired arterial blood sup-
ply to the legs may result in exacerbation of the arterial insufficiency'"'''.
Since the opinions of clinicians as well as the guidelines of their professional
organisations differ in the assessment of the utility of compression therapy for treat-
ment of deep vein thrombosis, there is a need for review of the literature ""^'.
The objective of this review was to determine the relative effectiveness of, and the
rate of complications in using non-phannaceutical interventions in patients with
deep vein thrombosis. Interventions of interest included compression therapy and
bed rest. These were compared with no intervention and with each other.
Thi\prim.iry outcome was the extent io whic.b tl\i
post-thrombotic syndrome. Secondary outcome measures included reduction of
pain, recurrence of deep vein thrombosis, pulmonary embolism, patient satisfac-
tion, quality of life, compliance with compression therapy and costs.
CRITERIA FOR CONSIDERING STUDIES FOR THIS REVIEW
Randomised controlled trials (RCTs), or controlled clinical trials (CCTs) evaluat-
ing compression therapy and other non-pharmaceutical measures in the treatment
of deep vein thrombosis were selected. Trials which used allocation processes
which .ire transparent before assignment such as open list of random numbers, case
record, day of the week, surname and so forth, were classified as CCT.
7 )'/>(•>• <>/"/>iirf iVi'/wuft
Men .tiul women of any age with a deep vein thrombosis objectively diagnosed.
Methods considered acceptable for diagnosis of deep vein thrombosis included
ultrasound, venography and impedance plethysmography.
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The primary' intervention was compression therapy. We compared with medical
elastic stockings, compression bandages, bed rest and no intervention. CComparison
against mechanical devices such as intermittent pneumatic compression was not
available. We will include such comparisons should they become available in
future.
Anticoagulant therapy and/or surgical intervention for deep vein thrombosis was
equal in the patient groups in the trials.
1) The primary outcome was the occurrence of post-thrombotic syndrome over
time. The definitions used in each trial paper lor poNt-ihrouihotic syndrome
were accepted, provided they included a systematic clinical history and scoring
of physical examinations.
2) Secondary outcomes included intervention-related complaints and/or compli-
cations. The most important of these was pulmonary embolism occurring in the
first two weeks after initiation of the treatment. Adverse etVects, after initiation
of the compression therapy, were of particular importance, as some treatments
liave trie potential'to affect trie patient adversely. Common complications were
identified and compared between interventions. These included discomfort,
pain, pressure sores, and recurrence of thrombosis.
3) Patient satisfaction and quality of life data.
Generic or specific measures of quality of life.
4) Economic analysis.
Cost-effectiveness or cost-benefit analysis.
This review will draw on the search strategy developed for the Cochrane Periph-
eral Vascular Diseases Croup as a whole. All publications describing (or which
might describe) randomised controlled trials (RCTs) and controlled clinical trials
(CCTs) of non-pharmaceutical measures of deep vein thrombosis were sought
through electronic searches of the Cochrane Peripheral Vascular Diseases Special-
ised Trials Register (latest date searched 31" March 2003). This Specialised Trials
Register has been constructed from regular electronic searches of MEDLINE
(1966 onwards), EMI3ASE (1980 onwards), and The Cochrane Central Register
of Controlled Trials (CENTRAL). The full list of journals that have been
handsearched, as well as the search strategies for the electronic databases, arc-
described in the 'Search strategies for the identification of studies' section within
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the editorial information about the Cochrane Peripheral Vascular Diseases Group
in the Cochrane Library.
In addition we handsearched the following journals: Scripta Phlebologica
(1993-2000), Journal of Thrombosis and Haemostasis (2003) and Conference Pro-
ceedings of the International society of Thrombosis and Haemostasis (2001, 2002)
and the International Union of Phlebology (Rome 2001). We also handsearched
Compression Bulletin and Scope on Phlebology, both contain abstracts and com-
ments on articles in the field of phlebology. Citations within identified studies
were searched. In .tddition, we wrote to specialists known to be involved in
phlebology and interested in post-thrombotic syndrome for details of unpublished
and ongoing trials. The relevant data provided were included in this review.
MET! lOHS OF THE REVIEW
One reviewer (DNK) assessed titles and abstracts of studies identified in terms of
their relevance and design, according to the selection criteria. Full versions of arti-
cles were obtained if, from the initial assessment, they satisfied the inclusion crite-
ria. Another reviewer (MHP or HAMN) checked those rejected. Full papers were
checked to identify those that fitted the criteria. Another reviewer (RS) repeated this
independently, for verification. Any disagreements were resolved by discussion.
r.\7r<i<7i'i»M
Details of the studies were extracted and summarised using a data extraction sheet.
If data were missing from reports then attempts were made to contact the authors
to obtain the missing information. Studies published in duplicate are included only
once. Data extraction was undertaken by one reviewer (DNK) and checked for
accuracy by a second (RS).
Each study was appraised using a standard checklist to assess the validity of the
methods used. Data were collected on:
• Trial setting (country, and whether primary or secondary care)
• Method of randomisation
• Objective outcome, method of assessment and whether blinded or not
• I cngth of follow-up
• Number of patients (or limbs) randomised
• Inclusion criteria
• Exclusion criteria
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• Description of interventions and co-interventions
• Baseline characteristics of groups for important variables (e.g. first deep vein
thrombosis, recurrent deep vein thrombosis)
• Definition of post-thrombotic syndrome
• Duration of follow-up
Results
• Intention to treat analysis
• Number and reason for withdrawals
• Source of funding
• Use of an a priori sample size / power calculation
It was intended to compare elastic compression stockings versus control, and other
comparisons will be made if available in future. We have allowed for:
• Mechanical compression therapy vs. no intervention
• Mechanical compression therapy vs. compression stockings
• Compression stockings versus different brands of compression stockings
RCTs were analysed separately to access the efficacy of the effect estimation calcu-
lated with Mantel Haenszel test (Cochrane Software). In the absence of clinical
heterogeneity, we performed a Chi-squared test for statistical heterogeneity.
Four trials were identified that met all the inclusion criteria. The trials of Mrandjes'
and Prandoni" consisted of 1*M and 180 patients, respectively. Both compared
graduated elastic compression stockings with an ankle pressure of 30-40 mmHg
versus no intervention. Patients were randomised in either group directly after the
documented deep vein thrombosis. Assessment took place at least ft/monthly for
up to 5 years. Primary outcome was the cumulative incidence of the post-throm-
botic syndrome. Both used a self developed scale for the assessment of the
post-thrombotic syndrome, based on symptoms and signs in the involved leg.
The trial of Ginsberg^" included 47 patients one year after the diagnosed deep vein
thrombosis and compared the effectiveness of below knee elastic compression
stockings (20-30 mmHg pressure at the ankle) with placebo stockings (one to two
sizes too large). Their patients had no pain or swelling of the leg at the time of
inclusion, but all had venous valvular insufficiency measured by plethysmography
or Doppler ultrasound. Primary outcome was treatment failure defined as pain and
swelling of the leg appearing during further follow up. Patients with symptomatic
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(n=33) and asymptomatic (n=12) deep vein thrombosis were included, while in
two patients the clinical presentation was unknown.
The study of Partsch" consisted of forty-five patients randomized into three
groups. Comparison was done with inelastic compression bandages (Unna boots
on the lower leg, adhesive bandages on the thigh), thigh-length compression
stockings (class II), and bed rest for nine days without compression. Primary out-
comes were the reduction of pain and leg circumference between baseline and day
9, while on both days the presence of pulmonary embolism and extent ot deep vein
thrombosis were objectively assessed by ventilation-perfusion lung scintography
and duplex ultrasound scans, respectively. After nine days all patients received elas-
tic compression stockings.
True randomisation with allocation concealment (i.e. the person recruiting the
patient into ihe trial was unaware of which group they would be recruited to) was
achieved in all tour trials. Study personnel were unaware of allocation at the time of
outcome assessment. In the trial of (linsberg^ the outcome was a relative scoring
of current symptoms versus previous symptoms over three months intervals.
RESULTS
fir .<yH</n>»Mf
In the study of Brandjes', any post-thrombotic syndrome occurred in 19 (20%) of
96 patients treated with stockings and was severe in 11 patients, while those num-
bers were -U> (47%), and 23, respectively of 98 patients in the control group.
Prandoni" obtained similar results in his study, any post-thrombotic syndrome
occurred in 22 (24%) of 90 patients treated with stockings and was severe in 3
patients, while those numbers were 44 (49%), and 9, respectively of 90 patients in
the control group. The risk reduction of any and severe post-thrombotic syndrome
were highly statistically significant, with p values for both of p < 0.001. In the study
of Ciinsberg". 0 (0%) of 24 of the active stocking group were considered treatment
failures compared with 1 (4.3%) of 23 treated with placebo stockings. We are
awaiting data about the incidence of the post-thrombotic syndrome of the patients
in the study of Partsch"\ As shown in figure 1 the overall use of elastic compression
stockings was associated with a highly statistically significant reduction in the inci-
dence of any post-thrombotic syndrome with OR 0.31 (95% CI 0.20-0.48). Fig-
ure 2 shows the incidence of severe post-thrombotic syndrome, reduction with
OR 0.39 (95% CI 0.20-0.76).
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Figure t Cumulative meidcncc of any post-thrombotu ondrome after 2 vearv treatment of
compression «lockings in order to prevent development of the post-thrombotu syn-
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Figure 2 Cumulative incidence of severe post-throinboric syndrome after 2 ye.irs treatment ot
compression stockings in order to prevent development of the post-thrombotu syn-
drome.
In the study of Ginsberg^, no patients developed leg ulceration and reduction of
edema and pain could not be measured because exclusion from the study was based
on these symptoms. No information was available in those three studies about the
recurrence of deep vein thrombosis, pulmonary embolism, compliance with com-
pression therapy, and costs.
In the article of Partsch"^ only the first ten days are described. In this period pain
level showed a statistically significant reduction starting after the second day in the
compression groups and after 9 days in the bed rest group (p < 0.05). The same was
found for the measurement of leg circumference. Improvement of the clinical
scores was significantly better in the compression groups compared with the bed
rest group (p < 0.01). There was no significant difference concerning the occur-
rence of new pulmonary eniboli and regression of thrombus diameter. Progression
of thrombi in the femoral vein was greater and occurred more frequently in the
bed rest group than in the other two groups (p was not significant).
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DISCUSSION
The results of this systematic review show that elastic stockings reduce not only the
incidence of any post-thrombotic syndrome, but also of severe post-thrombotic
syndrome, with a highly statistically significant OR of 0.31 and 0.39, respectively.
Only three major randomised clinical trials dedicated to the prevention of such a
prevalent disorder as the post-thrombotic syndrome were found in our broad
search, that included all languages as well as personal contact with other investiga-
tors involved in the clinical area. At a first glance, it seemed that the studies were
conflicting, because in the study of Ginsberg^ it was concluded that most patients
have no post-thrombotic syndrome one year after proximal deep-vein thrombosis
and do not require elastic compression stockings. However, they included patients
with asymptomatic deep vein thrombosis, who carry a low risk for the post-throm-
botic syndrome. In fact, in their sub-population of patients with symptomatic deep
vein thrombosis, the prevalence of post-thrombotic syndrome as assessed with a
different, non-validated and probably less sensitive scale was 27 percent, and cer-
tainly not distinctly different from both other studies. Another difference worth
mentioning is the use of one to two sizes too large stockings instead of no interven-
tion. Tim might have diminished the contrast between the treatment groups, since
even a stocking th.it is too large will certainly give some compression'"'. Indeed, it
lias been shown that stockings that are one or two sizes too large still exert consid-
erable pressure in comparison to stocking without elastic threads. Moreover, the
therapeutic stockings used exerted a pressure of 20-30 mmHg at the ankle region.
This is less than used in both other studies, which compared a stocking with an
ankle pressure of 30-40 mmHg. In addition, in this study the stockings were only
provided one year after the index thrombosis, i.e. at the moment that the majority
of patients will already have developed the post-thrombotic syndrome and a pre-
ventive effect can no longer be achieved.
We analysed the data of thigh- and knee-high stockings together, because in mea-
surements of venous pressure and foot volume no superiority of thigh high stock-
ings was found . No serious adverse effects after initiation of the compression ther-
apy were reported.
REVIEWERS' CONCLUSIONS
.v /or />rwfiVe
There is substantial evidence that elastic compression stockings reduced the occur-
rence of the post-thrombotic syndrome after deep vein thrombosis. No serious
adverse effects were mentioned in the studies. Hence, elastic compression stock-
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ings should be added to the treatment of deep vein thrombosis to prevent the
development of the post-thrombotic syndrome.
/wi/»/fVd/ioM.< /t>r rrsfdirfo
It is uncertain if stockings should be prescribed directly or after compression ban-
daging in the acute phase (one-to-two weeks) of the deep vein thrombosis. In
addition, it is still unknown how long stockings have to be worn. There is .1 need
for the comparison of elastic compression stockings with different compression
classes in the prevention of the post-thrombotic syndrome.
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APPENDIX A
CHARACTERISTICS OF INCLUDED STUDIES
Study Brandjcs HI». Buller MR. Henboer II. HUIMIUII MV. dc Rnk M. Mgt II. et ,il
Randomised tnal of effect of compression stocking in patients with wniptonutu
proxinul-vcin thrombosis. Lancet IW7;J4'»:75'M>2.
Methods Randomised controlled trial, observer and outcome assessor blinded In the treat-
ment group 4 were lost to follow-up and l'> died, compared to respectively, 2 and
18 in the none-mtcrvention group.Hollow-up assessments were scheduled at three
and six months, and then even, six months. At each follow-up visit, the presence
and severity of post-thrombotic syndrome were scored using a standardised scale.
Participants Setting: the Netherlands. 10') male and H(> female, mean age 60 yean.
Inclusion cntcnaconsecutive outpatients with a first episode of venogram proven
proximal deep vein thrombosis
Exclusion criteria: a life expectancy of less than 6 months, p.ir.ilv\i\ of the leg;
bilateral thrombosis; leg ulcers or extensive vancosity, and current use ot com-
pression stockings
Interventions Below knee elastic compression stockings, made-to-measure (Neodurelna
Vantex) with an inkle pressure of 40 mniHg compared to no intervention
Outcomes Cumulative incidence of mild-to-moderate post-thrombotic syndrome
Study Ginsberg JS, HirshJ, Julian J, Vander LaandeVries M, Magier I), MacKinnon 1),
et al. Prevention and treatment of postphlebitic syndrome: results of a .Vpart
studv. Arch Intern Med 2001; I6I:2IO5-V.
Methods Randomised double blind clinical trial, observer and outcome assesor blinded.
Participants Setting: Ontario. 26 male and 21 female, mean age 61 years
Interventions Elastic compression stocking Below knee elastic compression stockings with an
ankle pressure of 20-30 mniHg at the ankle region.
Outcomes Cumulative incidence ot post-thrombotic syndrome
Notes Three part study, only data of study 2 arc taken in account
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Study Pansch H, Blattler W. Compression and walking versus bed rest in the treatment
of proximal deep venous thrombosis with low molecular weight heparin. J Vase
Surg2000;32:861-9.
Methods Randomised double blind clinical trial, observer and assessor blinded. Of 148 con-
secutive patients only 45 were eligible, no drop-outs during the first 10 days.
Participants Setting: Vienna, Austria, 45 patients, 29 male and 16 female, mean ages: 58 years.
Inclusion criteria: Proximal deep vein thrombosis proven with compression ultra-
sound scan or phlcbography in mobile patients older than 18 years. The duration
of symptoms had to be less than 14 days. Exclusion criteria: compression therapy
or licpjnn therapy already started, massive symptomatic pulmonary embolism or
need for thrombolysis or thrombectomie. Anklc-brachial index lower than 0.8 or
contra-indication for compression, anticoagulant or both. In the study partici-
pated 7 patients with a previous deep vein thrombosis in the same leg and 11 with
a previous deep vein thrombosis in the contralateral leg.
Intervention» Group A: inelastic compression bandages (Uniu boots on the lower leg, adhesive
bandages on the thigh), group 13: thigh-length compression stockings (class II),
and group C: bed rest for nine days without compression
Outcomes Reduction of pain and leg circumference on days 0 and 9, on both days pulmo-
nary embolism and extend of deep vein thrombosis.
Clinical score was calculated for the following seven symptoms: pain during walk-
ing, painful foot sole, painful calf palpation, subfascial edema, increase of skin tem-
perature, redness/cyanosis. The seventy score comprised tour stages: absent, mild,
marked and severe
Study Prandoni P. Below-knee compression stockings for prevention of post-throm-
botic syndrome in patients with proximal-vein thrombosis. In: ISTH 2003; 2003;
Birmingham; 2003.
Methods Randomised controlled trial, observer and outcome assessor blinded. In the treat-
ment group 2 patients were lost to follow-up, 13 patients in the control group and
6 patients in the treatment group died. Follow-up assessments were scheduled at
three and six months, and then every six months. At each follow-up visit, the pres-
ence and severity of post-thrombotic syndrome were scored using a standardized
scale.
Participants Setting: Italy, 18(1 consecutive patients with a confirmed first episode of deep vein
thrombosis, 77 male and 103 female, mean age 62 years.
Inclusion criteria: a short life expectancy; bilateral thrombosis; leg ulcers or signs
of chronic venous insufficiency; or a contraindication for the use of elastic com-
pression stockings.
Interventions Below knee ready-nude clastic compression stockings with an ankle pressure of
30-40 mini Ig (Hehysan, RovigoKompared to no intervention
Outcomes Cumulative incidence of post-thrombotic syndrome.
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APPENDIX B
CHARACTERISTICS OF EXCLUDED STUDIES
Study Reason for exclusion
Hanley TP, Kiev J, Rice JC. Graduated compression stocking for No RCT
the prevention of skin changes in CVI. Vase Surg 1997:9
Kakkar VV, Lawrence I). Hemodviumic and clinical assessment No RCT
alter therapy for acute deep vein thrombosis. A prospective study.
AmJSurg 1985:150:54
Prandoni P. Lensing AW. Cogo A. Cuppini S. Villalta S, Carta M. No RCT. all patient« were
et al. The long-term clinical course of acute deep venous thrombo- instructed to wear stockings
sis. Ann Intcm Med 1996; 125:1-7 for at least 2 yean.
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Chapter 8
Compression therapy for treating stage I and II
(Widmer) post-thrombotic syndrome
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ABSTRACT
Post-thrombotic syndrome (PTS) is a long-term complication of deep vein thrombo-
tis characterized by chronic complaints, swelling, and skin changes in the affected limb. One in
every three patients with deep vein thrombosis develops post-thrombotic complications within five
yean.
Q6/'«7if« To assess the effectiveness of compression therapy in patients with stage 1 and II
post-thrombotic syndrome according to the classification of Widmer. Interventions of interest
included elastic compression stockings and mechanical devices, compared with no intervention and
with each other.
j/rafrgy The reviewers searched the Cochrane Peripheral Vascular Diseases Specialised
Trial« Register (last searched April 2<K)3), and the Cochrane Central Register of Controlled Trials
(CENTRAL) (last searched Issue 1. 2003). In addition, journals, conference proceedings and bibli-
ographies were h.iiicl scan lied. Personal contact with other investigators involved in the clinical area
was sought to get information about missed or unpublished studies.
.SV/f(7i<m frircri«! Trials that evaluated compression therapy for stage I and II (Widmer)
post-thrombotic syndrome Primary outcomes were leg ulceration. or deterioration of post-throm-
botu syndrome There were no restrictions on date or language. One reviewer (DNK) assessed titles
and abstracts for relevance. This was verified independently by a second reviewer (MWCS).
< i>//<'<7li>»l l^ (imi/y.os Details of eligible studies were extracted and summarized using data
extraction sheets. Data extraction was undertaken by one reviewer (DNK) and verified by a second
A/ill» ron/fr Only two trials were identified th.it addressed physical treatment of post-thrombotic
syndrome. Both tn.ils were initi.ited by the same group of investigators. A cross-over study lasting
two mouths compared low and high pressure with intermittent compression units for severe
post-thromhotic syndrome. This showed .i beneficial effect of higher pressures. The second study,
in patients with mild to moderate post-thrombotic symptoms, showed no effect of elastic compres-
sion stockings (30-40 mini Ig at the .inkle region) when compared to 'placebo' stockings that were
one to two sizes too large.
' f<>M(7n.vii>M.v There is some evidence of a beneficial effect of intermittent pneumatic
compression units, but the study was too small and of too short a duration to draw firm conclusions.
Further research is needed in order to assess whether intermittent pneumatic compression units give
long term reduction ol and relief from the symptoms caused by post-thrombotic syndrome, and pre-
vent deterioration and leg ulceration. The use of elastic compression stockings to treat post-throm-
botic syndrome cannot be supported on the basis of the currently available data.
BACKC.ROUND
Post-thrombotic syndrome (PTS) is a long-term complication of deep vein throm-
bosis that is characterized by chronic complaints, swelling, and skin changes in the
.itVcctcd limb. One in even- three patients with deep vein thrombosis will develop
post-thrombotic sequelae (complications resulting from a disease or condition)
within five years'. Although there is no gold standard for the diagnosis of
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post-thrombodc syndrome, the presence of typical clinical features of venous
insufficiency in a patient with previous deep vein thrombosis provides strong sup-
porting evidence. Three stages of chronic venous insufficiency are recognized by
Widmer ~. In the first phase edema (swelling of the tissues caused by excessive fluid
in the subcutaneous tissue) develops during the day and some skin changes (red-
ness, ankle flair) occur. In the second phase edema becomes evident,
hpodermatosclerosis and/or white skin atrophy occurs. (Lipodermatosclerosis is
the term given to a hardening of the skin, which may gam a red/brown pigmenta-
tion, and is accompanied by wasting of the subcutaneous fat. White skin atrophy
consists of small depressions of ivory-colored hard skin with stippled red spots.) In
the third, and final, stage venous ulcers develop. The CEAP classification also uses
a clinical classification system in their scoring system\
In PTS, valvular incompetence (failure of the vein valves to function properly) is
described as secondary because it is caused by a previous event - most frequently a
deep vein thrombosis - that may have led to destruction and/or dysfunction of the
deep venous valves. Objective evidence of deep venous valvular incompetence
helps to confirm the diagnosis of post-thrombotic syndrome in chronic venous
insufficiency.
The likelihood of PTS developing can be reduced by ensuring an adequate dura-
tion and intensity of anticoagulation for treatment of the initial deep vein throm-
bosis, and prescribing appropriate thromboprophylaxis after discontinuation of
oral anticoagulants. Daily use of elastic compression stockings after deep vein
thrombosis reduces the risk of post-thrombotic syndrome''. It also prevents wors-
ening of established PTS'. Compression therapy , in general, consists of circular
pressure on the leg using circular bandages of any kind. Initially removable ban-
dages or semi-pennanent bandages such as adherent tape and Unna's paste boot arc-
used, while elastic compression stockings are worn for long term treatment. In
cases of severe edema, intermittent pneumatic compression can be used. Compres-
sion therapy of the legs is assumed to reduce edema, accelerate venous blood flow,
and improve venous pump function''"'.
OBJECTIVES
The objective of this review was to determine the relative effectiveness of com-
pression therapy in patients with stage I and II post-thrombotic syndrome accord-
ing to the classification of Widmer. Interventions of interest included clastic com-
pression stockings and mechanical devices. These were compared with eachother
in the review, but will also be compared with no intervention, should appropriate
trials become available in future.
OHAKIIK
CRITERIA FOR CONSIDERING STUDIES FOR THIS REVIEW
Randomized controlled trials (RCTs), or controlled clinical trials (CCTs) evaluat-
ing elastic compression stockings and mechanical devices in the treatment of
post-thrombotic syndrome were selected. Trials which used allocation processes
that were transparent before assignment such as open list of random numbers, case
record, day of the week, surname and so forth, were classified as CCTs.
Types o/*/><?rf/'n/j«iMf.«
Men and women of any age with symptoms and/or clinical changes of the legs
after a previous deep vein thrombosis that had been objectively diagnosed. Meth-
ods considered acceptable tor diagnosis of deep vein thrombosis included ultra-
sound, venography, and impedance plethysmography.
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The primary interventions we studied were medical elastic stockings and intermit-
tent pneumatic compression. We allowed comparison of these with each other,
e.g. different brand of stockings, but also different pressure profiles of stockings,
diffcreni length of stockings, and different heights of pressure for the pneumatic
compression units.
Any drug treatment or surgical interventions for post-thrombotic syndrome were
required to be the same in the patient groups in the trials.
7 )'/><•>• i ' / (>/<f<<>»!<• / » C J . s i i r c . v
The primary outcomes included occurrence of leg ulceration over time, and dete-
rioration of post-thrombotic syndrome. The definitions used in each tnal paper tor
post-thrombotic syndrome were accepted, provided they included a systematic
dinic.il history and scoring of physical examinations (necessary because some trials
only report changes in symptoms over time which provides a less valid indicator ot
effectiveness, as symptoms may vary).
Secondary outcomes included complications and morbidity. Adverse effects, after
initiation of the compression therapy, were of particular importance, but were not
mentioned in the studies reviewed. If available in forthcoming studies, common
complications will be identified and compared between interventions in the stud-
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ics. These could include: discomfort, skin damage, pain, artenal leg ulceration and
recurrence of thrombosis.
Additional outcomes that will be included in future, w here adequate data are pro-
vided, will be patient satisfaction and quality of life (measured with generic or spe-
cific tools); economic analysis (either cost-effectiveness or cost-benefit analysis).
Se<w/i sfrafrjjy /ör ü/fMfi/uvifi'im o/ "s
This review has drawn on the search strategy developed for the Cochrane Periph-
eral Vascular Diseases (PVD) (iroup as a whole. All publications that described ran-
domized controlled trials (RCTs) and controlled clinical trials (CCTs) of compres-
sion therapy for stage I and II (Widmer) post-throinbotic syndrome were sought
through electronic searches of the Cochrane Peripheral Vascular Diseases Special-
ised Trials Register (last searched Apnl 2003), and the Cochranc Central Register
of Controlled Trials (CENTRAL) (last searched Issue 1. 2003). »nelly, the Spe-
cialised Trials Register of the Croup has been constructed from regular electronic
searches of MF.DLINE (1966 onwards). FMHASF. (1 *>K<> onwards), and the
Cochrane Central Register of Controlled Tnals (CENTRAL). The full list of
journals that have been hand searched, as well as the search strategies for the elec-
tronic databases, are described in the 'Search strategies for the identification of
studies' section within the editorial information about the Cochrane Peripheral
Vascular Diseases Group in the Cochrane Library. For details of the search strategy
used to search the Cochrane Central Register of Controlled Trials (CENTRAL)
database see additional tables (table 1).
In addition, we hand searched the following journals in the area of phlebology,
which are not included in MEDLINE and EMHASE: Scripta Phlebologica
(1993-2000), Journal of Thrombosis and Haemostasis (2003), and Conference
Proceedings of the International Society of Thrombosis and Haemostasis (2001,
2002) and the International Union of Phlebology (Rome 2001). We also screened
review journals in the field of phlebology including: Compression Bulletin and
Scope on Phlebology.
Citations within identified studies were searched. In addition, we wrote to special-
ists known to be involved in phlebology and interested in post-thrombotic syn-
drome for details of unpublished and ongoing trials. We included in this review the
relevant data provided.
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T»bl« 1 Search strategy
Last searched: Issue 1, 2003
VF.NOUS THROMBOSIS explode tree I (McSH)
TIIROMHOIMBOI.ISM explode all trees (MeSH)
(deep next vein next thrombosis)
(deep next venous next thrombosis)
(post next thrombotic next syndrome)
widmer:ab
(# I or #2 or #3 or #4 or #5 or #6)
HANDAdES explode tree I (McSH)
compression
bandages
(compression next bandages)
(elastic next compression*)
(clastic next stocking*)
(#H or #9 or # 10 or # II or # 12 or # 13)
(#7 and #14)
treatment
(#15 anil #16)
prophylaxis
tlirnniboproplivl.ixis
prevention
(WIHor #19 or #2D)
(#17 Jiul (not #21))
METHODS OF THE REVIEW
7'nW <i.<vc.<.s7»ir«f
One reviewer (I)NK) assessed titles and abstracts of studies identified in terms of
their relevance and design, according to the selection criteria. Full versions of arti-
cles were obtained if, from the initial assessment, they satisfied the inclusion crite-
ria. Full papers were checked to identify those that fitted the criteria. Another
reviewer (MWCS) repeated this independently, for verification. Any disagree-
ments were resolved by discussion (MHP and HAMN).
Details of the studies were extracted and summarized using data extraction sheets.
If data were missing from reports then attempts were made to contact the authors
to obtain the missing information; no data were forthcoming. No studies were
found that had been published in duplicate, however, if duplicates are identified in
future tliev will onlv be included once.
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Data extraction was undertaken by one reviewer (DNK) and checked tor accuracy
by a second (MHP). Each study was appraised using a standard checklist to assess
the validity of the methods used. Data were collected on:
• Tnal setting (country, and whether primary or secondary care);
• Method of randomization;
• Objective outcome, method of assessment and whether blinded;
• Length of follow-up;
• Number of patients (or limbs) randomized;
• Inclusion criteria; exclusion criteria;
• Description of interventions and co-interventions;
• Baseline characteristics of groups for important variables (e.g. first deep vein
thrombosis, recurrent deep vein thrombosis);
• definition of post-thrombotic syndrome.
Results
• Intention to treat analysis;
• Number and reason for withdrawals;
• Source of funding;
• Use of an a pnon sample size/power calculation.
It was intended to compare elastic compression stockings versus control, and other
comparisons will be made in future if available. We have allowed for:
• Mechanical compression therapy versus control;
• Mechanical compression therapy versus compression stockings;
• Compression stockings versus different brands of compression stockings.
The comparison of interventions as well as the format of the reported outcome
made the results ot these studies not suitable for the calculation of a summary statis-
tic, so we performed a narrative overview. In future, if appropriate, heterogeneity
will be explored by examining factors that may be influential such as definition of
post-thrombotic syndrome used, care setting, time of follow-up, and incidence of
recurrent deep vein thrombosis. In the absence of clinical heterogeneity we will
test for statistical heterogeneity using the chi-squared test. If applicable, in future,
RCTs and CCTs will be analyzed separately to access the efficacy of the effect esti-
mation calculated with the Mantel Haenszel test.
Dwcripfiow q/*5
Four trials were identified. Two were excluded"''. The study by Kakkos", was not
designed to treat patients but rather to test the effectiveness of a new intermittent
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pneumatic compression system on 10 patients with post-thrombotic syndrome and
10 patients with varicose veins. The study by Kahn', was designed to evaluate the
effect of graduated elastic compression stockings on leg symptoms and signs during
exercise in patients who had had a deep vein thrombosis one year previously. In
this crossover study 40 patients were excluded, of whom 19 were diagnosed as post
thrombotic syndrome.
Two trials were identified that met the inclusion criteria. These trials were both
reported by Ginsberg et al . '"" . One compared the effectiveness of intermittent
compression units, applying a low (15 mmHg) or a higher therapeutic pressure (50
miiiHg), in a randomized cross-over design for one month". Fifteen patients with
severe post-thrombotic syndrome were included. Treatment was considered to be
successful in patients who preferred the therapeutic pressure, wished to continue to
use this pressure, and who demonstrated an improvement on a symptom score list.
Unfortunately, changes in signs and symptoms of the post-thrombotic syndrome
were not reported separately.
The other trial compared the effectiveness of elastic compression stockings (40
mini Ig pressure at the ankle) with placebo stockings (one to two sizes too large) in
,i.\tticiitvwith,no'»t-thronibonf svndrome defined bv a svniptom list, independently
of severity'". Patients were screened for post-thrombotic syndrome one year after
deep vein thrombosis had been diagnosed. Follow-up was planned for two years.
Patients who had symptomatic (n = 30) and asymptomatic (n=3) deep venous
thromboses were included. For two patients it was not clear it they had symptom-
atic clinical presentations. The primary outcome in this study was treatment fail-
ure, defined as pain and swelling that did not improve, or worsened, after the first
three months; or worsening of symptoms during further follow-up; or symptoms
that prevented patients from performing their daily activities for five or more days
in any three-month period; or developing a leg ulcer.
True randomization with allocation concealment (i.e. the person recruiting the
patient into the trial is unaware to which group the patient will be assigned) was
achieved in both trials. Blinded outcome assessment was achieved by cross-over
design with and without therapeutic pressure in the trial with intermittent com-
pression units", and in the other study by comparison with placebo stockings'".
Study personnel were unaware of allocation at the time of outcome assessments. In
the trial with elastic compression stockings'", scoring of current symptoms was
compared against scoring of previous symptoms after three months. Since the defi-
nition of failure was driven by a worsening of symptoms during a three month
interval, patients with fluctuating symptoms could be classified as treatment fail-
ures, even in the presence of long-term improvement.
1KIMM1.M IM IMM-IIIKilMltOlirSVNliROMIi
RESULTS
In the study with intermittent compression units' ' ,12 of the 15 patients (K0%) had
the perception of an important difference in tavor of the therapeutic prevsure levels
(95% Cl 52% to 96%). However, after discontinuation of the study only tune
patients (mean 60%, 95% CI 32-100%) continued to use the compression pump
successfully, at pressures between 40 and 50 mmtlg between one and four times a
day. They experienced benefit six to 30 months alter their enrolment in the origi-
nal study. The symptom score at therapeutic pressure levels was 14.3 (SI) 5.4)
compared to 16.5 (SI) 6.1) at placebo pressure levels. When analyzed as a crossover
study (paired Student's t-test) the mean difference in scoring at the two pressure
levels was -2.1 with a 95% Cl -3.6 to -0.7, p = 0.007
The second study'", was conducted as a part of a larger study. The authors used a
specially developed scoring system for the patient response to treatment. We eval-
uated only the part ot the study in which they enrolled patients widi symptomatic
post-thrombotic syndrome. The definition used in this study was: chronic (dura-
tion of more than one month), typical (better after a night's sleep and leg elevation,
worse at the end of the day and after prolonged standing or sitting), and p.mi and
swelling of the leg(s) six months or more after a proximal deep vein thrombosis.
Patients were categorised as having post-thrombotic syndrome only if they had
both pain and swelling. Of the group with active stockings, 11 (61.1%) of 18
treated were considered to be treatment failures, compared with 10 (5K.K%) of 17
treated with placebo stockings.
In this study no patients developed leg ulceration. In addition, no adverse effects
after initiation of the compression therapy were mentioned. No information was
available on reduction of edema, pain, recurrence of deep vein thrombosis, pulmo-
nary embolism, compliance with compression therapy and costs.
DISCUSSION
It is unfortunate that only two randomised clinical trials dedicated to the physical
treatment of such a prevalent disorder as post-thrombotic syndrome could be iden-
tified. Both trials were initiated by the same group of investigators. Our search was
broad, and included all languages as well as personal contact with other investiga-
tors involved in the clinical area. Hence, it was unlikely that major trials had been
missed.
As intermittent compression units" were used for severe post-thrombotic syn-
drome, their effect on mild to moderate symptoms is unknown. The study lasted
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two months, which is a limited rime in which to evaluate a treatment for a chronic
disease such as post-thrombotic syndrome. Important additional information that
would be required are the long-term effects, patient satisfaction (quality of life),
and compliance with the treatment modalities. However, the beneficial effect of
compression therapy is in line with the observed increased ulcer-healing rates
compared with no compression'^.
In the other study'", no effect was found for compression stockings for patients
with mild to moderate post-thrombotic symptoms. Assessment of the post-throm-
botic syndrome was done with a different, non-validated and probably sensitive
scale. A blinded comparison was enabled by the use of a stocking that was one to
two sizes too large. This might have influenced the results by diminishing the con-
trast between the treatment groups since; even a stocking that is too large will give
some compression. Indeed it has been shown that stockings that are one or two
sizes too large still exert considerable pressure in comparison to stockings without
elastic threads". Thus, it is possible that an effect could have been present had the
comparison been done with a true placebo stocking. Additionally, we analyzed the
il.it.i of thigh- and knee-high stockings together because in measurements of venous
pressure and loot volume no superiority of thigh high stockings was found''.
In conclusion: there is some evidence of a beneficial effect of intermittent pneu-
matic compression units, but the study was too small and too short to draw firm
conclusions. lurther research is needed in order to assess whether intermittent
pneumatic compression units give long term reduction and relief of symptoms due
to post-thrombotic syndrome, as well as prevent deterioration and leg ulceration.
No evidence was found for the use of elastic compression stockings to treat
post-thrombotic syndrome.
REVIEWERS' CONCLUSIONS
in patients with severe post-thrombotic syndrome, intermittent compression ther-
apy is potentially effective in the treatment of post-thrombotic syndrome. No evi-
dence was found for elastic compression stockings in the treatment of post-throm-
botic syndrome.
i>r n'.iTiin7i
There is an urgent need for more research in this field. Large randomized trials that
evaluate the long term ertect on the clinical course of post-thrombouc syndrome
are needed.
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APPENDIX A
CHARACTERISTICS OF INCLUDED STUDIES
Study Ginsberg JS, Magier II, Mackinnon B, Gent M, Hirsh J. Intermittent compression
unit« for severe post-phlcbitic syndrome: a randomized crossover study. CMAJ
Canadian Medical Association Journal 1999; 160(9): 13<O-6.
Methods Randomised, cross-over design with independent blinded assessment of the outcome
events. Exclusions post-r.indonmation: none Lowes to tollow-up: none. Study dura-
tion: 2 months.
Participants Setting: Ontario teaching hospital. No. of patients = 15. Sex: 12 women and 3 men.
Age: mean age 6O
Inclusion intern, diuuincnted DVT and intrai table symptoms of PPS causing signif-
icant limitation ol lifestyle, significant morbidity or both, .is indicated by any of the
following: loss of job or absenteeism from work because of PI'S; interference with
day-to day activities, e g housework, sports; frequent loss of sleep; failure of condi-
tion to improve with use of graduated compression stockings; or patient's intolerance
of. or refusal to use such stockings.
Exclusion criteria. I )VT within the past 3 months or it they were unable to travel to
t h e i h i m
Interventions Extremity pump twice daily (20 minutes per session) randomly assigned to use either
SO mini Ig pressure or I S mini Ig pressure for the first month, the other pressure was
used the so oiul month
Outcomes Successful treatment: defined as preferring the high pressure, and continuing the use
of the extremity pump and difference between the two pressures of at least slight
importance.
Study Ginsberg JS, Hirsh J, Julian J. Vander LaandeVnes M, Magier I). MacKinnon B.et al.
Prevention and treatment of postphlebitic syndrome: results of a 3-part study.
Archives ol Internal Medicine 2001 ;H>l(l7):21O.S-9.
Methods Randomised, double blind study. Patient and outcome assessor blinded. Exclusions
post-randomisation: none described. Losses to follow-up: one in treatment group
due to death Mean follow-up: treatment group =25.6 months
placebo group =25.4 months.
Participants Setting: affiliated hospitals Hamilton University-. Ontario Canada Evaluation was
clone one year alter proximal HVT PPS was defined as chronic pain and swelling as
scored on a standardized questionnaire. Hollow-up was done every 3 months. Exclu-
sion criteria: previous graduated compression stockings, geographic inaccessibility
and failure to provide informed consent.
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Interventions Comparison was done with compression stockings (30-40 nuntig) or placebo stock-
ings (one to two sues too Urge). Below knee or thigh length compression stockings
were administered depending on the localisation of complaints.
Outcomes Treatment failure: defined as pain and swelling llul did not improve, or worsened
after the tint three months, or if these symptoms worsened during further tollow-up.
or if a patient could not perform his daily activities for live or more days in any
three-month period, or developed a leg ulcer.
DVT = Deep vein thrombosis; PPS = I'ost-phlebitic syndrome
APPENDIX B
CHARACTERISTICS OF EXCLUDED STUDIES
Study
Kahn SR, Azoulay L. Hirsch A, Haber M.
Strulovitch, Shrier I. Effect of graduated clastic com-
pression stockings on leg symptoms and signs during
exercise in patients with deep venous thrombosis: a
randomized cross-over trial. Journal of Thrombosis
and Haemostasis 20()3;l(3):494-9.
Reason for exclusion
Crossover study to evaluate the effect of
graduated elastic compression stockings on
leg symptoms and signs during exercise ill
patients who had had a deep vein thrombosis
one year previously. Artificial situation with
treadmill exercise session, with and without
stockings.
Kakkos SK, Szendro G, Griffin M, Sabetai MM, Study was not a treatment for post-throin-
Nicolaides AN. Improved hemodynamic effective-
ness and associated clinical correlations of a new
intermittent pneumatic compression system in
patients with chronic venous insufficiency. Journal of
Vascular Surgery 2001;34(5):915-22.
botic syndrome but designed to test the effec-
tiveness of a new intermittent pneumatic
compression system.
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Recurrent leg ulcers in a young man with
hyperhoniocysteineniia, factor V Leiden and
impaired tibrinolysis
Kolbach DN . Veraart JCJM , ! . Sp.upen 1,|M .
Neumann HAM' .
Departments of I )erniatologv ,ind Henurnk>^\. Ai.idcnik 1 lospu.il M.i.i^rn In.
'Biochemical (lenetics. Stuhting klinische ^cnctui Zuid-Oost Ncdcrl.iiid,
The Netherlands
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AUSTRAGT
We present a young male patient referred to our hospital with leg ulcers on both legs that had been
refractory for more than 3 years to standard treatment with compression therapy. By thrombophiha
screening, factor V Leiden mutation, hyperhomocystememia and evidence for impaired fibnnolysis
were found. Treatments with folic acid in combination with long term oral anticoagulant therapy
were added to non-elastic compression therapy. The leg ulcers showed slow improvement and
complete healing within 3 years. During a 6 year follow-up period no new thromboembohc events
occurred, nor was there recurrence of ulcerations.
Thi» case suggests a potential synergistic pathogenic role of factor V Leiden, hyperhomocysteinenua
and impaired fibnnolysis in the development of post-thrombotic syndrome and its sequelae. We
postulate that increased formation of thrombi in the microcirculation of the skin, in combination
with ambulatory venous hypertension due to recurrent deep vein thrombosis, might explain our
observation.
BACKGROUND
Venous leg ulcers affect 0.5 to 2% of the general population'". In 5()% of patients
with leg ulcers, a history of deep vein thrombosis (DVT) exists'. A common
(22.8% - 60% after 2 years), and often disabling, consequence of DVT is
post-thrombotic syndrome (PTS), with symptoms ranging from mild edema to
incapacitating swelling with pain and ulceration. PTS is strongly associated with
ipsilateral recurrent DVT"'''. Several risk factors for DVT are known, including a
number of inherited coagulation defects''". Some of these inherited defects are
rare, but factor V Leiden anil hyperhomocysteinemia are quite frequently found.
Among European populations, factor V Leiden is the most common genetic defect
causing thrombosis which is currently known. Heterozygous factor V Leiden
increases the risk of thrombosis from three- to eightfold. In the Netherlands, with
±4% of the population being carriers of factor V Leiden and having a relative risk
of 8, factor V Leiden contributes to 22% of all thrombotic events'*. Mildly elevated
plasma levels of homocysteine are also associated with an increased risk of venous
thrombosis. In the Netherlands, basal levels exceeding 18.5 umol/1 were found in
5% of healthy individuals and were associated with a two-fold increased relative
risk of venous thrombosis'". Hyperhomocysteinemia may be caused both by
genetic and acquired factors, such as deficiency of vitamin 136, B12 and folic acid".
Both factor V Leiden mutation and hyperhomocysteinemia have been proven to
increase the risk for venous thromboembolism. When both factors exert their
action simultaneously, these etVects may interact, and the combined effect may
exceed the sum of the separate effects'-' \ The mechanism of interaction is not
known. In 70% of carriers of the factor V Leiden mutation, the occurrence of DVT
was associated with a precipitating condition, most commonly: pregnancy and sur-
gery"
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in this report we present the history of a young man referred to us. who had a 3
year history of recurrent leg ulcers based on severe I'TS. which followed several
episodes of DVT associated with factor V Leiden, hyperhoinocystememia and
impaired fibrinolysis.
CASE REPORT
A 24 year-old male was finally referred to our hospital because of longstanding
ulcerations of the lower leg. He was known to have had a history of l.egg-IVrthes
disease when he was seven years old and three documented episodes of proximal
spontaneous deep vein thrombosis of both legs. The first spontaneous thromhotic
event occurred in his left leg when he was IV) years old. Documentation of DVT
was made by duplex sonography. After 3 months, anticoagulant therapy was
stopped. A few months later, after a trauma, he developed a DVT in his right leg,
documented by duplex sonography. At the age of 21 years old, he developed a
third spontaneous DVT in his left leg and anticoagulant therapy was restarted tor (>
months. Soon after anticoagulant therapy was stopped, he developed a severe
post-thrombotic syndrome with bilateral leg ulcers. Venography .it this time
showed residual thrombus in the left and right temor.il vein. At the nine of referral
to our clinic, the ulceration had been present for more than 3 years. He was only
treated with high pressure compression therapy and did not use oral anticoagulant
therapy. There was no evidence for underlying acquired disorders. I he family his-
tory' was negative tor venous thromboembolism; Ins mother was known to have
had unexplained recurrent abortions.
On presentation in our hospital, we saw a tall man with normal hotly proportions
(height 197 cm; weight 88 kg). There were bilateral ulcers with some debris at the
medial malleolar regions on both legs. There were signs of white atrophy and
extensive pigmentation on the lower legs, including lipodermatosclerosis (photo
1). There were no venous varicosities visible. The dorsal pedis and posterior tibial
pulses were palpable on both legs. Color-coded duplex sonography showed
venous reflux of the superficial femoral vein and popliteal veins, the groin area
revealed several superficial collaterals. Ascending venography showed remains of
an old thrombus in the left and right femoral vein (photo 2); retrograde filling of
the venous system in both legs. Left and right long saphenous veins showed no fill-
ing. Photoplethysmography showed a venous refill time decreased to 10 sec (nor-
mal 25 sec)''. Functional investigations with air-plethysmography showed an
increased venous filling index, (left leg: 8.9 ml.sec and right 14.3 ml/sec; normal
value < 2 ml/sec) and diminished ejection fraction (left leg: 38.7% and right
34.5%; normal value > 60%).
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Photo 1 Skin Symptoms of severe post-thrombotic syndrome with bilateral venous leg ulcers at
ago 2.V
Photo 2 Ascending phlebography ot" the right leg. The left picture showes a frontal view and
the right picture a 3/4 lateral view. I: remains of an old thrombus and reconahzahon in
the right femoral vein II: several superficial collaterals can be seen in the calf area.
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Extensive thrombophilia studies revealed that he was heterozvgeouo for the factor
V Leiden mutation. In the presence of normal values for folic acid, vitamin Bo and
vitamin B12 . we found an abnormal fasting homocysteine level (20.2 umol/1, nor-
mal value < 18 uniol/l, mean ±2 SO) and an increased homocysteine concentra-
tion six hours after an oral intake of MM) mg methioniiu*/ kg bodv weight (64.4
uinol/1, nonnal < 56.3 umol/l. mean ±2 SO). A control metluomiu- loading test
after 3 months and after 4 years using folic acid was normal. His basal plasinmogen
activator inhibitor type I (I'AI-1) activity was slightly increased (28 AU/ml, nor-
mal < 20 AU/ml) on several measurements in blood s.unpls taken between •> and
10 am after an overnight fast. A venous occlusion test was performed in order to
estimate his fibnnolytic response. Upon venous occlusion no decrease of his I'AI-1
activity was found, suggesting unpaired tibnnolysis also to be present.
The leg ulcers were treated with local petrolatum-gauze and a firm non-elastic
compression bandage. Oral anticoagulant therapy was restarted (in principle life-
long), and folic acid 5 mg once a day added. His leg ulcers slowly improved, with
complete healing after 3 years. There have been no recurrent thromhocmholu
events after starting treatment in our hospital.
DISCUSSION
Clinical presentation of PTS is a rare complication before the age of 30. Our
patient had already developed leg ulcers based on I'TS at the age of 21 The pres-
ence of factor V Leiden, hyperhomocysteinemia and unpaired fibrinolysis suggests
a potential synergistic role in the development of both recurrent venous thrombo-
sis and the development of venous leg ulcers, which are difficult to treat.
In the development of venous leg ulcers, damaged deep leg veins are of major
pathogenic importance. Ambulatory venous hypertension arises as the result of an
incapacity of the valves of the leg veins and the associated phenomenon of venous
reflux resulting in a decrease of the output of the calf muscle pump"'. The more
extensive and the more distal this reflux, the greater the probability that a leg ulcer
will occur'^-'". In our patient with documented deep and superficial insufficiency,
the only known effective ambulant treatment is high-pressure compression ther-
apy '. It is of interest to note that adequate compression therapy had been given for
several years in our patient without clinical improvement. While a slow, but com-
plete healing of the ulcers obtained by restarting oral anticoagulants and introduc-
ing folic acid supply, suggests that the abnormalities found in the thrombophilia
investigations might contribute to non-healing of the ulcers.
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In a previous study it was shown that compared to matched controls significantly
more often the factor V Leiden mutation is found in patients with venous leg ulcers
(23% compared to 7.5%, p = 0.03)*'.
In factor V Leiden mutation, microthrombi formation at the site of the leg ulcer-
ation is probably present. It has also been proposed that impaired fibrinolysis may
contribute to an increased thrombotic tendency. Increased ambulatory venous
pressure increases also the capillary pressure leading to leakage of capillaries with
halo formation consisting of fibrin. Dilated capillaries and consequent flow
decrease leads to low pO, and white cell trapping at the level of the micro-
circulation. Ultimately, this leads to vessel wall damage-'. Microthrombi have also
been found in the skin of patients with chronic venous insufficiency-". This altered
nncrocirc illation can be the cause of skin ulceration. As the protein C pathway is
especially important in the microcirculation of the skin^' **, oral anticoagulant
therapy is therefore a trcatnient option. Controversial data are known on the use of
aspirin*'', in that a positive effect of aspirin on the healing of leg ulcers has not been
continued by other studies. There are no data on the use of coumann derivatives.
This case illustrates a potential clinical benefit of oral anticoagulants. Another inter-
esting aspect of this case is the Legg I'erthes disease treated at the age of seven years.
In the study of" (Ilueck et .il.-'\ factor V Leiden is seen in 75% of patients with Legg
IVnlu-> disease. Legg I'erthes disease is also a thrombotic disorder, in which charac-
teristic- thrombotic venous occlusion of the femur leads to venous hypertension
and osteonecrosis of the femur head.
The factor V Leiden mutation underlies resistance to activated protein C (AI'C).
Nie activated form of" coagulation factor V (Va) is an essential coractor for
thrombin generation at the site of vessel injury. In order to prevent excessive
thrombin generation normal factor Va is efficiently inactivated by AFC. This effi-
cient negative feedback mechanism is disturbed in patients with factor V Leiden
mutation, because the mutation is located on one of the major APC-cleavage sites.
Thus, excessive thrombin formation takes place at the site of endothelial damage.
Several mechanisms have been postulated to explain the thronibotic tendency in
patients with hyperhomocysteinemia, including interference with the protein C
pathway as well. It is unknown if the combination of factor V Leiden mutation and
hereditary hyperhomocysteinemia is associated with earlier and more severe FTS.
1 )VT at a young age. especially without the presence of environmental risk factors,
is an indicator for inherited thrombophilia. Patients with chronic and/or recurrent
venous leg ulcers should be considered for testing of factor V Leiden and
hvperhoniocysteineniia. Both thrombophilia are frequently found in the Caucasian
population. In conclusion, we recommend screening for both thrombophilia in
young people with symptomatic venous thrombosis or venous leg ulcers.
vASIRUHORT 10?
REFERENCES
1. Callam MJ. Ruckley CV. Harper DR. Dale JJ Chronic ulceration of the leg: extent of the pro-
blem and provision of care. Br Mcd | (Chn Re» LJ) 1985.290:1855-6
2. Widnier LK. Stathelin HU. Nissen C, A. Sd. Venen-, Artenen-, Krankheiten, koronaire
Herzkrankhei bei berufstätigen In. Bern: Verlag Harn Huber; 1981 66-82
3. Fucrstein W. Was ist das wirklich Postthronibotisi h Ulcus crunx? Phlebologte |W4;4:150-2.
4. Prandoni I', Lensing AW, Cogo A. Cuppim S. Villalta S, Carta M, et al. The long-term clinical
taunt ol acute deep venous thrombosis. Ann Intern Mcd |9*J6,I25:1-7
5. Brandjes DP. Buller HR. Heijbocr H. I IUIMIUH MV. de Rijk M.Jagt II. ft al Randomised dial
of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lan-
cet 1997;349:759-62.
6. Salzmann EW, Hirsch J The epidemiology. pathogenesi\. and natural hiMnrv ol 'venous ihiom
bos». In: C'olman RW. Hirsch. J . Marder. V | . Sal/man. I- W .. cd lleiuostasis and thrombo-
sis: bassic principles and clinical practice. 3rd cd I'liiladclplua J B lippuuot. I'J'J4. 1275-'Mi
7. Rosendaal FR. Risk factors for venous thrombosis: prevalence, ruk, and interaction. Seiiiin
Henutol 1997;34:171-87.
8. Rosendaal PR. Risk facton for venous thrombotic disease Thronib Haemost l'*')>*,82 t>l" '»
9. ReesDC. CoxM.CIeggJU. World distribution of fat tor V leiden 1 am et I'»'»5.346 I I V\-4
10. den Heijer M. Blom HJ. Germs WB. Roscndaal FR. I laak IIL. Wijeriiuns I'W. et al Is hyper-
homocysteinaenua a nsk factor for recurrent venous thrombosis? Lancet l*W5;J45:HH2-5.
11. MuddSH. Levy HL, Skovby F. Disorders of transsulfaration ('Itapter 35 In Sinver l"R. Be.iu-
det AL. Sly WS, eds. The Metabolu and Molecular liases ol Inherited Disease 7ih ed.
McGraw-Hill, me; 1995. 1279-97.
12. Ridker I'M, Hennekens C"H, SelhubJ, Miletuh |P. Malinow MR. Stampfer MJ. Interrelation
of hyperhomocyst(e)inemia, factor V Leiden, and risk ot future venous tliromhocuihuliMii (!n
culation 1997;'J5:1777-82.
13. Mandel H, Brenner B, Berant M. Rosenberg N, Lanir N, Jakobs C^ , et al. (!oexistenie of here-
ditary honiocystinuria and factor V Leiden-effect on thrombosis. N ling) J Med 199t>;334:
763-8.
14. Lensen RP, Bertina RM, de Ronde H, VandenbrouckcJP, Rosendaal FR. Venous tliromhotic
risk in family member; of unselected individuals with factor V Leiden. Thromh ll.ieuiust
2000:83:817-21.
15. Neumann HA, Boersma I. Light reflection rheography. A non-invasive diagnostic tool tor
screening for venous disease. J Dcmiatol Surg Oncol 1992; 18:425-30.
16. Consensus paper on venous leg ulcer. The Alexander House Ciroup J Derm.itol Surg Omol
1992:18:592-602.
17. Bassi G. |Ulcer and pre-ulcerous dennatoses in primary insufficiency of the external saphenous
vein|. Phlebologie 1974:27:119-22.
18. Bjordal R. Flow and pressure studies in venous insufficiency. Atta Oiir Stand Suppl 1988;
544:30-3.
19. Pansch H. Compression therapy of the legs. A review. J Dermatol Surg On« ol I99IJ7;
799-805.
20. Maessen-Visch MB. Hamulyak K. Tazelaar DJ. C'rombag N i l . Neumann HA. The prevalence
of factor V Leiden mutation in patients with leg ulcers and venous insufficiency. Arch Dermatol
1999:135:41-4.
21. Neumann HAM, Tazelaar DJ. Compression Therapy. In: Bergan JJ, ed Varicose veins and felc-
angiectasias - diagnosis and treatment.; 1993. 103-122.
22. Bollinger A. Leu AJ. Evidence for nucrovascular thrombosis obtained by intravital fluorescence
videonucroscopy. Vasa 1991:20:252-5.
108 CHAPTER 9
23. Marciniak E, Wilson HI), Marlar RA. Neonatal purpura fulminans: a genetic disorder related to
the absence of protein C in blood. Blood 1985;65:15-20.
24. Bauer KA. Counurin-induced skin necrosis. Arch Dcrmatol 1993; 129:766-8.
25. Ibbotwxi SH, Layton AM, DavicsJA, Goodfield MJ. The effect of aspirin on haemostatic acti-
vity in the treatment of chronic venous leg ulceration. Br J Dermatol 1995; 132:422-6.
26. Glueck CJ. Brandt G, Gruppo R, Crawford A. Roy Ü, Tracy T, et al. Resistance to activated
protein C and Lcgg-Pcrthcs disease. Clin Orthop 1997:139-52.
Chapter 10
Local endothelial function and leg symptoms in
patients after deep vein thrombosis
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ABSTRACT
The fundamental pathophysiological disturbance in the post-thrombotic syndrome
(ITS), a long tern» complication of deep vein thrombosis (DVT) is sustained venous, and conse-
quently, capillary hyperu-mion. We hypothesized this could lead to endothelial dysfunction that
mi^ht be expressed in local abnormalities such as coagulation or fibrinolysis.
I'atients with ultrasound documented DVT were age and gender matched with controls.
All subjects underwent invasive ambulant venous pressure measurement. Blood was collected from
the .inn and, after ten minutes standing, from the leg. Analyses were performed with paired Stu-
dent's t-tcsts
CLAI' classification was CO-C'4 among IS patients (median time since DVT 4 years) and
C0-C2 among IS controls, while the ambulant venous pressure was 45 (±17) and 16 (±9), respec-
tively (p < l).(X)l). After ten minutes standing, the increase in von Willebrand Factor (p = 0.004) in
the leg was higher in p.itu-ncs with previous DVT than in controls. In DVT patients with I'IS sys-
temic vWF antigen was higher in comparison to patients without ITS. Increase in fibnnogcn was
statistically significantly different in DVT and control group, p < 0.001 and p = 0.002 hictor V111: c,
il iliiiK-r .iiul I'AI-I increased also in patients with previous DVT, Mean increase in I'AI-1 in DVT
.nul control was O.'J .iiul 0.2. respectively.
(.'<>»<<7I(.«II>H.< Increases in vWF after ten minutes standing was higher in patients with previous
DVT than in lontrols. This indicates, since substantial volumes are accumulated during standing,
tlul loi.il oiulollu-li.il ilvsfuiu tion uuglu coutnlnitc to dilferences in coagulation status between
patients with DVT and iiiirm.il subjects.
INTRODUCTION
The fundamental pathofysiologic.il disturbance that can be observed in patients
after a deep vein thrombosis is sustained venous hypertension, which results from
valvular incompetence, outflow obstruction, calf muscle pump dysfunction, or a
combination of these'. This venous hypertension is thought to lead to leg symp-
toms and even to venous leg ulcers, based upon alterations of the micro-
circulatioir. However, additional mediating pathofysiological mechanisms have
been implicated in the process. Several hypotheses have been postulated, e.g. white
cell trapping theory\ fibrin cuff theory'' and formation of microthrombP. All those
mechanisms might impair the microcirculation, resulting in dystrophic changes of
the skin, or if severe, leading to leg ulceration.
We hypothesised that venous hypertension and consequently capillan- hyperten-
sion could lead to endothelial dysfunction that might be expressed in local abnor-
malities of coagulation or fibrinolysis.
I lence. the purpose of this study was to evaluate in the leg a local response of coag-
ulation and tibnnolytic parameters to a stimulus of venous hypertension in patients
with a previous deep vein thrombosis, as compared to matched controls.
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METHODS
This was a case-control study, designed to explore differences in local responses in
coagulation and fibnnolytic parameters in reaction to venous hypertension in the
leg in subjects with and without previous deep vein thrombosis (DVT). Patients
with DVT were eligible it" they had a lower limb DVT. more than a year prior to
that and no documented ipsil.ucr.il recurrent I )VT. Controls were m.iu hed tor age
(±3 years) and sex. Controls consisted of patients attending the outpatients depart-
ment dermatology and healthy volunteers, who were without spontaneous leg
complaints. Exclusion criteria were current use of anticoagulant therapy, use of
aspinn or other drugs known to interfere with lucmostasis. All subjects gave
informed consent, and the protocol was approved by the medical ethics review
committee.
In all patients a standardized clinical and physical examination was performed with
special attention to signs and symptoms of the lower limb. A blood sample was col-
lected from the antecubital vein (systemic circulation) after a resting period often
minutes. Hereafter invasive venous pressure measurement was performed m the
affected leg for DVT patients or the left or right leg of controls Then, participants
were asked to stand, without any movement of legs and body and without speak-
ing for ten minutes. Directly thereafter a blood sample was collected from the leg
circulation in the dorsal foot vein. This sampling was performed through the access
needle of the invasive venous pressure measurement after spilling the- first 2 ml
The clinical status of the leg was classified according to the consensus report of the
American Venous Forum in 1994, also known as the CEAI' classification'', in tins
classification the clinical signs and symptoms are graded 0-6, with CEAI' 0-1 rep-
resenting no signs of post-thrombotic syndrome (I'TS) and CEAI' 2-6 represent-
ing mild to severe signs and symptoms, compatible with I'TS.
Invasive ambulant venous pressure measurement was performed with a 21 gauge
(0.8 mm) butterfly needle (VYCiON microflex) inserted into a vein on the dorsuin
of the foot . The needle was connected through a pressure monitoring set
(Edwards lifesciences) filled with physiological salt solution and an amplifier to a
112 CHAPTER 10
computer and printer. First, the standing venous pressure (SVP) was measured in
steady state in the subject who supported himself in the standing position by hold-
ing onto a frame. Then, the subject performed a standardized exercise of 10 tiptoe
movements at the rate of 1 per 1.5 seconds, synchronous with a metronome. The
ambulant venous pressure (AVP) was measured at the end of the 10 tiptoe move-
ments. Then, the subject remained still while recovery of the pressure to baseline
levels was recorded. The exercise was then repeated.
Blood for biochemical analyses was collected from the antecubital vein without
venous stasis and from a dorsal foot vein as described in the experimental design.
We used a V.icutainer PrecisionGlide*^ connecting system (0.8 x 38 mm) to col-
lect blood. The first 2 ml were discarded and the remaining was sampled into 4.5
ml Vacutainer tubes containing 0.129 M sodium citrate (Becton Dickinson
Europe) and serum tubes (no anticoagulant). The blood samples were processed
within 30 minutes after collection. Citrated platelet poor plasma was made using
two centrifugation steps: 5 minutes at 4000 rpm at room temperature and 10 min-
utes at 11000 rpm at 4"C. The plasma samples were stored at -70°C in aliquots of
500 ul until .nulysis. Factor VIILc. vWF:ag, fibrinogen. CRP. PAI-1 and d-dimer
were measured in one blinded batch. Hence, the laboratory technicians were
unaware of the patients' characteristics while they determined the test results. CRP
was measured according to the manufacturer's specifications (Beckman-Coulter)
by turbidimetry in a Beckman-Coulter 1.X20. Factor VIII:c activity was deter-
mined using a one stage clotting assay with factor VIM-deficient plasma
(l)adc-Behring, Germany) and automated activated partial thromboplastin time
(APTT; Actin FS, Dade Inc. Aguada, USA). Von Willebrand antigen was deter-
mined using an F.I.ISA assay with polyclonal rabbit and human vWf antibodies
(AO82 (capture antibodies) and pO22(> (conjugated antibodies), Dako ITK, Den-
mark). D-dinier was quantified with an automated quantitative assay based on the
E1.FA (enzyme linked fluorescent assay) technique using a VIDAS according to
the manufacturer's instructions (BioMerieux. France). Fibrinogen was measured in
citrated plasma by the method described by Clauss. PAI-1 activity was determined
by a commercial assay Spectrolyse* /PL PAI (Biopool, Sweden). This assay is
based on a two-stage, indirect enzymatic method as first described by
Chmielewska" and was performed according to the manufacturer's instructions.
Genetic analysis ot the factor V Leiden mutation (R506Q) was performed using a
commercial assay based on fluorescent resonance (Roche. Germany) on a light
cycler* real time PCR analyser (Roche. Germany). All measurements were per-
formed in duplicate. The final result was considered to be the mean of these mea-
surements. Pooled normal plasma, from one hundred healthy volunteers, was used
as a reference.
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Statistical analyses were performed with the software package SPSS 10.1. The
independent Student's t-test was used to test for statistical significance of differ-
ences in ambulant venous pressure. The paired Student's t-test was used to test for
statistical significance of differences in concentrations in systemic circulation
between cases and matched controls. In addition tins tost was used to analyze
changes in systemic and local circulation in individuals separately. The differences
in systemic and local circulation were calculated and compared with paired Stu-
dent's t-test between cases and controls. In addition, the differences in concentra-
tions in patients with and without signs of post-throinbotic syndrome were ana-
lyzed with the independent sample t-test. The severity of leg symptoms (C!EAP
classification), differences in thromhophilia and family history were analyzed with
Wilcoxon signed ranks test.
RESULTS
A total of 30 subjects, 15 patients with prior DVT and 1 r> age .iiul gender matched
controls, were enrolled. Of the controls, 4 had other dermatological conditions
and 11 were healthy volunteers. The demographic characteristics of the subjects,
details of the episode of DVT and the CEAP classification of the clinical character-
istics of the leg are given in table 1.
The results of the comparison of differences in mean (isd) laboratory values of
inflammatory, coagulation and fibrinolytic parameters between leg and arm in
individuals are given in table 2. In addition, we show the P-value for the calculated
differences between arm and leg in individuals, compared between DVT and
matched control. C-reactive protein (CRP) concentrations were normal in all sub-
jects and similar in both groups. Elevated concentrations of factor V111: c and vWH
antigen were more common among DVT than among controls. In part, this is
caused by the 5 patients (33%), who were heterozygous for factor V Leiden among
the DVT group, compared to none in the control group. Factor VIILc and vWF
antigen in the systemic circulation were statistically significantly different in the
DVT group compared to the control group, p = 0.004 and p < 0.001, respectively.
When measured in the leg after ten minutes standing, factor VIII showed an
increase in concentration compared to the systemic circulation in the DVT group,
179% and 189%, respectively, which represented a trend (p = 0.096). Factor VIII
in the control group showed no difference after ten minutes standing. The differ-
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encc in change was -10 (±43)(95% CI -34 to 14) and was not statistically significant
(p = 0.37) between both groups. In the leg, after ten minutes standing. vWF anti-
gen showed an increase in concentration compared to the systemic circulation in
the DVT group, which was statistically significant (p = 0.004), while among con-
trols no increase could be measured (p = 0.81). The mean difference in increase for
vWF between the DVT group and controls was -10 (± 17) (95% CI -20 to -1) and
wax statistically significant p = 0.03.
Levels of d-dimer and PAI-1 were increased in the group of DVT p.itients and sta-
tistically significantly different betweeti cases and controls. After ten minutes stand-
ing no increase was observed in the leg in the d-dimer concentration in both
groups. The mean difference in increase for d-dimer between the DVT group and
controls was 14 (±109) 95% ('.I -47 to 74, p = 0.63. In the leg after ten minutes
standing I'AI-1 showed a similar increase in concentration in both groups. While
this increase represented a trend for the DVT group (p = 0.132), it was statistically
significant .unong controls (p = 0.009). The mean difference in increase for I'AI-I
between the DVT group and controls was -O.OO7(±2.5) (95% Cl -l.Sto 1.3)
p = 0.91. Fibrinogen levels measured in the leg after ten minutes standing showed a
similar increase in concentration compared to the systemic circulation in both
groups. This increase was statistically significant for the DVT group (p < 0.001)
,iiul among controls (p = 0.002). The mean difference in increase for fibrinogen
between the DVT group and controls was -0.13 (±0.30) (95% CI -0.30 to 0.004)
p = 0.137 .
Table 3 shows the results of the comparison of differences in mean (±sd) laboratory
values of inflammatory, coagulation and fibrinolytic parameters measured in the
systemic circulation between patients with and without clinical characteristics of
PTS. CRP concentration showed a trend (p = 0.054) toward being higher in
patients with mild to severe PTS (CEAP 2-5) compared to those without signs of
PTS (CEAP 0-1), means 7.1 mg/1 (±2.7) and 4.9 mg/1 (±1.3). respectively.
Although in the systemic circulation factor VIII concentrations were lower in
patients with mild to severe PTS than those without PTS, means 173% (±27) and
183"" (±54), respectively, this difference is not significant (p = 0.69). The higher
values for vWF antigen in the systemic circulation in patients with mild to severe
PI'S compared to those without PTS. means 194% (±35) and 154% (±29), respec-
tively, was statistically significantly different (p = 0.031). Neither the Factor VIII
concentration in the systemic circulation nor the increases after ten minutes stand-
ing, differed between patients with signs of mild to severe PTS (CEAP 2-5) and
those without PTS (CEAP 0-1). Also, values of d-dimer were equally divided
between p.itients with and without clinical characteristics of CEAP classification.
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Table 3 Mean difference in the systemic circulation of the inflammatory, coagulation and
fibnnolytic parameters (±sd) in DVT patients with no PTS compared with mild-to-moderate PTS.
No PTS (n=9) Mild-to-moderate ITS (n=6) p-value
Mean (tsd) Mean (±sd)
CRP(m|{/l) 4.9 (±1.3) 7.1 (±2.7) 0.054
Factor VIII (%) 183 (±54) 173 (±27) 0.69
vWI antigen (%) 154 (±29) 194 (±35) 0.031
d-tinner (ng/l) 412 (±237) 454 (±257) 0.75
I'AI-I activity (AU/ml) 10.1 (±5.5) 20.8 (±13.1) 0.104
Fibnm>t;en (g/l) 3.17 (±0.54) 3.73 (±0.54) 0.082
PAI-1 concentrations were higher in patients with mild to severe PTS than those
without PTS, means 20.H AU/ml (±13.1) and 10.1 AU/ml(±5.5), respectively,
p = 0.104. Fibnnogen concentrations were higher in patients with mild to severe
PTS than those without PTS, means 3.73 g/l (±0.54) and 3.17 (±0.54), respec-
tively, tins represented only a trend (p = 0.082).
DISCUSSION
After ten minutes standing, the increases in vWF antigen in the leg were higher in
patients with previous DVT than in controls. Also between DVT patients with
clinical characteristics of PTS, concentration of vWF antigen increased more. This
might point to a locally increased endothelial response to stress, that could contrib-
ute to the dirterences in coagulation status between patients with DVT and normal
subjects. Although concentrations of factor VIH:c and vWF antigen are strongly
related anil factor VIII activity also increased more in patients with previous DVT,
this difference did not reach statistical significance.
Factor VIII:c and fibrinogen are both acute phase proteins, but no arguments were
found for chronic inflammation, since CKP concentration were normal in all sub-
jects witli previous DVT, and similar to the concentration in controls. This is in
accordance with a prospective study (LITE study) in which also no relation
between (recurrent) thrombosis and markers of inflamation was found**. We
observed, again in accordance with previous studies, a large proportion of subjects
with elevated factor VIII and vWF antigen among those with previous DVT'"" .
We observed in our 1WT group a mean factor VIII:c of 17')% (±44). This is higher
than could be expected based on the reported prevalence ot 25% tor factor VIII
higher than 150%'*. In fact, 12 patients (80%) in our group had a factor VIII higher
than 150 1U/1. Potentially, the higher levels of factor VIII we found, can be attrib-
uted to increased production, and/or reduced clearance of factor VIII over the
U K Al C HANGLN IN f i V V C l i AVION A N P I IHRINOLYSIS I 117
years. Our patients were measured at a median of 4 years after the deep vein
thrombosis while in most other studies patients were measured 3 months alter their
thrombotic event". Such an acquired contribution to higher factor Vlll is com-
patible with previously reported studies in which a close relation between vWF
antigen and factor VIIlx activity was found, but no genetic contributions to this
relationship were observed. Additionally, even in female twins, the genetic contri-
bution to factor VIIlx and vWF antigen was estimated only at
Moreover, it should be realized that the increase in volume that occurs from supine
position to the standing position is substantial and has been estimated to be up to
400 ml in patients who have had a DVT. previously compared to KM)-150 ml in
normal subjects'".
It is well established that environmental factors have an influence on blood coagu-
lation and fibrinolysis. These include exercise'' and any cause of an acute phase
response. Both groups did the same exercise and after the ten minutes standing,
matched controls showed less increase in the coagulation and libnnolytic system.
In previous studies increased tl'A. PAI-1 level and d-dimer values were found for
patients with venous insufficiency compared to controls-" and for DVT patients
compared to healthy volunteers''. This is m accordance with our results, however,
after ten minutes standing no difference was found in the increase of l'AI-1 and
d-dimer levels between DVT and the compared control group.
One of the limitations of our study is the small group of patients. Therefore, con-
firmation with more DVT patients will be required. Another limitation of this
study is that we didn't take a blood sample of the foot vein before the 10 minutes
standing period, but assumed this would be equal to the sample of the anteiubital
vein. Additionally, more convincing evidence for the hypothesized mechanism
could be given if both affected and non-affected legs were sampled. This is neces-
sary to provide proof for our suggestion that venous pressure influences the endo-
thelial system and in this way gives rise to increased vWF levels and fibrinogen. In
turn the increased endothelial vWF production could lead to higher factor V111: c
levels. On the other hand, it is unlikely that any selection bias influenced the assess-
ment of the different coagulation and fibrinolytic parameters of our DVT group.
Our group showed C> patients with moderate to severe post-thrombotic syndrome
according to the CEAP classification, which is in line with clinical expectations^'.
Also we objectively measured the muscle pump function by a gold standard, the
invasive venous pressure measurement, which showed a significant difference
between both groups. The signs and symptoms of the post-thrombotic syndrome
mostly develop within the first two years after the DVT^. In our study the DVT
was diagnosed with a median of 4 years previously. Differences between the
groups couldn't be explained by gender or age because we matched on these
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parameters. We suggest that apart from the genetic risk profile an additional effect
from venous hypertension may contribute to a higher concentration of vWF and
fibrinogen by endothelial damage.
In conclusion we believe we have elicited an acquired new mechanism, an increase
of vWF antigen, leading to a pro-coagulant status in DVT patients which can addi-
tionally contribute to the clinical events of post-thrombotic syndrome.
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ABSTRACT
Impaired microcirculation in chronic venous insufficiency leads to chronic inflamma-
tion and dystrophic changes of the skin, and finally to leg ulceration. The purpose of this study was
to investigate in more detail coagulation and fibrinolytic protein response of the capillaries in skin
biopsies of the lower extremity.
From eighteen ambulant patients with venous leg ulcer(s) (n=8) and controls (n=10)
with various degrees of venous insufficiency according to the CEAI' classification, we obtained 4
mm punch biopsies. Inuminohistochemical staining with tissue derived plasminogen activator
(tl'A), urokinase derived plasminogen activator (ul'A). plasminogen activator inhibitor (PA1-1) and
von Willcbrantl Factor (vWF) was performed and analyzed with bright field microscopy.
Kfjn/r.« The amount of staining with vWF (p = 0.04) and ul'A (p = 0.02) showed statistically sig-
nificant differences. I'AI-I (p = O.IW) and tl'A (p = 0.50) showed no difference between leg ulcer
and control groups. An increase of the number of capillaries with tortuous capillary loops in the pap-
illary dennis w.i\ seen, but no statistically significant difference (M-W test, p = 0.10) was found
between the groups. Comparison between CEAP classes 0-6 showed a statistically significant
increased staining pattern of vWF (p = 0.0ft), ul'A (p = 0.02) and I'AI-I (p = 0.02), but not from
tl'A (p = 0.30).
(.'(»Hi/ii.v/<m In skin biopsies of the lower extremity of patients with severe venous insufficiency
im Teased deposition ot vWI, I'AI-I .uul ul'A were lound in the capillaries. These findings point to a
local imbalance in coagulation and fibnnolytic status, which might contribute to impaired
inn roc in ul.ition .mil finally to the development of venous leg ulceration.
INTRODUCTION
Although venous hypertension is a prerequisite for the development of venous leg
ulcers''", additional factors are considered of importance for this development,
especially, impaired microcirculation which leads to chronic inflammation,
dystrophic changes ot the skm, and finally to leg ulceration".
Venous hypertension is just one important point of the very complex patho-
physiologic mechanism in chrome venous insufficiency; several other theories
have also been published in this field i.e. fibrin cuffs, trapping of growth factors and
white blood cells, disturbance of lymphatic circulation'*"
Several studies have focused on markers of coagulation and fibrinolysis in relation
to chronic venous insufficiency (C'VI) *" ' . In progressive stages of CV1 increased
systemic levels of plasminogen activator inhibitor type 1 (PAI-1) and tissue derived
plasminogen activator (tPA) were found". In skin biopsies of progressive CVI and
in a group of patients with lipodcrmatosclerosis (C'4 according to CEAP classifica-
tion) elevated expression of urokinase derived plasminogen activator (uPA), but
not iPA was found'"". In severe C'VI patients (C4-6) increasing numbers of
microthrombi were found in the capillaries of the papillary dennis' \ It has also
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been described that venous leg ulcers treatedwith Sulodexide''*. a glyco-
saminoglycan. heal faster and this treatment is associated with statistically signifi-
cantly decreased fibnnogen levels in the systemic circulation. Factor Xlll'"* "'sig-
nificantly accelerated healing of venous leg ulcers after topical application.
Furthermore, an increased rate of ulcer healing occurred in patients receiving aspi-
rin". In a recent study of our group we demonstrated a statistically significant local
increase ot von Willebrand factor activity after a stimulus (l(> minutes standing) in
patients with previous deep vein thrombosis and increased venous hypertension "\
We found no evidence for chronic inflammation, as CRP levels in both groups
were comparable.
The purpose of this study was to investigate in more detail coagulation and
fibrinolytic protein response of the capillaries in skin biopsies of the lower limb in
patients with different stages of chronic venous insufficiency by immunohisto-
chemical evaluation of tl'A, ul'A. I'AI and vWF.
PATIENTS AND METHODS
We explored differences in local depositions of vWF, I'AI-1, tl'A anil ul'A in the
skin ot the lower extremity in subjects with varying degrees of venous insufficiency
according to the CEAI' classification. Subjects were recruited from patients attend-
ing the outpatient's department of dermatology and volunteers. All patients
included were ambulant. Exclusion criteria were: present use of anticoagulant
drugs or aspirin, arterial insufficiency, diabetes mellitus, malignancy, major surgery
in the three previous month and/or active infections evaluated by clinical status.
Diagnosis of deep vein thrombosis was documented in the past with venography or
duplex ultrasound. The protocol was approved by the medical ethics review com-
mittee. All subjects were informed about the purpose and consequences of this
study, and gave their informed consent.
In all patients a standardized clinical and physical examination was performed with
special attention to signs and symptoms of venous insufficiency of the leg. A punch
biopsy with a diameter of 4 mm was taken at the median side ot the ankle region or
one centimeter outside the border of the ulcer. All punch biopsies were taken
under local anesthesia with 1% lidocaine. The biopsies were fixed in 10% phos-
phate-buffered formalin, processed by routine histological procedures and embed-
ded in paraffin for further processing. Paraffin section (4 (im) were stained with
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hematoxylin and eosin and used for histochemical evaluation of pathologic
changes in the epidermis, dermal capillaries, and the presence of capillary loops.
The clinical status of the leg was classified according to the consensus report of the
American Venous Forum in 1994, also known as the CEAP classification'*'. In this
classification the clinical signs and symptoms are graded 0-6. In the C classes we
compared the results of C5-6 (leg ulcer group) with C0-4 (the control group). The
control group consisted of patients without a history of venous leg ulcers.
Paraffin sections (4 um) were mounted on superfrost microscope slides
(Menxel-Glascr; Braunschweig, Germany). The sections were dewaxed and
rehydratcd, the sections underwent a microwave pretreatment with citric acid for
20 minutes tor the PAI-I, tPA and uPA staining. The skin biopsy tissue sections
were incubated with 10% normal calf serum for 10 minutes and then incubated for
2 hours with primary antibodies (nuinne Anti-Human PAI-1 (Ali 3H0); goat
Ami-Human tPA (AB3N7)(Anieruan Diagnostic.!, Greenwich, CT) or rabbit
Anti-I luiiun uPA, (I )AKO, Glostrup, Denmark). The immunostaining was done
in accordance to the protocol as described by Ferrier et al. (20). For the vWF stain-
ing, sections were pretreated with pepsin (1 ing/ml in 0.01 N HC1) for 30 minutes
room temperature. Then the sections were incubated for 30 minutes with the
vWF antibody (DAKO). After the first antibody step, the sections were washed
and incubated with biotinylated secondary antibodies for 30 minutes. Subse-
quently, the sections were incubated with alkaline phosphatase-conjugated ABC
incubation (DAKO) for 45 minutes and Vector Ked substrate kit (DAKO) to
localize the specific binding of the antibodies. Sections were counterstained with
Mayers' hematoxylin (Merck: Darmstadt Germany) and mounted (Imsol mount-
ing medium; Klinipath, Duiven. the Netherlands).
C/<i.<.<i7i<"iJf/<'H (>/ f//c i'»»»Hi<»('.<fi»'H/'m; .WIJ;M/
The imimmostaining signal was evaluated using bright field microscopy. Signal
strength was assessed using a score system with a five point scale: (-), no detectable
specific signal; (±), signal occasional in vascular structures; (+), specific signal in
limited amount of vascular structures; (++) specific signal in moderate amount of
vascular structures; (+ + + ), specific signal in all vascular structures, extending from
the capillaries into the surrounding matrix. All specimens were evaluated blindly.
To check the reproducibility. the slides were examined by two independent
observers, in case of disagreement another observer adjudicated.
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The paneni of vasculansation was assessed on vWF stained tissue sections using
bright field microscopy. All capillary loops in the papillary demus of the skin were
counted over the whole length of the biopsy. The numbers of counted capillary
loops were normalized by epidermal length of the evaluated tmtological section.
Statistical analyses were performed with the software package SPSS 11.5. The
degrees ot staining (ordinal scale) between control and leg ulcer group were com-
pared with chi-square test for trend, while comparison for the CEAP categories
were calculated with Somer's I), a bidirectional test for trend"' The difference in
number of capillaries seen in the skin biopsies of control and the leg ulcer group
were analyzed with the Mann-Whitney U test, because of small groups exact
significances were calculated. The independent sample t-test was used to calculate
differences in age and history of deep vein thrombosis for the control and leg ulcer
group.
RESULTS
(7/<ir<j(7cn'.s7iV.<.
Eighteen subjects were included in this study; their demographic characteristics .ire
presented in table 1. Nine women and nine men with a mean age of 56 + 14 years
were included. To evaluate the microvascular changes in more detail, we divided
the varying degrees of venous insufficiency into two major groups, namely leg
ulcer and controls. Eight patients were known with present (n = 6) or prior (n = 2)
leg ulcer (mean age 62116 years) and 10 patients had various degrees of venous
insufficiency and no history of leg ulcers (mean age: 52±l 1 years). In the control
group 3 patients had no venous insufficiency (CO), no ("1 was classified, classifica-
tion in ("2, C3 and C4 was found in 2, 2 and 3 patients, respectively.. The differ-
ence in age was not statistically significant between the leg ulcer and the control
group (p = 0.153).
5toiniHf> rrcn/fs ofrfcmift/ IM fdrioiu rfrjjrm o/"wwoi« iM5i< i^n'fMfy
Results of the staining signal are presented in table 1. Analysis of difference in the
amount of signal from vWF. uPA. and l'AI-1 between (!EAP classes (CO-6) sho-
wed statistically significant increases in staining with more severe chronic venous
insufficiency, p = 0.06, p = 0.005 and p = 0.02, respectively. The staining with
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Table 1 I )emographic characteristics of the patients in the control and leg ulcer group and the results of
immunostaining of the skin biopsies of the lower extremity with PAI-1, uPA, tPA and vWF .
CHAP Age Documented Blood
DVT vessels
VWF uPA PAI-1 tPA
Control group
CO
CO
CO
C2
C2
C3
c:.3
C4
CM
C4
Leg ulcer group
CS
CS
C6
c:6
c:6
C6
CO
CO
p-values of coni|
between control
leg ulcer group
49
30
36
51
53
62
54
66
53
63
60
43
76
82
60
79
37
60
i.irison
.mil
0.15*
no
ye»
no
no
ye»
no
no
ye»
ye»
y«
no
ye»
no
no
ye»
no
ye»
no
0.02*
80
25
35
56
24
71
OH
19
75
19
5
81
59
inn
III)
K9
120
42
(1.07**
NA
NA
0 .04* * 1.02*** 0.09*** 0.50***
* independent T-s.unple test ** p = 0.101 after correction for biopsy length. ***non-parametnc test
(M.inti Whitney U test) NA = not available
tl'A showed no association (p = 0.30) with more severe chronic venous insuffi-
ciency.
/or /<;tj i</cer
In addition, we also analyzed for difference between leg ulcer and control groups.
In photo 1 a-d the different staining results with ul'A. tl'A, PAI-1 and vWF in a
patient from the leg ulcer group are given. The amount of staining with vWF, and
ul'A showed a statistically significantly difference between both groups, p = 0.04
and p - 0.02. respectively. The amount of staining signal of l'Al-1 showed a trend
to significant difference, p = 0.09. The staining with tPA showed no difference
(p = 0.50) between both groups.
Photo 1
Photo 2
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In the severe chronic venous insufficiency group vWF staining revealed a pattern
of staining in the capillary with extension into the surrounding matrix. Photo 2
shows a picture of staining results with vWF in one of the patients of the venous leg
ulcer group. In patients with leg ulcer or prior leg ulcer a strong increase of the
number of capillaries with tortuous capillary loops in the papillary dennis was seen
as compared to control patients (CO-4), where a more regular pattern of vascu-
larisation was seen. Moreover in progressive venous insufficiency microscopically a
pattern of areas with only a few or no capillaries (photo 2 #) and tortuous capillaries
were seen (photo 2 *). The number of vessels in the leg ulcer group compared to
controls showed a trend toward statistically significant increase (M-W test, p =
0.10).
DISCUSSION
In skin biopsies of the lower extremity of patients with venous insufficiency, inten-
sity of depositions ot vWI\ l'AI-1 and ul'A in the capillary wall of the capillaries in
the papillary dermis was elevated with increasing severity of the venous insuffi-
ciency. In a previous study we suggested that venous pressure influences the endo-
(lu'li.il system .mil in this w.iy gives rise to increased vWF levels"*. While ul'A was
statistically significant increased, we observed no difference ot tl'A staining
between groups. This is in line with the ul'A and tl'A staining results of Herouy et
al. in patients with venous leg ulcers". Evidence from transgenic and knockout
mouse studies suggests that ul'A and tl'A can form plasmin from its inactive precur-
sor plasminogen and that either activator can compensate for the other*. In another
mouse study it was found that the ul'A supplied sufficient fibrinolytic potential to
clear fibrin deposits and support wound healing without the benefit of ul'A or tl'A""*.
In mice with a disrupted plasminogen gene, dermal wound healing was associated
with impaired keratinocyte migration, but an intact inflammatory response"^.
The positive association of the severity of chronic venous insufficiency with the
immunostaining results of l'AI-1 and vWF. both of which are released by endothe-
lial cells, points to possible endothelial perturbation in patients prone to leg ulcers.
We suggest that apart from the genetic risk profile of venous thromboembolism
leading to macro and microthrombi. an additional effect, probably from venous
hypertension leads to endothelial damage of the microcirculation. This may con-
tribute to a higher concentration of vWF, ul'A and l'AI-1 and can lead to
micro-thrombi and initially insufficient fibrinolytic response in the micro-
circulation of the skin. Increase of vWF leads to hypercoagulation in the
microcirculation. Evidence for this can be found in an linmunohistochemical
study, where the amount of microthrombi in capillaries of the skin at the median
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ankle was highly statistically significantly increased (p < 0.001) in patients with
severe chronic venous insufficiency'*. In line with these findings and in intravital
fluorescence videomicroscopy as well, microthrombi were found in skin capillaries
of the lower extremity^".
Another intriguing phenomenon is the strong increase in the numbers of capillaries
with tortuous capillary loops in patients with severe chronic venous insufficiency.
We suppose this increased amount of capillaries is not due to active proliferation
but to an elongation and tortuous deformation of single capillaries. (loal ol our
study was to investigate in more detail coagulation and fihrinolytu protein
response of the capillaries. So, we haven't done research of the above mentioned
problem. Future research is needed to look more in detail which part of capillary
formation is due to elongation and which part is due to proliferation. Possibly,
changes of the capillaries could be either influenced by the viscosity of the blood or
by high shear stress forces. Studies of cultured endothelial cells have shown that
shear stress forces elongate and align cells in the direction of flow. The shear stress
forces at the capillary wall is related directly to flow velocity and inversely to capil-
lary diameter: thus high shear stresses occur when blood flows rapidly in narrow
capillaries^. At present nothing is known about the relationship between high
shear stress forces and the increased expression of uPA. I'AI I and vWF at the cap-
illary wall in the skin.
The small group of patients used is one of the limitations of our study. Our study
population was small and heterogeneous, possibly an additional explanation might
be the presence of congenital or acquired thrombophilia. In patients with venous
leg ulcer higher proportion of thrombophilia was found, which might indicate a
higher risk of (previous) venous thromboembolisnr""*". Another limitation is the
age difference; acquired alterations in haemostatic parameters can be the result of
both thrombotic events and aging. Indeed, aging is associated with an increased
risk of leg ulceration, which may be due to physiological alterations of the
haemostatic system or the capillary wall. On the other hand, our leg ulcer group
was not statistically significantly older than the control group. Also, it is unlikely
that any selection bias influenced the assessment of the different coagulation and
fibrinolytic parameters of chronic venous insufficiency. In a former study of our
group, age and gender matched patients with a history of deep vein thrombosis
were demonstrated to have increased PAI-1 and vWF levels"*.
In conclusion, in skin biopsies of the lower extremities of patients with severe
venous insufficiency, increased deposits of vWF, PAI-1 and uPA were found in
the capillaries. This points to a local imbalance in coagulation and fibrinolytic sta-
tus, which might contribute to impaired microcirculation and finally to the devel-
opment of venous leg ulceration.
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Chapter 12
Epilogue and future research
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CLINICAL ASPECTS
The occurrence of the post-thrombotic syndrome may dramatically affect the
long-term quality oflife' and places strain on health care resources. There is a great
need for furnishing information to both health care professionals and patients in the
area of post-thrombotic syndrome.
The definition of post-thrombotic syndrome is still under debate. Our first step
was to evaluate definitions of the post-thrombotic syndrome. We discussed the
well-known definitions and presented a pictorial guide for the clinical characteris-
tics. The next step will be to evaluate the usefulness of the definition of Frandoni in
daily practice. We expect this definition is a good tool for classification of chronic
venous insufficiency as well. Validation of the definition of Frandoni for clinical
severity of chronic venous insufficiency has not yet been done and will be neces-
sary. Ideally. •» clinical assessment should be accompanied by an objective test that
establishes the presence of the post-thrombotic syndrome. The underlying
pathophysiological feature of the post-thrombotic syndrome is ambulatory venous
hypertension. We have shown that experts in the field give different interpreta-
tions of invasive ambulant venous pressure measurement. Hence, a first step would
be to establish clear guidelines for the performance and interpretation ot this test.
Only after that, can non-invasive tools be developed and validated with the opti-
mised invasive venous pressure measurement.
Trcrtf/MCHf <i«rf /wt'ff»rieH in'f/i f/ii'rrt/)fH/ir r/<wf/V .«tort»««».«
Elastic therapeutic compression stockings prescribed shortly after the diagnosis of
deep vein thrombosis successfully reduced the development of a post-thrombotic
syndrome by approximately 50%". As shown in chapter 7, the overall use of elastic
compression stockings led to a significant reduction, OR 0.31 (95% Cl 0.20-0.48)
in the occurrence of the post-thrombotic syndrome. Although these data are avail-
able, still not all physicians incorporate the routine prescription ot elastic stockings
in their treatment of venous thromboembolism.
In daily practice, patients with deep vein thrombosis should be instructed to wear
compression stockings. However, there is a huge diversity in treatment among
physicians. In a survey among general practitioners concerning the general man-
agement of deep vein thrombosis, compression therapy was not mentioned'.
Among dermatologists, m the initial, acute phase after deep vein thrombosis, treat-
EWUXiUE 135
ment consists mostly of compression bandages and in the maintenance phase elastic
compression stockings are applied"*. Ambulant therapy tor deep vein thrombosis
gives a faster resolution of pain and swelling. The nsk of pulmonary embolism is
not significantly increased by this approach*. As soon as the leg circumference has
reduced, several steps sliould be taken: prescription of stockings specifying brand
and classes; instructions about how to put on the stockings and about mobilization
at home and what exercises are advised. Furthermore, it is generally known that a
substantial proportion of patients do not get stockings prescribed or do not wear
their stockings very regularly since the wearing of compression stockings can be
troublesome in daily lite due to discomfort, warmth, transpiration and adverse cos-
metic appearance. This was continued in our survey of dermatologists: 47% of the
respondents estimated that the compliance is 3<>-7(>%. 41% estimated the compli-
ance < 30% and 12% more than 70%"*. Additionally, after a certain period of time,
the stockings will be frayed and worn and the prescription ot new stockings will be
necessary. However, in the Netherlands, the prescription of new stockings is
mainly not based on signs of wear, but occurs after standard periods, which are
contracted for in the insurance policy. Due to the diversity of treatment, there
seems to be room for improvement. There is little evidence concerning how last
alter the deep vein thrombosis stockings should be applied. In daily practice, it is a
difficult business to decide which stocking should be prescribed for the individual
patient. Every brand has its own different characteristics in hysteresis, slope or still-
ness factor, pressure exerted at the ankle region, knitting of the stocking (round- or
flat-knitted), and quality of material (silk, cotton, lycra, rubber).
PATHOPHYSIOLCXIY
The underlying pathophysiological feature of the post-thrombotic syndrome is
ambulatory venous hypertension, this is for a large part created, in addition to per-
sistent venous obstruction and impaired microcirculation, by valvular destruction
in the thrombosed venous segments'". Differences in the extent of thrombus reso-
lution leave a variable degree of vein damage, which results in ambulatory venous
hypertension. Despite these consequences, prevention of the post-thrombotic syn-
drome often receives little attention. Only a limited number of studies have been
performed to identify risk factors for the post-thrombotic syndrome. The develop-
ment of ipsilateral recurrent deep vein thrombosis was strongly associated with the
risk for the post-thrombotic syndrome (hazard ratio 6.4; 95% C"I 3-13)'. This find-
ing was continued by a study of Van Dongen et al. who also found an increased risk
(OR 8.5; 95% CI 3-29) for patients with an ipsilateral recurrent event". This find-
ing is consistent with the notion that the post-thrombotic syndrome is a conse-
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quence of venous damage and obstruction. Additionally, Van Dongen et al.
observed that patients who spent a large amount of their time at less than the thera-
peutic range of vitamin K anticoagulant therapy had an almost three time higher
risk for the post-thrombotic syndrome. One of the causes of this period of
under-treatment could, be non-compliance of the patient with the vitamin K anti-
coagulant treatment, which could be a lead for further research for the prevention
of the post-thrombotic syndrome. However, several studies about the relationship
between compliance and therapeutic quality could not show statistically significant
differences. Another antithrombotic therapy, thrombolytic therapy, offers the
promise of dissolving the thrombus within the deep venous system, restoring
patency and preserving valve function, which would lead to the prevention of the
post-thrombotic syndrome'. Indeed, long-term follow-up of patients who had
participated m a randomized trial on comparing thrombolytic with conventional
anticoagulant management suggested that venous valve function can be maintained
and the incidence of the post-thrombotic syndrome be reduced with thrombolytic
therapy'". Unfortunately, thrombolytic therapy carries a three time higher risk for
bleeding complications compared to conventional anticoagulant therapy. More-
over, in a decision analysis," the potential beneficial effect of thrombolytic therapy
to prevent the post-thrombotic syndrome did not outweigh the effects of compli-
cations of this therapy.
Knowledge about the local pathophysiological changes in the different stages of leg
symptoms after deep vein thrombosis is lacking. Although the precise
microcirculatory events leading to venous ulceration have not been determined,
there is general agreement that persistent elevation of ambulatory venous pressure
is the driving force leading to the microcirculatory changes associated with venous
ulceration. Alterations in cutaneous microcirculatory physiology accompany the
formation of a venous ulcer'^. Pericapillary fibrin deposition, alterations in
tibrinolysis and/or plasminogen activation, and microcirculatory leukocyte trap-
ping (with associated cutaneous capillary and lymphatic destruction) all appear to
interact in a complex and incompletely defined manner to produce local condi-
tions conducive to ulcer formation.
Several treatment modalities are used to speed up the healing of leg ulcers, such as
topical application of Sulodexide'\ a glycosaminoglycan and Factor XIII
(antitibnnolytic) '"*•'*. Furthermore, an increased rate of ulcer healing occurred in
patients receiving aspirin"'. Moreover, with the introduction of new drugs (direct
thrombin inhibitors) with a more predictable phannacokinetic and phamiody-
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namic profile, or a wider therapeutic range, the quality of long-term anticoagulant
treatment will improve.
These new treatment modalities not only can be used in treatment of deep vein
thrombosis but also in chronic venous insufficiency. Markers of coagulation and
ribrinolysis in the inicrocirculation might bo a key to evaluating the potential use-
fulness of these new drugs in the treatment of the post-thrombotic syndrome.
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Summary
Chapter 1 constitutes a short introduction to the post-thrombotic syndrome
(PTS). From a dermatologist's viewpoint this syndrome seemed so simple at a first
glance. However, its complexity is highlighted by describing studies dedicated to
the diagnosis, prevention and treatment as well as the pathophysiological mecha-
nisms of this syndrome.
PART ONE
The first part of this thesis deals with the diagnosis of leg symptoms after deep vein
thrombosis. Chapter 2 shows a pictorial guide to careful physical examination of
the skin of the lower extremity. Those pictures can be used to interpret the signs
described in the various definitions of the post-thrombotic syndrome. Chapter 3
describes the interobserver variation between 3 experts by reading Ambulatory
Venous Pressure (AVP) from graphs of intravenous pressure measurements, lor
each observer the association between the presence of post-thrombotic syndrome
and the level of AVP readings was statistically significant (p < 0.001). Median AVP
readings by the 3 experts for all graphs were SI .4, 43.0 and 32.2. showing system-
atic differences in the way AVP was estimated. The random interobserver variation
was expressed as the standard deviation of the differences in readings by a pair of
experts; these standard deviations were 13, 10 and 10 mniHg, respectively. Even
though AVP readings from the 3 experts in this study seemed as correct as those
reported in the literature, there is proof of large systematic and random errors in
estimating AVP from intravenous pressure measurement graphs. It is likely that
other phlebologists would show at least similarly large measurement error. In order
to improve the situation, clear reading instructions should be devised, based on
consensus between experts in the field of intravenous pressure measurements.
Chapter 4 presents the various definitions of PTS that are used and their relation-
ships with invasive venous pressure measurement. In total 124 patients were
enrolled of whom both legs underwent a physical examination. Evaluated were the
definition of Widmer, the CEAP classification, the Venous Clinical Severity
(VCS) score also without compression therapy and the definitions according to
Prandoni and Brandjes. Comparison of none, mild-to-moderate and severe scor-
ing was done in 76 legs with invasive ambulant venous pressure measurement. In
the DVT legs, 10 (7%) to 29 (21%) were defined as severe PTS, compared to 0 to 4
(4%) in the control legs. Mild-to-moderate PTS in the DVT legs ranged from 23%
- 49%, compared to 13%. - 34% in the control legs. Overall the presence of any
PTS in the DVT legs varied from 30% (VCS without compression) to
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(Brandjes). The scoring systems of Brandjes and VCS showed a tendency towards
more legs to be defined as severe FTS. Absolute frequencies of FTS in DVT legs
were highest for the classifications according to Widmer, Prandoni and Brandjes.
Differences in proportions of any PTS calculated between DVT and control legs
varied from 18% to 39%, while odds ratios varied between 2.2 and 5.2 for the dif-
ferent definitions. The CEAF classification and definition of Brandjes show a mod-
erate relation to Widmer, K 0.53 and K 0.52, respectively. The VCS shows in all
comparisons a poor correlation (K 0.22-0.41). Frandoni has a moderate correlation
with most definitions (K 0.40 - 0.44). Although all clinical definitions of FTS were
highly statistically significantly associated with the gold standard, invasively deter-
mined ambulant venous pressure, their ability to discriminate between DVT and
control legs as well as the observed prevalence of FTS differed substantially. The
definition that combines good discriminatory power with a plausible correlation to
the gold standard was the definition of FTS according to Frandoni. Since this defi-
nition has known measurement properties, it seems to be the definition of choice
for future studies, especially if criteria for the grading of individual elements of the
scorings system were to be made explicit.
I'ART TWO
The second part of this thesis describes prevention and treatment of the
post-thrombotic syndrome. Chapter 5 summarizes the result of a postal question-
naire sent to .ill of the dermatologists in the Netherlands about the use of compres-
sion therapy in the management of deep vein thrombosis. The overall response rate
was 81%. Availability of a treatment protocol was indicated by 60%. In the acute
phase, treatment was mostly (91%) initiated by internists, in 70% of these cases, com-
pression therapy was given by the dermatologist. A clear association (p < 0.001) was
found between the use of diagnostic procedures by the dermatologist and the pre-
scription of compression therapy. Home treatment protocols were available in
50%; dermatologists were involved in only half of these protocols. The majority of
the dermatologists preferred early mobilization, 54% prescribed class III flat knitted
elastic compression stockings tor treatment. Our survey indicated that in the Neth-
erlands deep vein thrombosis generally is treated by internists. Compression ther-
apy is still not fully incorporated as a treatment to prevent post-thrombotic syn-
drome. Involvement of dermatologists in the actual management as well as the
development of standardised treatment protocols is limited. Chapter 6 deals with a
retrospective study to which extent in the past, bed rest in the care of deep vein
thrombosis and pulmonary embolism was given compared to the current situation.
To gain better insight into factors underlying the bed rest advice, appropriateness
of the patient's hospital stay was assessed by the Dutch Appropriateness Evaluation
Protocol. Only 27.1% of the treatment for deep vein thrombosis was found to be
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appropriate in a hospital setting and related to specific hospital care. The inappro-
priate stay was mostly related to delays in hospital and discharge procedures. Of the
patients with pulmonary embolism. 50.2 % needed hospital stay. This proportion
was statistically significantly higher than in deep vein thrombosis patients (p <
0.001). The extent of the deep vein thrombosis was not related to the length ot bed
rest prescribed or mortality. The Dutch Appropriateness Evaluation Protocol was
sensitive to identity' inappropriate hospital stay in the past within venous
thromboembolism patients. Chapter 7 presents a systematic review of the relative
effectiveness of, and the rate of complications in using non-pharm.ucutical inter-
ventions in patients with deep vein thrombosis for prevention of the post-throm-
botic syndrome. Three randomised controlled trials on the development of the
post-thrombotic syndrome were identified. Two studies compared elastic com-
pression stockings with a pressure of 30-40 mmllg at the ankle with no interven-
tion applied directly after the deep vein thrombosis. The other small study com-
pared elastic compression stockings (pressure 20-30 inmHg) with one to two sizes
too large stockings in patients one year after the deep vein thrombosis. The overall
use of elastic compression stockings was associated with a highly statistically signifi-
cant reduction in the incidence of any post-thrombotic syndrome with an OR of
0.31 (95% CI 0.20-0.48). Also the incidence of severe PTS was reduced with OR
0.39 (95% CI 0.20-0.76). In another randomized controlled trial regarding the first
nine days after deep vein thrombosis, no difference in pulmonary embolism and
extent of thrombus in the femoral vein was found. A statistically significant reduc-
tion (P < 0.05) of pain, swelling and clinical scores was found, favoring the com-
pression group. There is substantial evidence that elastic compression stockings
reduced the occurrence of the post-thrombotic syndrome after deep vein throm-
bosis. No serious adverse effects were mentioned in the studies. Hence, elastic
compression stockings should be added to the treatment of deep vein thrombosis
in order to prevent the development of the post-thrombotic syndrome. (ihapter 8
presents a systematic review to assess the effectiveness of compression therapy in
patients with stage I and II post-thrombotic syndrome according to the classifica-
tion of Widmer. Interventions of interest included elastic compression stockings
and mechanical devices, compared with no intervention and with each other.
Only two trials were identified that addressed physical treatment of post-throm-
botic syndrome. Both trials were initiated by the same group of investigators. A
cross-over study lasting two months compared low and high pressure with inter-
mittent compression units for severe post-thrombotic syndrome. This showed a
beneficial effect of higher pressures. The second study, in patients with mild to
moderate post-thrombotic complaints, showed no effect of elastic compression
stockings (30-40 mniHg at the ankle region) when compared to 'placebo' stock-
ings that were one to two sizes too large. We concluded that there is some evi-
dence of a beneficial effect of intermittent pneumatic compression units, but the
study was too small and of too short a duration to draw firm conclusions. Further
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research is needed in order to assess whether intermittent pneumatic compression
units give long term reduction and relief of the symptoms caused by post-throm-
botic syndrome, and prevent deterioration and leg ulceration. The use of elastic
compression stockings to treat post-thrombotic syndrome cannot be supported on
the basis of currently available data.
PART THREE
The third part of this thesis is dedicated to pathophysiological mechanisms of the
post-thrombotic syndrome. Chapter 9 reports on a young male patient with
venous leg ulcers on both legs that had been refractory for more than 3 years to
standard treatment with compression therapy. By thrombophilia screening, factor
V Leiden mutation, hyperhomocysteineinia and evidence tor impaired fibnnolysis
were found. Treatment with folk acid in combination with long term oral antico-
agulant therapy were added to non-elastic compression therapy. This combination
eventually led to healing of the leg ulcers. During a 6 years follow-up period, no
new thromboembohc events occurred, nor was there recurrence of ulcerations.
Chapter K) describes some local aspects of coagulation and fibnnolysis. After ten
minutes standing, the increase in vWF:ag (p = 0.004) in the leg was higher in
patients with previous DVT compared to age and gender matched controls. In
DVT patients with PTS systemic vWF antigen was higher in comparison to
patients without PTS. Increase in fibrinogen was statistically significantly different
in DVT and control groups, p < 0.001 and p = 0.002, respectively. Factor VIII:c,
d-dimer and l'Al-1 also increased in patients with previous DVT. The mean
increase in PAI-1 in DVT and control group was 0.9 and 0.2, respectively. The
higher increase ot vWF in the DVT group indicates, since substantial volumes are
accumulated during standing, that local endothelial dysfunction might contribute
to differences in coagulation status between patients with DVT and control sub-
jects. Chapter 1 I presents, in more detail, coagulation and fibrinolytic protein
response of the capillaries in skin biopsies of the lower extremity in patients with
and without venous insufficiency. The amount of staining with vWF (p = 0.04)
and uPA (p - 0.02) showed statistically significantly differences, PAI-1 (p = 0.09)
and tPA (p = 0.50) showed no difference between leg ulcer and control groups. An
increase of the number of capillaries with tortuous capillary loops in the papillary
dennis was seen, but no statistically significant difference (M-W test, p = 0.10) was
found between the groups. Comparison between CEAP classifications showed a
statistically significant increased staining pattern of vWF (p = 0.06), uPA (p = 0.02)
and PA1-1 (p = 0.02), but not from tPA (p = 0.30). We concluded that in skin
biopsies of the lower extremities ot patients with severe venous insufficiency
increased deposition of vWF, PAI-1 and uPA were found in the capillaries. These
findings point to a local imbalance in coagulation and fibrinolytic status, which
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might contribute to impaired microcirculation and finally to the development of
venous leg ulceration. Chapter 12 gives a general overview of the clinical aspects
and the pathophysiology of the post-thrombotic syndrome. The new insights
gained with this thesis and the problems still not solved are briefly discussed.
Finally, the innovative treatment possibilities with several drugs arc described.
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Samenvatting
In hoofdstuk 1 wordt een kortc inleiding over hot post-trombotisch. syndroom
gegeven. Het post-trombotisch syndroum bcstj.it uit chronische kl.ichten en
Symptomen na een doorgemaakte diep veneuze troinbose. Dcnnatologisch be/ien
leek het aanvankelijk een dindelijk probleem. Er zijn echter nog veel onduidelijk-
heden over de diagnose, de preventie, dc behandcling en de pathofysiologische
aspecten.
HEEL EEN
In het eerste deel Staat de diagnose van beenklachten na een diep veneuze troin-
bose centraal. Hoofdstuk 2 geeft een beschrijving van de huidafwijkmgcn die
voorkomen in de verschillende defmities voor het post-trombotiscli syndroom. In
hoofdstuk 3 beschnjven we de verschillen tussen drie experts in het .itlezcn van de
ambulant veneuze druk (AVP) uit grafieken, verkregen bij intraveneuze drukme-
ting. De associatie tussen de diagnose post-trombotisch syndroom en de w.i.irdc
van de AVP was statistisch significant (p < 0,0(11). Mediane AVI' waardeu voor de
drie experts van alle grafieken waren respectievelijk 51,4; 43,0 en 32,2 mini Ig. I )it
toont systematische verschillen aan in de beoordeling van AVI'. I )e toevallige tout
tussen de verschillende beoordelingen van de drie experts, werd uitgedrukt als de
standaard deviatie van de verschillen tussen de afleeswaarden bij een combinatic
van twee experts, deze waarden voor de standaarddeviaties waren 13, 10 en 10
inmHg. Hoewel het aflezen van de AVP door de drie experts even correct lijkt als
de afleeswaarden beschreven in de literatuur, is er bewijs voor grote systematische
en toevallige fouten in het beoordelen van de AVP. Het lijkt aannemclijk dat
andere tlebologen een minstens even grote beoordelingstout /ouden kimnen
maken. Om deze situatie te verbeteren is het ontwikkelen van duidelijke aflecsin-
structies voor AVP in grafieken gewenst. Hoofdstuk 4 vermeldt de verschillende
klinische defmities voor het post-trombotisch syndroom en hun relatie tot de
AVP. Bij 124 patienten met een voorafgaande diep veneuze troinbose werden
beide benen beoordeeld met de volgende defmities: de classificaties van Widmer,
CEAP, de Venous Clinical Severity score (met en zonder compressietherapie),
defmities volgens Brandjes en Prandoni. Vergelijking van geen, nuld-tot-matig en
ernstig post-trombotisch syndroom met de gemeten AVP waarde werd voor 76
benen gedaan. Van de trombosebenen werd 10 (7%) tot 29 (21%) gedefinieerd als
ernstig PTS, vergeleken met 0 tot 4 (4%) in de controle benen. Mild-tot-matig
ernstig PTS in de trombosebenen verschilde van 23%-49%, vergeleken met
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13%-34% in de controle benen. De prevalentie van PTS in de trombosebenen
varieerde van 30% (VCS zonder therapie) tot 66% (Brandjes). De scores met de
definitie van Brandjes en VCS toonden een tendens tot ernstig PTS. Absolute fre-
quenties van PTS in trombosebenen waren het hoogst voor de classificatie van
Widmcr, Prandoni en Brandjes. Verschil in aantal PTS berekend tussen trombose-
en controlebenen varieerde van 18% tot 39%, (odds ratios 2,2-5,2) voor de ver-
schillende definities. The CEAP classificatie en definitie van Brandjes toonden een
gemiddclde relatie tot Widmer (K 0,53 en K 0,52).De VCS toonde in alle vergelij-
kingen ecu inatige correlatie (K 0,22-0,41). Prandoni had een gemiddelde correla-
tie met de ineeste definities (tc 0,40-0,44). Hoevvel de klinische definities van PTS
een statistisch significante associatie tonen met de gouden standaard (AVP), zijn de
vcrschillcn die door de definities tussen trombose- en controlebenen worden aan-
gcbracht en de prevalentie van PTS substantieel verschillend. De definitie van
Praudoni gat een duulelijk verschil in vvel/niet PTS met een adequate correlatie tot
de gouden standaard. Deze definitie is gevalideerd en lijkt hiermee een goede
leidr.i.id voor toekomstige studies. Het is zeer belangrijk um de gradering van de
verschillondc elementen van de definitie duidclijk to omschrijven.
HEEL TWEE
In het tweede deel worden preventie en behandeling van PTS beschreven. Hoofd-
stuk 5 geeft de resultaten weer van een schriftelijke enquete onder alle dennatolo-
gen in Nederland over het beleid rondoin diep veneuze trombose en de plaats van
conipressietherapie. We hadden een respons van 81% van de dermatologen. De
aanvvezigheid van een behandelingsprotocol voor DVT werd aangegeven door
60%. De behandeling in de acute situatie word in 91% gedaan door internisten. in
70% van doze situatios werd conipressietherapie gegeven door de dennatoloog.
Indien de dennatoloog zeit diagnostisch onderzoek verriehtte bleek dit statistisch
significant (p < 0,001) gecorreleerd met het voorschrijven van conipressietherapie.
Een protocol voor thuisbehandeling was in 50% aanwezig, slechts bij de helft hier-
van was de dennatoloog betrokken. De ineeste dennatologen geven de voorkeur
.i.in vrooge tnobilisatie, 54"» schrijft klasse III kousen voor. Deze enquete liet zien
il.it mternisten in Nederland de hoofdbehandelaars waren. De dennatoloog werd
onvoldoendc betrokken in de actuele therapie als ook in de ontvvikkeling van pro-
tocollen voor behandeling. Conipressietherapie als preventie voor de ontwikke-
ling van P IS was onvoldoende opgenoinen in de behandeling van DVT. Hoofd-
stuk 6 is een retrospectieve Studie waannee terecht verblijt'in het ziekenhuis voor
zowel 1)VT als longembolie werden beoordeeld met het Appropriateness Evalua-
tion Protocol (AFP), aangepast aan de Nederlandse situatie. AEP toonde aan dat in
slechts 27.1% van de DVT er een noodzaak was voor verblijt" in het ziekenhuis.
I let onterechte verblijt"werd vooniamelijk veroorzaakt door vertraging in zieken-
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huis- en ontslagprocedures. De longcmbolie patienten blijken in 50,2% terecht in
het ziekenhuis te verblijven. Hit verschil was statistisch significant hoger (p <
0,001). De hoogte van de troinbose was noch aan de duur van bednist nodi aan de
murtaliteit gerelateerd. De aangepaste AE1' was sensitief voor het identificeren van
onterecht verblijf. Hoofdstuk 7 is een systematische review naar de relatieve ctVec-
tiviteit en de mate van complicaties van niet inedic.imcntcu7c behandelingen bij
paticnten met DVT, ter preventie van het ontstaan van l'TS. Dne gcrandomi-
seerde gecontroleerde studies naar de ontwikkehng van het PTS werden gevon-
den. In twee studies werd gccn interventie vergeleken met het gebruik van elasti-
sche therapeutische kuusen (3O-4OmmHg enkeldruk) direct na de DVT. l)e
andere kleinere Studie vergeleek bij paticnten 1 jaar na de 1)VT, elastisch therapeu-
tische kousen (2O-3OmmHg enkeldruk) inet 1-2 nuten te grote kuusen. In de ana-
lyse bleek dat het gebnuk van elastisch therapeutische kousen statisch significant
geassocieerd was met de incidentie van l'TS met een OR 0,31 (95% Cll
0,20-0,48). Ook de incidentie van ernstig l'TS venninderde inet OK 0,39 (95%
CI 0,20-0,76). In een andere gerandonnseerde gecontroleerde Studie die de eerste
9 dagen na DVT beoordeelde, werd geen verschil in de incidentie van longembu-
lie en uitbreiding van de trunibusinassa in de vena temoralis gevondeu. In de/e stu-
die werd in de compressietherapie groep een statisch significante vennindering (p
< 0,05) van de pijn, zwelling en klinische verschijnselen gevonden. Wij conclu-
deerden dat er voldocndc bewijs is dat het dragen van elastisch therapeutische kou-
sen gedurendc 2 jaar na een DVT de incidentie van het l'TS vermindert. 1 iootd-
stuk 8 is een systematische review naar de erlectivitcit van compressietherapie in
patienten met een stadium I uf II l'TS volgens de criteria van Widmer. In de verge-
lijking werden elastisch therapeutische kousen en mechanische compressieinachi-
nes vergeleken met geen interventie en met elkaar. Slcchts twee studies van
dezelfde onderzoeksgroep voldeden aan de criteria. In een cross-over Studie werd
een intermitterende compressiemachine met een läge (15 mm Hg) en hoge (60
mm Hg) druk vergeleken bij patienten met een ernstig l'TS. Er was een verbete-
nng in de behandeling met de hoge druk. De andere Studie vergeleek elastische
kousen (30-4()mm Hg enkeldruk) inet placebokousen in patienten met mild-tot
matig ernstig l'TS. We concludeerden dat er enig bewijs is van het effect van een
intermitterende compressiemachine, maar dat de Studie te klein was en slcchts 2
maanden duurde. Het gebruik van elastisch therapeutische kousen voor de
behandeling van PTS kan met de huidige beschikbare gegevens niet worden
onderbouwd.
DEEL DRIE
Het derde deel is gewijd aan pathofysiologische aspecten van het l'TS. Hoofdstuk
9 geeft een beschrijving van een jongeman. die ondanks adequate compressiethe-
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rapic cen zccr matige genezingstendens van ulcera cruris (open benen) vertoonde.
Iiij trombofilie onderzoek werd factor V Leiden, hyperhomocysteinemie en een
verhoogde fibrinolytische respons gevonden. Na toevoegen van foliumzuur en
orale antistolling aan zijn behandeling, genazen de ulcera. Hoofdstuk 10 geeft een
beschrijving van lokale aspecten van coagulant- en fibrinolyse. Na 10 minuten
staan blijkt het verschil in stijging voor vWF:ag (p = 0,004) hoger in DVT patien-
ten vergeleken met controles van dezelfde leeftijd en geslacht. Bij degenen met
ITS van de I >VT groep, was de hoogte van het vWF in de circulatie hoger. Ver-
hoogd fibnnogeen was statistisch significant verschillend in de DVT en de controle
groep, p < 0,001 en p = 0,002. Factor VIII:c, d-dimeren en PAI-1 waren ook
hoger in de DVT groep. De gemiddelde verhoging in PAI-1 in de DVT en de
controle groep was 0,9 en 0,2. CJezien het veneuze volume dat zieh in het been
bevindt gedurende staan, is er een forse stijging van vWF in de DVT groep. Endo-
thcel disfunctie kan hierdoor een mogelijke bijdrage leveren in de verschillen in
coagulatie tussen DVT en controle personen. Hoofdstuk 11 is een histopatholo-
gischc studie w.i.irbij coagulatie en fibrinolytische readies op het niveau van de
capill.nrcn werd bekeken in liuidbiopten van het onderbeen van patienten met en
zonder veneuze insutFicientie. De mate van aankleuren met vWF (p = 0,04) en
ul'A (p = 0,02) toonde statistisch significante verschillen. PAI-1 (p = 0,09) en tPA
(p " 0,50) waren niet verschillend in de ulcus en controle groep. Er was een ver-
hoogd aantal capillairen met kronkelende uitlopers in de papillaire dernus zicht-
baar, maar niet statistisch significant verschillend (M-W test, p = 0,10) tussen de
groepen. Vcrgelijking tussen de verschillende CEAP klassen toonde een statistisch
significant verhoogd aankleuringspatroon voor vWF (p = 0,06), uPA (p = 0,02) en
PAI-1 (p = 0,02), maar niet voor tPA (p = 0,30). We concludeerden dat bij pati-
enten inet chronisch veneuze insufficientie in de microcirculatie van de huid ter
hoogte van de enkel, vWF, PAI-1 en uPA in verhoogde mate tot expressie komen.
De/e bevindingen kunnen wijzen op een lokale verstoring van de balans tussen
coagulatie en fibrinolyse, wat kan leiden tot verandenngen in de microcirculatie en
tenslotte tot een ulcus cruris. Hoofdstuk 12 is een overzicht van de klinische aspec-
ten en de pathofysiologie van het post-trombotisch syndroom. Nieuwe inzichten
verkregen door dit proefschnft en de nog op te lossen problemen worden kort
besproken. Tenslotte wordt nog een korte introductie van mogelijke
medicamenteuze behandeling gegeven.
Dankwoord
Bij het tot stand komen van een proefschrift zijn lioel voel monson direct on indi-
rect betrokken. Hot persoonlijk bedanken van loderoon. die eon stcont|e aan imjn
proefschnft heeft bijgedragen, is wolhaast onmogclijk. Hot waren or velen. Ik ga
proberen om zoveel mogelijk mensen te noemen. Allercerst natuurlijk alle pati-
enten en proerpersonen die hebben doelgenomon aan mijn studios. Hot contact
met u, jullie was geweldig leuk. do boroidhoid om moo te werken was fantastisch.
Het post-trombotisch syndrooni is eon probleem waar nog veel onder/ook n.i.ir
gedaan moet worden. Doorjullie bereidheid om vragenfonnulioron in to vullen en
de vele metingen te laten verrichten is er weer een klein dool van do puzzel inge-
vuld.
Bij mijn promotio hceft mijn promotor prof.dr. M.H. Prins de belangrijksto n>l
gespocld, beste Martin, het werken met jou is heel stimulerond, je hobt eon gewol-
digo kennis op hot gobiod van do opidoiniologio on do veneuze tromboembolio in
het bijzonder. De wijze waarop je mijn ideeen op dit gebied ondersteundc lioelt
mij docn groeien in dit wetenschappelijk onderzoek. l)e nauwkeurighoid on snel-
heid waanneeje mijn artikelen corngeerde zijn onvoorstelbaar. I lot voort/etten
van onze samenwerking verhougt mij dan ook zeer.
Prof.dr. H.A.M. Neumann, beste Martino, je geloofde in mij, was vanaf onze cer-
ste kennismaking bereid om in mij to investeren. Mijn wens om to promovcrcn
heb lk in do lange periode tot aan hct atrondon van mijn opleiding als dormatoloog
uiteindelijk toch gerealiseerd. Jouw visie op het post-trombotisch syndroom en je
ideeen over microcirculatic liggen ten grond.slag aan dit proefschrift. Dank voor
het vertrouwen in do goodo afloop.
Mijn co-promotor dr. K. Hamulyäk, beste Karly, al die jaren gafjc mij adviezen en
corrigeerde mijn artikelen, jouw vertrouwen heeft me gesteund.
For prof.dr. H. Partsch: Dear Hugo, Thank you so much for taking part in my
committee. I would like to gratefully acknowledge your invaluable assistance
because you are the export on the post-thrombotic syndrome. You began as one of
the first research-workers in the field of phlebology; you have continued to do
research on ambulant compression therapy for many years; and moreover, you
understand the importance of the statistical analysis of data. I am very pleased to
have had your help as expert and co-author of chapter 3. In my forthcoming pro-
jects, I will take your suggestions into account with respect to the definition of
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how to read AVF measurements. I'm thankful that our cooperation in research will
carry on.
Frof.dr F.M. Steijlen, beste Peter, bedankt voorje begrip en de ruimte die je me
gelaten hebt om te promoveren. Dat jij de voorzitter van mijn beoordelingscom-
missie bent, stel ik erg op prijs.
Frof.dr. H. Duller, bedankt voor uw bereidheid om in mijn beoordelingscommis-
sie zitting te neinen. Dat u daarna ook nog op het symposium spreekt vind ik
geweldig.
Frof.dr. H. ten Gate, beste Hugo, in de laatste fase van mijn onderzoek ben je in
Maastricht gekomen, waar je als lid van de beoordelingscommissie je visie over
mijn proefschrift hebt gegeven. Hopelijk zullen we in de toekornst samen verder
werken aan onderzoek op het gebied van het post-trombotisch syndroom. De eer-
ste stap is het symposium.
Dr. E.M.J. lie Doer, beste lidith, jij hebt mijn enthousiasme voor de dennatologie
gewekt. Ik vind het dan ook heel bijzonder dat je in mijn corona zitting hebt.
Prot.dr. J.I 1. Kuiper, bedankt voor uw snelle en accurate manier van samenwerken
in liooldstuk 3.
Fieter Letters, het was erg leerzaam en aangenaam om met je van gedachten te wis-
selen, bedankt voor je hulp.
Kene van Ocrlc. dankzij jou heb ik een beter begrip van de stolling. Je hebt me
fantastisch geholpen. De bloedafnames bij de invasieve dnikmeting waren samen
met jou vecl getnakkelijker te doen.
Bert Fanis, onze kennismaking was heel bijzonder. Je was er als de kippen bij toen
je hoorde dat ik gebruik ma.ikte van DAEF criteria voor mijn onderzoek. We
besloten s.unen verder te gaan, vvaarna je opnieuw alle statussen doorkeek, waar-
door het echt jouw onderzoek werd. Toen je ook nog dezelfde proinotor bleek te
hebben, word ons contact nog intensiever.
Jacques Cleutjcns, na eilige oinzwervingen van mijn biopten kwam ik bij jou
terecht met mijn vraagstelling. Het zoeken van de juiste antilichamen kostte tijd,
die vve gezamenlijk in het laboratorium doorbrachten. Daarna samen met Goby de
finale proeven. Bedankt voor jullie hulp. Graag doe ik bij volgende studies weer
een beroep op julhe.
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Lidwine Tick, de Mega-PTS Studie bracht ons samen. Een gedeelte van de
metingen voor mijn dw arsdoorsnede onderzoek heb je samen met nuj. Kia Sand-
brink en Daniel Oser gedaan. Helaas door alle problemen rondom de validatie en
het faillissement van Domed zijn deze resultaten nog niet verwerkt. Toch bedankt
voor je hulp en steun bij mijn onderzoek.
Ria Sandbnnk, mijn paranimf. je bent geweldig. Jouw aanbod om mij to helpen
heb ik direct omannd. Je onuitputtelijke kennis van excel en andere computersott -
ware heeft mij heel veel tijd bespaard. Jouw visie als bedrijfsarts op do problomen
na diep veneuze trombose leidde ertoe dat mijn onderzook oils onderzoek word.
Het is mij dan ook een groot genoegen om je straks bij jouw promotie to mögen
helpen. Ik hoop dat we nog lang vriendinnen blijven.
Caroline Vos, mijn paranimf, we zijn een geweldig team bij het organisercn van
allerlei activiteiten. Het zoveelste symposium regelen is dan ook geen problcem.
Het maken van een website? Och, dat kan Ali wol doon. liodankt voor jullie
vnendschap en do samen working op vole fronton.
Eddie Vanderweijer, een betere buurman en vnend kan ik mij met wcnsen. Do
vele evenementen die jo org.inisoerde (skivakantie, chainpagneweekend. gewoon
gezellige dingen) waren voor mij altijd woor wclkonie momenten van ontsp.mmng
tijdens de afgelopen hectische periode. Je bent een van do belangrijkste mensen uit
mijn vriendenkring. Ik stel het dan ook erg op prijs dat je de org.misatie v.in hei
feest op je genomen hebt. In feite ben jij ook een van mijn paranimfen.
Sylvia Schins en Marianne van Gemert, jullie hulp bij de dataverwerking was heel
efficient en heeft me veel tijd bespaard. Bedankt.
Mark Drcsen, als student inaakte je voor mij eon DVT database. Door do jaren
heen heb je mij geholpen bij allerlei hardware en software problemen. Ik hoop dat
onze vriendschap nog lang zal duren.
Appie Derks en Geertjan van Zonneveld, samen met jullie werken aan de foto's
was een feest voor mij. Ik ben trots op het eindresultaat. Dank voor jullie onaf-
latende inzet.
Sherne Saive: Dear Sherrie, thank you very much for your help. I enjoyed our
conversations about all kinds of problems, not just those as a dermatologist and
research-worker, but also as a mother, a wife and a woman.
Het doen van onderzoek leidt tot vele vragen, organiseren van allerlei afspraken,
verzenden van vele brieven en altijd weer opnieuw zoeken naar oplossingen.
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Oplossen van al deze problemen was alleen maar mogelijk dankzij de hulp van
Petra, Annelies, Ingrid, Nicole, Els, Kim, Lilian Kreusch, Irene van Hoof en Wil
Lokkerbol. Jullie zijn goud waard.
Anita, Marie-Paulle, Irene, Germaine, Marlene, Paulette, Frits, Janneke, Nelleke,
Brigitte, Mieke, Pascalle, Patricia, Anouk, Gerda, Anke, Fiona, en Frida wil ik heel
hartelijk bedanken voor de hulp bij mijn onderzoek en het organiseren van de
patientenstroom op de polikliniek.
Staf dermatologic en arts-assistenten, Joep, Gertraud, Anja, Judith, Monique,
Charles, Pierre, Kees-Peter, Francoise, Adrienne, Carmen, Patricia, Nicole,
Jeroen, Yolande, Saskia, DanitMle en Jose, bedankt voor de tijd en ruimte die jullie
mij voor het onderzoek hebben gegeven.
Het contact, de belangstclling en dc financiele ondersteuning van vele medewer-
kers van de farmaceutische Industrie heb ik zeer gewaardeerd. Twee niensen wil ik
in hot hijzondcr noemen: Pascal Herveille je hulp bij de nietingen was heel erg
welkoin. Dan Marc Ditmarsch, jij hebt echt indruk op me gemaakt. Nadat je me
een half nur kende was je al bereid om twee huidbiopten af te staan voor mijn
onderzoek. J.i, je beneii zal ik blijven bewonderen.
Ook de hulp en het begrip van mijn vrienden, mijn familie en schoonfamilie voor
de enorme hoeveelheid werk die promoveren met zieh meebrengt zijn hartver-
warmend. I )e bereidheid om Klaas en Adriaan op te vangen was er altijd en ik kan
iedereen daar niet genoeg voor bedanken. In het bijzonder wil ik mijn schoon-
moeder, Ankie en Adriaan, Ron en Marga, en niet te vergeten Miets bedanken. Pa
en Moeke, dat jullie trots op me zijn weet ik zeker.
Tenslotte, maar zeker niet in de laatste plaats wil ik de niet aflatende steun van
Peter noemen, zijn begrip voor mijn wens om te promoveren en de ruimte die hij,
s.imeii met Klaas en Adriaan, voor mij creeerde was grenzeloos. Ik houd van jullie.
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